data_1wr7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wr7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 12' ' ' GLY . 53.8 Cg_exo -54.28 147.21 46.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.445 1.43 . . . . 0.0 110.941 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.81 10.02 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.454 2.769 . . . . 0.0 114.159 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 10' ' ' PRO . . . -111.96 -0.18 27.11 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -104.74 128.75 52.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 110.467 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -114.96 111.31 20.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.631 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.598 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -85.53 115.4 23.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.231 0.539 . . . . 0.0 110.424 176.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -113.91 142.58 45.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.277 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 17' ' ' ILE . 2.9 mm -93.07 101.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.296 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 153.79 72.02 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.407 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.64 -16.98 16.14 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.944 2.429 . . . . 0.0 112.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -63.61 -25.99 68.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.429 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.93 -0.37 44.94 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.13 125.4 32.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.53 0.205 . . . . 0.0 111.229 -176.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.33 123.79 14.17 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.926 2.417 . . . . 0.0 111.493 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.415 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 22.0 p90 -121.22 137.52 54.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.299 0.571 . . . . 0.0 109.902 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 20.5 m-85 -101.2 112.44 24.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.477 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.56 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -100.51 119.19 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.654 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 1.1 t70 -83.41 132.41 34.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.896 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -100.77 8.57 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.415 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -88.29 -58.26 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 109.882 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 47.6 p -98.94 -23.45 15.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.845 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 78.94 70.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.904 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -129.21 166.6 19.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.574 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.428 HG21 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -128.49 109.89 11.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.664 -174.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 t -124.02 146.82 48.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.486 0.184 . . . . 0.0 110.709 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.415 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 21.6 m95 -90.25 -36.23 14.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.486 0.66 . . . . 0.0 109.398 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.93 121.51 19.21 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.754 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -61.12 115.23 13.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.409 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.4 -12.18 34.6 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.005 2.47 . . . . 0.0 113.072 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 39' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 110.355 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.71 152.77 71.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.279 1.986 . . . . 0.0 111.122 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.83 -2.19 5.11 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.918 2.412 . . . . 0.0 113.511 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.36 -11.55 59.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.588 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -99.35 111.98 24.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 110.118 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -100.59 104.19 15.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.585 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 127.54 33.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.539 0.685 . . . . 0.0 109.592 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -125.6 123.66 39.51 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.581 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 102.98 14.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.688 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.46 152.19 92.8 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.119 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.2 -4.0 2.77 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.001 2.468 . . . . 0.0 112.273 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.19 -25.39 61.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.31 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.25 5.78 48.97 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.522 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.28 120.36 47.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.458 0.17 . . . . 0.0 110.802 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.35 113.18 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.286 1.99 . . . . 0.0 111.252 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.504 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.0 p90 -111.43 135.99 51.21 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -101.16 116.4 32.73 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.597 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -102.48 113.64 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.954 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 35.9 t0 -80.65 126.37 31.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.549 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -90.16 -7.79 52.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.83 0.348 . . . . 0.0 110.521 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -82.52 -54.59 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.274 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -94.43 -12.48 27.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.45 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 1.2 mtmt 62.83 58.27 1.58 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.279 0.562 . . . . 0.0 111.076 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.7 152.75 47.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.633 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.83 112.86 18.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.693 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t -123.97 147.13 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.853 0.359 . . . . 0.0 110.877 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.504 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 48.8 m95 -91.27 -9.54 44.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.859 0.838 . . . . 0.0 109.858 177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.66 125.75 52.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.337 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -61.19 116.0 17.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.67 -16.28 50.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.561 2.84 . . . . 0.0 113.528 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 -178.647 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.529 HD11 ' CD1' ' A' ' 25' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 20.4 Cg_exo -66.68 148.84 83.67 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.109 1.873 . . . . 0.0 111.409 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -47.04 110.47 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.506 2.804 . . . . 0.0 112.724 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.06 -26.8 5.24 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.576 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 86.2 m95 -82.05 120.43 25.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.815 0.341 . . . . 0.0 110.302 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -112.84 105.35 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.444 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.41 ' HB3' HD11 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -79.15 130.58 35.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.394 0.616 . . . . 0.0 110.846 178.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.27 153.06 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.85 124.08 60.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.683 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.72 55.62 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -58.4 -11.71 11.69 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.507 2.805 . . . . 0.0 114.552 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -18.19 55.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.14 5.77 32.46 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.872 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' H ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.87 118.96 51.63 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.724 0.297 . . . . 0.0 111.2 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.57 123.81 13.06 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.745 2.296 . . . . 0.0 111.296 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.554 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 13.4 p90 -116.06 142.97 46.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.235 0.54 . . . . 0.0 109.599 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 10.9 m-85 -110.17 116.83 32.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.681 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.581 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -98.39 110.44 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.046 0.927 . . . . 0.0 110.032 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.45 126.71 31.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.394 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -98.98 6.3 46.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.332 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -88.56 -58.61 2.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.069 0.461 . . . . 0.0 109.774 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.0 p -104.38 -4.1 23.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.528 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.88 64.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.339 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.1 143.94 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.54 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -117.53 100.9 7.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.01 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.5 t -123.86 149.12 46.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.96 0.409 . . . . 0.0 111.494 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.554 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.2 m95 -96.67 5.02 51.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.55 108.68 19.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.596 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.539 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 19.7 t0 -63.19 113.75 10.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.814 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.61 -1.86 11.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.403 2.735 . . . . 0.0 112.56 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 0.0 110.04 176.812 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.37 153.01 36.32 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.569 2.179 . . . . 0.0 112.148 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.44 110.73 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.024 2.483 . . . . 0.0 112.162 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.14 -20.26 6.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.343 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 81.9 m95 -82.14 120.33 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -114.31 111.11 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.746 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.484 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.45 104.72 9.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.183 175.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 16' ' ' ARG . 27.2 mtt-85 -103.01 121.83 43.36 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.25 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mm -80.52 109.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.844 0.354 . . . . 0.0 110.271 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . . . -81.75 148.8 62.42 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.033 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.38 3.46 1.06 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.591 2.861 . . . . 0.0 114.525 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.614 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -87.38 -15.17 38.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 10.87 29.32 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.581 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -107.68 112.42 62.15 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.54 109.53 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.866 1.711 . . . . 0.0 110.659 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -105.8 125.92 51.56 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.592 0.711 . . . . 0.0 109.256 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 26.2 m-85 -91.88 109.84 21.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.156 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.439 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.87 114.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.937 178.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 118.61 21.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.035 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -91.41 6.56 44.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.335 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -95.9 -54.6 3.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.916 0.388 . . . . 0.0 110.355 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -111.89 5.02 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm 64.38 74.13 0.41 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.13 175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.58 145.4 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.492 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.439 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.75 105.17 8.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.711 0.291 . . . . 0.0 110.537 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 t -123.87 146.95 48.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -89.91 -11.35 42.08 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.759 0.79 . . . . 0.0 109.747 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.39 119.91 40.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.269 -171.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 64.1 t0 -48.32 116.87 5.31 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.057 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.38 -13.4 35.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.249 2.633 . . . . 0.0 113.517 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 39' ' ' ARG . 4.0 mtm105 . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.962 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.29 152.82 80.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.697 2.265 . . . . 0.0 112.1 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.94 116.19 2.75 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.113 2.542 . . . . 0.0 112.325 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.5 -14.38 9.31 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.933 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.403 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 60.7 m95 -88.94 94.95 10.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 110.009 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -86.84 107.39 18.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.587 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.51 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.54 122.71 27.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.403 0.62 . . . . 0.0 110.804 178.136 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -130.92 133.96 46.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.272 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -89.18 112.03 23.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.775 0.322 . . . . 0.0 110.498 -177.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.409 ' HB2' ' HZ3' ' A' ' 35' ' ' TRP . . . -79.07 152.84 77.1 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.236 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.74 -1.62 3.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.158 2.572 . . . . 0.0 112.504 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -75.16 -23.62 57.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.526 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.34 -4.01 29.73 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.56 123.39 37.44 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.938 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 36.2 Cg_exo -63.3 114.63 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.0 110.531 166.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.4 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 10.9 p90 -106.03 135.04 48.2 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -103.65 114.52 28.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.044 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -99.16 111.68 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.117 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 0.0 OUTLIER -81.48 120.48 25.06 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.57 -178.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -91.72 -4.3 55.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.174 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -84.05 -56.18 3.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.466 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.4 p -108.01 0.96 22.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.068 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 69.61 69.94 0.24 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.738 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.57 149.51 52.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.18 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.15 106.67 9.73 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -123.13 147.32 46.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.017 0.437 . . . . 0.0 111.336 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.409 ' HZ3' ' HB2' ' A' ' 18' ' ' ALA . 25.7 m95 -93.87 -15.95 24.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.44 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.45 115.79 31.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.525 ' OD2' ' HG2' ' A' ' 39' ' ' ARG . 3.9 t70 -53.48 127.0 48.83 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.924 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.37 -32.84 95.03 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.192 2.594 . . . . 0.0 114.166 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.525 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.195 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.408 ' CD2' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.89 140.04 92.44 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.765 1.643 . . . . 0.0 111.246 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.12 117.56 2.92 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.806 2.337 . . . . 0.0 112.393 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.421 ' HA3' HD22 ' A' ' 29' ' ' ASN . . . 121.27 -24.08 7.44 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.007 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -78.49 112.61 15.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 110.569 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.494 ' HB3' HG21 ' A' ' 26' ' ' ILE . 18.5 tt0 -107.4 106.72 17.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.637 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.493 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.1 ptp -81.77 133.36 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 110.83 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -134.53 138.93 45.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.056 175.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.506 HD12 HG23 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -89.63 108.3 19.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.181 0.515 . . . . 0.0 110.347 -178.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.6 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . . . -76.24 152.95 84.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.386 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.31 7.19 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.393 2.729 . . . . 0.0 114.278 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.6 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -90.51 -17.5 26.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.35 31.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.781 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.77 124.42 34.34 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.677 0.275 . . . . 0.0 111.355 -177.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.95 123.42 11.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.555 2.17 . . . . 0.0 111.339 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.5 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 20.5 p90 -114.4 139.33 49.58 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.203 0.525 . . . . 0.0 109.629 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 19.6 m-85 -104.67 112.56 25.69 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.581 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -97.51 112.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.666 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 4.0 t70 -77.71 124.36 27.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.02 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -94.27 2.73 55.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.231 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.421 HD22 ' HA3' ' A' ' 12' ' ' GLY . 53.4 m-80 -86.85 -62.2 1.56 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.084 0.469 . . . . 0.0 110.112 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.1 p -106.51 -1.3 23.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.897 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 68.15 72.39 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.846 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.17 141.89 51.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.492 HG21 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -116.29 97.72 6.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.758 0.313 . . . . 0.0 110.54 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.68 149.38 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.763 0.316 . . . . 0.0 111.011 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.5 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.1 m95 -89.83 -16.87 29.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -79.95 124.89 29.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.631 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 39' ' ' ARG . 10.8 t70 -72.83 120.61 81.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.577 . . . . 0.0 111.435 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD2' ' CD2' ' A' ' 9' ' ' LEU . 49.4 Cg_endo -92.26 14.45 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.475 2.784 . . . . 0.0 114.884 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 1.4 ptp180 . . . . . 0 N--CA 1.448 -0.565 0 CA-C-N 118.952 0.796 . . . . 0.0 109.899 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 39' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.39 140.8 94.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.124 1.216 . . . . 0.0 110.015 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.68 -27.91 16.05 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.262 2.642 . . . . 0.0 113.898 -174.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.59 -9.15 82.13 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.035 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -93.32 119.46 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.05 0.453 . . . . 0.0 110.195 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -109.81 108.11 18.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.76 131.24 37.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.29 0.567 . . . . 0.0 110.537 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -133.77 142.63 48.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.276 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -97.85 109.11 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 109.97 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.492 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . . . -81.24 159.29 68.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.535 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.67 0.82 1.28 Allowed 'Trans proline' 0 N--CA 1.478 0.59 0 C-N-CA 123.474 2.782 . . . . 0.0 114.53 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -87.03 -7.61 57.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 13.65 65.16 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.64 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -108.18 120.01 48.08 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.608 0.242 . . . . 0.0 111.429 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -63.62 114.42 2.54 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.328 2.019 . . . . 0.0 111.536 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.514 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.8 p90 -113.13 139.88 48.36 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' HD1' ' HB3' ' A' ' 15' ' ' MET . 20.4 m-85 -105.05 113.0 26.34 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.625 0.726 . . . . 0.0 110.027 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -94.4 115.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.66 126.08 32.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.872 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.52 10.61 39.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.411 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -93.84 -46.12 7.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 109.975 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 18.71 8.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.67 58.53 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.843 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 148.35 43.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.924 0.392 . . . . 0.0 111.235 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.58 102.03 6.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.209 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 t -123.65 149.59 45.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.514 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.5 m95 -91.69 -20.99 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.298 0.57 . . . . 0.0 110.477 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -86.08 118.47 25.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.533 -176.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -64.53 117.89 42.18 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.77 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.34 -17.55 58.03 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.952 2.435 . . . . 0.0 112.958 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 35.3 mtm180 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 0.0 110.899 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 12.2 Cg_exo -70.73 147.84 57.48 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 111.619 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.4 125.59 6.06 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.072 2.515 . . . . 0.0 112.492 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.74 -29.99 7.78 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.463 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.553 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 68.0 m95 -79.67 122.72 26.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.192 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -120.12 116.22 25.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 136.33 36.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 0.0 110.463 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.58 155.8 47.26 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.92 112.63 41.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.506 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.517 ' HB1' ' OD1' ' A' ' 20' ' ' ASN . . . -80.07 151.94 73.53 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.31 -7.47 6.82 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.774 2.983 . . . . 0.0 114.458 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.517 ' OD1' ' HB1' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -84.02 -9.08 58.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.076 177.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.27 10.33 51.54 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.735 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.43 116.07 56.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.219 . . . . 0.0 111.349 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.39 122.95 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.375 2.05 . . . . 0.0 111.146 166.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.514 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.0 p90 -122.08 145.19 48.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.57 112.99 25.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.009 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.482 HD12 HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -97.33 110.5 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.018 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 9.2 t70 -77.52 119.82 21.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.038 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.75 -1.91 58.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.949 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -84.74 -67.69 0.78 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.105 0.479 . . . . 0.0 110.475 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.6 p -99.57 -1.6 37.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.62 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER 65.85 75.92 0.33 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.548 177.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 142.73 50.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.445 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.56 93.35 4.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.04 0.447 . . . . 0.0 109.952 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.47 150.21 33.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.514 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 5.1 m95 -100.43 -36.79 9.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.457 0.646 . . . . 0.0 109.58 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.42 111.29 10.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.729 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.95 128.96 89.89 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-O 121.124 0.488 . . . . 0.0 111.867 -174.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.77 6.32 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.04 2.494 . . . . 0.0 112.38 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 . . . . . 0 C--N 1.328 -0.337 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.725 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 11.4 Cg_exo -70.01 142.65 47.37 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.964 2.443 . . . . 0.0 111.347 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.11 101.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.078 2.519 . . . . 0.0 111.878 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.41 -27.69 1.67 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.536 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 69.5 m95 -84.01 116.67 22.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -111.04 102.75 11.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.715 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.66 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 3.7 ptt? -83.16 105.13 13.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.337 0.589 . . . . 0.0 110.424 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 16' ' ' ARG . 2.3 mpp_? -102.72 143.35 32.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 mm -89.19 110.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.84 0.353 . . . . 0.0 110.939 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.98 143.51 96.31 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.402 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.75 -21.27 24.86 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.363 2.708 . . . . 0.0 113.383 -175.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.68 -13.97 61.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.494 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.53 9.02 39.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.738 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.77 108.73 61.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.744 -0.228 . . . . 0.0 110.755 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -55.81 122.01 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.303 2.002 . . . . 0.0 111.478 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.518 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 p90 -112.57 133.48 54.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.648 0.737 . . . . 0.0 109.488 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 12.9 m-85 -99.83 106.67 18.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.778 -173.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -93.25 110.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.703 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t70 -77.47 123.6 26.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.21 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -90.5 0.7 57.22 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.927 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -84.51 -54.88 4.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.854 0.359 . . . . 0.0 110.22 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.9 p -106.49 -2.34 22.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 62.7 64.63 0.89 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.149 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -113.91 141.93 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.426 176.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -115.46 95.67 5.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.312 0.577 . . . . 0.0 110.084 176.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.05 142.87 49.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.206 -173.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.518 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 2.1 m95 -92.42 -23.56 19.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.608 0.718 . . . . 0.0 109.381 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.44 102.84 6.15 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.483 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -51.57 130.1 35.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.589 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.44 14.78 2.34 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.314 2.676 . . . . 0.0 113.971 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-O 121.409 0.623 . . . . 0.0 109.376 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' CD2' ' HD2' ' A' ' 38' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.96 157.11 13.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.076 1.851 . . . . 0.0 111.915 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -50.68 -35.52 47.68 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.296 2.664 . . . . 0.0 113.323 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.2 5.71 79.0 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.604 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -108.14 119.85 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.477 0.638 . . . . 0.0 110.623 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -107.6 111.77 24.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.733 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.2 OUTLIER -84.21 127.18 33.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.304 0.573 . . . . 0.0 110.206 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -136.79 133.45 35.97 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.8 OUTLIER -87.04 120.43 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.288 -178.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . . . -82.95 147.8 55.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.405 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.33 -1.07 3.38 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.386 2.724 . . . . 0.0 114.044 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.562 ' OD1' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -79.87 -29.09 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.33 -2.92 8.94 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.289 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.28 123.92 36.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 122.624 -0.339 . . . . 0.0 111.338 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 33.3 Cg_exo -61.35 128.41 24.86 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.593 2.196 . . . . 0.0 111.006 167.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.531 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.1 p90 -119.66 148.45 43.35 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.104 0.478 . . . . 0.0 109.781 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -114.4 112.85 23.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.592 0.71 . . . . 0.0 109.694 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.552 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -95.19 112.08 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.562 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.91 127.25 31.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.238 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -100.61 11.3 39.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -94.64 -48.75 5.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.1 p -115.72 2.47 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.197 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.24 65.5 0.97 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.266 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.95 142.31 51.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.481 HG22 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -108.23 99.19 8.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 t -117.93 152.15 36.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.531 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.7 m95 -95.37 -12.92 25.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.622 0.725 . . . . 0.0 109.9 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.38 122.48 31.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.888 -175.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.85 116.97 51.57 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.773 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD2' ' CD2' ' A' ' 9' ' ' LEU . 72.4 Cg_endo -76.78 15.19 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.363 2.709 . . . . 0.0 113.347 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 171.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 1.3 mp . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.449 ' CD ' ' HB3' ' A' ' 9' ' ' LEU . 39.8 Cg_exo -59.12 153.74 50.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.359 2.04 . . . . 0.0 112.302 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.18 118.6 4.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.294 2.663 . . . . 0.0 112.438 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.2 -22.59 12.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.836 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -83.38 127.01 33.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.535 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -118.9 107.86 14.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.66 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.456 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.1 OUTLIER -81.27 118.55 22.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.377 0.608 . . . . 0.0 110.208 175.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -127.27 141.98 51.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.084 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 17' ' ' ILE . 1.6 mm -95.3 112.63 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.635 -175.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.31 153.68 92.14 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.284 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.44 -11.85 18.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.018 2.479 . . . . 0.0 112.558 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -79.74 -1.64 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.63 66.12 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.93 120.21 46.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.13 -173.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.39 120.62 8.25 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.641 2.228 . . . . 0.0 111.029 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.8 p90 -116.23 141.8 47.67 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.445 ' CD1' HD11 ' A' ' 9' ' ' LEU . 8.1 m-85 -108.0 111.47 23.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.909 -175.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.499 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -97.63 115.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.17 126.51 31.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.646 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.02 8.1 44.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -94.92 -49.87 5.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -113.29 7.39 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? 58.67 67.28 0.95 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.071 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.68 145.47 51.52 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.924 0.392 . . . . 0.0 111.189 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.489 HG22 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -112.08 109.11 18.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.146 178.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.43 143.73 49.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.411 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 9.3 m95 -97.11 -33.46 11.5 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.862 0.839 . . . . 0.0 108.808 174.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.15 111.74 14.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.442 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.0 132.38 67.88 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.652 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.75 12.83 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.078 2.519 . . . . 0.0 112.748 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.211 0.529 . . . . 0.0 109.882 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.403 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.632 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 13.7 Cg_exo -70.33 149.42 63.25 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.599 2.2 . . . . 0.0 111.279 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.59 114.01 1.39 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.936 2.424 . . . . 0.0 112.263 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.69 -23.55 5.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.632 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 77.3 m95 -78.8 125.03 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 111.208 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -122.13 107.86 12.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.137 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.429 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptm -81.2 126.02 31.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.415 0.626 . . . . 0.0 110.181 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -124.85 142.95 51.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.012 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 17' ' ' ILE . 1.1 mm -93.32 119.48 41.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.318 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.0 156.77 71.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.082 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.37 -20.1 24.55 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.998 2.465 . . . . 0.0 112.378 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -18.82 65.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.2 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.6 11.33 59.46 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.42 117.93 53.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.775 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 120.11 7.73 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.395 2.063 . . . . 0.0 111.32 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.428 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.6 p90 -115.7 134.68 54.79 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 24.5 m-85 -99.13 113.25 25.39 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.066 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -100.12 114.81 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.561 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -84.46 126.02 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.007 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -90.81 4.08 52.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -89.63 -55.68 3.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.331 0.586 . . . . 0.0 110.069 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.3 p -95.24 -11.52 27.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.392 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? 65.54 44.52 3.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.95 155.46 26.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.904 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.467 HG21 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.46 116.32 25.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -124.54 149.51 46.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.498 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 42.7 m95 -91.43 -20.13 22.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.611 0.719 . . . . 0.0 109.703 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.79 109.1 19.89 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.733 -172.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -49.09 124.75 13.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.7 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.36 -10.8 26.04 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.79 2.327 . . . . 0.0 113.077 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.744 0.307 . . . . 0.0 110.909 177.487 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.27 160.09 24.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.735 2.29 . . . . 0.0 111.892 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.24 -25.76 66.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 112.521 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.44 ' HA3' ' OD1' ' A' ' 29' ' ' ASN . . . -77.9 -4.58 85.9 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.692 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -105.02 131.28 52.74 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.55 -0.382 . . . . 0.0 110.273 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HB3' HG23 ' A' ' 26' ' ' ILE . 20.4 tt0 -114.67 103.01 10.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.573 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.548 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -82.0 128.12 33.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.255 0.55 . . . . 0.0 110.095 176.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -134.86 131.99 38.04 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -90.69 109.49 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 151.49 74.31 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.467 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.8 13.01 0.19 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.56 2.84 . . . . 0.0 114.442 -173.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -9.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.66 53.39 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.396 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.27 112.19 61.33 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.608 0.242 . . . . 0.0 110.814 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 26.0 Cg_exo -65.4 114.27 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.142 1.895 . . . . 0.0 111.255 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.474 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 8.0 p90 -107.81 133.62 51.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.45 0.643 . . . . 0.0 109.811 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.53 115.96 31.5 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.949 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.58 ' CG1' HG22 ' A' ' 33' ' ' THR . 0.0 OUTLIER -102.01 110.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 122.165 0.983 . . . . 0.0 109.799 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.72 126.39 30.79 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.648 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -100.74 7.91 43.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.748 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.44 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 1.7 m-80 -88.34 -50.12 6.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -115.54 2.5 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.267 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 63.21 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.056 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.56 150.15 49.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.421 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.58 HG22 ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -123.24 113.69 19.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.726 -179.101 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -123.5 140.94 52.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.474 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 32.9 m95 -89.1 -17.91 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.904 0.859 . . . . 0.0 108.831 172.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -93.28 112.57 24.53 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.913 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.99 129.09 78.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.98 6.51 5.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.062 2.508 . . . . 0.0 113.654 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.806 0.336 . . . . 0.0 110.764 179.429 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.489 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.202 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 21.3 Cg_exo -67.05 160.45 47.26 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.152 2.568 . . . . 0.0 111.659 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.08 -15.7 41.12 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.911 2.407 . . . . 0.0 113.136 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.98 -5.3 83.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.712 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.467 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 65.1 m95 -104.77 135.91 45.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.906 0.353 . . . . 0.0 110.665 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -128.08 112.46 14.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.76 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.446 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.58 122.28 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.288 175.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 17.5 mtt180 -124.54 153.65 41.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.42 112.88 41.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.061 0.457 . . . . 0.0 110.7 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.64 158.64 65.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.481 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.15 -10.89 6.76 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.171 2.58 . . . . 0.0 112.405 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.28 -26.97 68.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.235 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.62 57.11 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.75 121.44 44.09 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.865 -176.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.87 116.94 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.728 2.285 . . . . 0.0 111.778 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 32.8 p90 -111.91 140.16 46.8 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 37' ' ' ASP . 42.9 m-85 -103.33 110.14 22.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.679 0.752 . . . . 0.0 110.136 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -92.99 117.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.591 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -84.21 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.638 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -100.49 11.09 40.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -93.18 -45.54 7.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 42.4 p -121.31 -0.9 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.364 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 64.53 63.26 0.75 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.972 176.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.78 144.64 49.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.578 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.488 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -111.7 103.32 11.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.237 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.05 150.67 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.499 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -95.41 -2.82 48.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.79 102.83 15.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.451 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 5.0 t0 -55.95 120.43 33.6 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.422 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.34 -11.78 29.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.891 2.394 . . . . 0.0 112.921 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HD2' ' HA ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.5 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.528 HD22 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.5 152.35 77.91 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.531 2.154 . . . . 0.0 111.418 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.48 118.16 3.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.783 2.322 . . . . 0.0 112.495 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.75 7.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.678 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -83.7 130.85 34.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 111.483 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -128.38 115.2 17.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.511 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -97.68 135.06 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.344 0.592 . . . . 0.0 111.688 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -136.95 142.29 42.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.962 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -92.44 114.35 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.209 -175.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.598 ' HB1' ' OD1' ' A' ' 20' ' ' ASN . . . -82.45 149.27 60.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.092 177.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.28 -6.39 9.9 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.231 2.621 . . . . 0.0 114.675 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.598 ' OD1' ' HB1' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -80.5 -7.77 59.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.52 3.83 52.96 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.29 111.96 62.99 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.636 0.255 . . . . 0.0 111.06 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 24.1 Cg_exo -65.64 120.48 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.121 1.881 . . . . 0.0 110.283 167.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.53 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.4 p90 -105.06 138.92 40.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' CE2' HD22 ' A' ' 9' ' ' LEU . 16.4 m-85 -109.41 109.76 20.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.066 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.588 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -93.35 120.85 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.943 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.58 119.27 29.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -84.53 -6.16 59.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.382 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.63 -55.78 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 110.137 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -90.58 -9.91 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.716 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.97 53.35 3.07 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.994 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.39 150.38 50.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.876 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.521 HG22 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -107.84 114.82 29.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.967 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 155.97 25.02 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.53 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 99.6 m95 -90.11 -74.34 0.49 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.874 0.845 . . . . 0.0 110.016 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -70.47 129.18 38.55 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -61.37 149.92 81.78 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-O 121.312 0.577 . . . . 0.0 112.191 -171.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -82.98 15.37 2.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.997 2.465 . . . . 0.0 111.78 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.997 177.794 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.99 142.06 93.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.172 1.915 . . . . 0.0 111.464 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.29 112.91 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.776 2.317 . . . . 0.0 111.729 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.43 -24.74 4.37 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 68.4 m95 -86.96 125.36 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.817 0.342 . . . . 0.0 110.533 176.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -117.61 112.83 21.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -76.02 118.27 18.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.19 175.106 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -121.81 134.83 54.91 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mm -88.77 114.47 27.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.158 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.7 150.98 73.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.93 1.82 2.1 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.279 2.653 . . . . 0.0 114.412 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -13.75 41.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.96 8.1 37.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.136 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.99 117.78 54.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.878 -0.19 . . . . 0.0 111.402 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -60.0 121.23 9.47 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 111.043 166.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.501 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.9 p90 -117.98 136.16 53.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.2 113.17 25.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.61 0.719 . . . . 0.0 110.154 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -100.34 116.99 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 124.35 27.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.121 178.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -92.93 5.41 51.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.518 -175.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -92.01 -52.84 4.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.5 p -112.02 0.83 16.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.141 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER 62.04 70.48 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.531 176.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.91 150.37 46.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.343 175.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.03 108.04 12.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.66 0.267 . . . . 0.0 111.056 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.5 t -124.2 143.95 50.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.501 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.6 m95 -89.65 -21.69 22.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.773 0.797 . . . . 0.0 109.517 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -83.05 113.57 20.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.374 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.77 120.38 41.3 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.129 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.14 9.47 1.41 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.02 2.48 . . . . 0.0 113.931 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.96 138.09 76.44 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.977 2.452 . . . . 0.0 112.072 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.5 111.56 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.759 2.306 . . . . 0.0 111.599 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.38 -27.35 4.0 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -84.16 101.57 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.526 ' HG2' ' HD2' ' A' ' 16' ' ' ARG . 2.7 tt0 -98.6 104.48 16.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.323 -174.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.625 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -79.65 119.03 22.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.0 109.866 174.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.526 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -124.36 139.66 53.69 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 17' ' ' ILE . 1.7 mm -88.72 104.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.877 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.17 156.11 92.23 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.391 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 -3.01 2.94 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.208 2.605 . . . . 0.0 113.046 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -78.33 -17.19 56.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.277 0.561 . . . . 0.0 109.534 172.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.34 1.55 55.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.943 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HG2' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.57 129.35 24.11 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.66 -0.27 . . . . 0.0 110.926 -175.267 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 121.74 9.57 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.789 2.326 . . . . 0.0 111.412 168.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.567 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.1 p90 -119.51 141.04 49.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.162 0.506 . . . . 0.0 109.948 176.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.625 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.3 m-85 -106.24 112.63 25.74 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.988 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -98.23 112.82 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.653 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.97 113.94 18.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.418 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -81.94 13.29 3.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.371 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -97.42 -57.69 2.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.23 0.538 . . . . 0.0 109.899 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -93.5 -14.39 26.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.5 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 mttt 71.95 37.49 1.02 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.305 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.73 154.27 21.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.768 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.503 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -119.41 116.12 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.715 -175.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 t -123.59 141.43 52.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.567 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -92.23 -10.55 38.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.884 0.849 . . . . 0.0 109.221 174.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.93 112.2 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.554 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.537 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 33.1 t0 -62.45 112.57 6.74 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.32 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HG2' HD21 ' A' ' 9' ' ' LEU . 42.8 Cg_endo -69.86 -9.64 26.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.871 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 121.128 0.489 . . . . 0.0 109.899 175.543 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.39 147.95 92.2 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.733 1.622 . . . . 0.0 110.249 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -58.47 -10.92 9.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.802 2.334 . . . . 0.0 113.606 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.07 1.24 80.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.509 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.477 ' HE3' ' HB3' ' A' ' 25' ' ' PHE . 37.9 m95 -105.14 115.17 29.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.022 0.439 . . . . 0.0 110.061 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB3' HG23 ' A' ' 26' ' ' ILE . 21.0 tt0 -98.47 99.73 10.93 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.707 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.636 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.3 ptp -79.63 92.92 5.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.434 0.635 . . . . 0.0 110.455 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 16' ' ' ARG . 44.5 mtt-85 -85.71 128.55 34.82 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.031 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 17' ' ' ILE . 3.7 mm -88.03 102.12 12.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.185 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.78 146.02 90.24 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.696 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.27 -5.62 5.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.842 2.361 . . . . 0.0 112.502 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.18 -17.05 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 0.0 109.874 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.76 60.05 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.037 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.94 110.3 62.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.925 -177.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.0 117.65 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.025 . . . . 0.0 110.861 167.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.9 p90 -111.6 127.53 55.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.727 0.775 . . . . 0.0 109.862 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.636 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.9 m-85 -93.58 103.94 16.09 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.463 -172.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.416 HG23 ' HB3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -95.22 109.09 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.455 176.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.9 127.29 32.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.247 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -100.18 12.0 38.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.0 111.023 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -100.42 -51.02 3.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.021 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.5 p -111.67 4.6 18.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.905 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 64.88 1.19 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.366 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.74 144.53 48.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.766 174.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.37 101.77 7.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.403 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.769 0.318 . . . . 0.0 111.566 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.544 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -89.78 -17.78 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.768 0.794 . . . . 0.0 109.101 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.85 114.55 21.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.486 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.45 120.8 68.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.979 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.05 10.19 3.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.161 2.574 . . . . 0.0 113.767 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.88 148.31 89.81 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.522 2.148 . . . . 0.0 111.52 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.65 119.58 5.36 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.844 2.363 . . . . 0.0 112.093 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.47 -24.37 6.89 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.914 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -83.86 125.99 32.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 110.918 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.07 122.12 33.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.494 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.615 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 1.9 ptt? -89.26 124.03 34.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -128.55 143.85 51.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.92 125.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 0.0 110.597 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.506 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . . . -89.43 165.09 27.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 21.6 Cg_endo -60.88 -15.0 35.57 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.357 2.705 . . . . 0.0 113.928 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.13 56.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.008 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.93 20.66 60.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.057 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.428 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 9.5 mmm180 -107.8 120.94 45.6 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.82 -0.224 . . . . 0.0 110.435 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.45 113.64 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.048 1.832 . . . . 0.0 111.061 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.7 p90 -112.45 138.45 49.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.615 ' CE2' ' HB3' ' A' ' 15' ' ' MET . 7.2 m-85 -103.58 114.47 28.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.885 -174.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.519 HD12 HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -101.3 112.68 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.53 -178.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.2 120.41 22.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.348 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -89.81 -1.51 58.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.436 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.19 -57.63 3.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.2 p -113.23 6.87 17.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.978 -176.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.04 67.95 0.65 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.59 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 149.5 42.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -126.05 108.23 11.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.817 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 36' ' ' GLU . 4.1 t -124.19 148.53 47.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.335 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.44 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 38.9 m95 -91.26 -15.46 29.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.611 0.719 . . . . 0.0 110.153 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -107.19 107.88 19.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.863 -175.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -58.38 146.26 72.47 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.708 -175.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.14 11.8 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.79 2.326 . . . . 0.0 112.268 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 . . . . . 0 N--CA 1.441 -0.925 0 CA-C-O 121.353 0.597 . . . . 0.0 109.726 175.098 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.24 150.66 39.33 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 121.997 1.798 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.38 -27.92 25.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.299 2.666 . . . . 0.0 113.7 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.82 -13.41 83.46 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.22 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.407 ' CE3' ' HG3' ' A' ' 38' ' ' PRO . 80.5 m95 -92.84 121.42 34.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.976 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -118.52 105.58 11.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.447 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.495 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptp -83.19 128.73 34.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.258 0.551 . . . . 0.0 110.731 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.85 152.35 48.61 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.71 111.61 32.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.089 0.471 . . . . 0.0 110.328 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.83 155.81 82.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.689 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.64 -7.75 7.88 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.391 2.727 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -70.4 -21.54 62.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.6 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.73 -0.14 59.3 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.64 46.52 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.703 -177.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.03 126.8 23.35 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.723 2.282 . . . . 0.0 111.208 169.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.402 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.1 p90 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.508 0.67 . . . . 0.0 109.952 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.495 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 20.3 m-85 -104.78 114.41 28.61 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.531 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.615 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -98.05 118.8 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.723 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.64 119.97 28.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.197 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -85.12 -3.84 58.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.855 0.36 . . . . 0.0 110.905 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -80.56 -57.29 3.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 109.609 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -90.35 -12.75 36.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.488 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 mttm 60.92 55.07 3.25 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.09 152.88 48.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.366 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.74 116.39 26.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.947 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -123.21 145.26 48.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.499 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.402 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 7.4 m95 -89.66 -20.05 24.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.739 0.781 . . . . 0.0 109.411 176.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.8 110.16 17.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.911 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -49.82 120.77 11.68 Favored Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.012 0.82 . . . . 0.0 111.738 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HG3' ' CE3' ' A' ' 13' ' ' TRP . 29.9 Cg_endo -64.05 -12.65 33.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.113 2.542 . . . . 0.0 113.049 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 174.477 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.8 -51.31 55.16 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.56 -15.26 15.18 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.672 2.248 . . . . 0.0 114.14 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.38 12.36 57.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.199 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.03 101.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.839 0.352 . . . . 0.0 110.446 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -68.43 116.21 8.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.64 73.35 3.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.906 -177.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -83.3 -76.51 0.28 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.43 178.68 1.07 Allowed Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 172.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 12' ' ' GLY . 53.8 Cg_exo -54.28 147.21 46.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.445 1.43 . . . . 0.0 110.941 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -63.81 10.02 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.454 2.769 . . . . 0.0 114.159 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 10' ' ' PRO . . . -111.96 -0.18 27.11 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 174.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -104.74 128.75 52.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 110.467 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -114.96 111.31 20.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.631 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.598 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -85.53 115.4 23.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.231 0.539 . . . . 0.0 110.424 176.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -113.91 142.58 45.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.277 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 17' ' ' ILE . 2.9 mm -93.07 101.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.296 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 153.79 72.02 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.407 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.64 -16.98 16.14 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.944 2.429 . . . . 0.0 112.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -63.61 -25.99 68.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.429 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.93 -0.37 44.94 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.13 125.4 32.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.53 0.205 . . . . 0.0 111.229 -176.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.33 123.79 14.17 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.926 2.417 . . . . 0.0 111.493 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.415 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 22.0 p90 -121.22 137.52 54.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.299 0.571 . . . . 0.0 109.902 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 20.5 m-85 -101.2 112.44 24.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.477 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.56 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -100.51 119.19 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.654 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 1.1 t70 -83.41 132.41 34.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.896 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -100.77 8.57 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.415 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -88.29 -58.26 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 109.882 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 47.6 p -98.94 -23.45 15.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.845 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 78.94 70.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.904 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -129.21 166.6 19.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.574 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.428 HG21 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -128.49 109.89 11.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.664 -174.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 t -124.02 146.82 48.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.486 0.184 . . . . 0.0 110.709 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.415 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 21.6 m95 -90.25 -36.23 14.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.486 0.66 . . . . 0.0 109.398 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.93 121.51 19.21 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.754 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.544 ' HB3' ' HG ' ' A' ' 40' ' ' LEU . 66.1 t0 -61.12 115.23 13.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.409 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.4 -12.18 34.6 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.005 2.47 . . . . 0.0 113.072 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 39' ' ' ARG . 0.7 OUTLIER -92.26 2.27 56.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 110.355 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' A' ' 37' ' ' ASP . 63.6 mt -75.21 -11.34 60.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.044 175.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.961 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.428 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.217 -0.353 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 60.57 70.41 0.99 Allowed Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 122.913 0.485 . . . . 0.0 111.513 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 4' ' ' GLY . 7.9 Cg_endo -87.55 -144.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.126 2.551 . . . . 0.0 111.757 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 3' ' ' PRO . . . 110.2 -66.92 0.23 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.141 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -93.59 -11.91 8.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.787 0.803 . . . . 0.0 110.78 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.29 -17.36 24.85 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.811 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.11 125.7 49.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.636 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.21 -158.99 0.67 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.731 0.3 . . . . 0.0 110.577 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.06 175.27 2.53 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.71 152.77 71.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.279 1.986 . . . . 0.0 111.122 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.83 -2.19 5.11 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.918 2.412 . . . . 0.0 113.511 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -92.36 -11.55 59.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.588 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -99.35 111.98 24.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 110.118 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -100.59 104.19 15.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.585 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.09 127.54 33.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.539 0.685 . . . . 0.0 109.592 174.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -125.6 123.66 39.51 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.581 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 102.98 14.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.688 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.46 152.19 92.8 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.119 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.2 -4.0 2.77 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.001 2.468 . . . . 0.0 112.273 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.19 -25.39 61.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.31 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.25 5.78 48.97 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.522 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.28 120.36 47.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.458 0.17 . . . . 0.0 110.802 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.35 113.18 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.286 1.99 . . . . 0.0 111.252 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.504 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.0 p90 -111.43 135.99 51.21 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -101.16 116.4 32.73 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.597 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -102.48 113.64 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.954 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 35.9 t0 -80.65 126.37 31.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.549 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -90.16 -7.79 52.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.83 0.348 . . . . 0.0 110.521 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -82.52 -54.59 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.274 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -94.43 -12.48 27.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.45 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 1.2 mtmt 62.83 58.27 1.58 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.279 0.562 . . . . 0.0 111.076 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.7 152.75 47.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.633 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.83 112.86 18.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.693 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t -123.97 147.13 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.853 0.359 . . . . 0.0 110.877 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.504 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 48.8 m95 -91.27 -9.54 44.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.859 0.838 . . . . 0.0 109.858 177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.66 125.75 52.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.337 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -61.19 116.0 17.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.67 -16.28 50.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.561 2.84 . . . . 0.0 113.528 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -72.52 -16.54 61.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 mt -82.83 -16.81 46.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.197 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.421 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.33 -51.44 1.24 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.17 156.84 17.39 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.92 1.746 . . . . 0.0 111.998 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.99 -116.59 4.82 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.202 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mt 54.35 67.4 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.276 0.56 . . . . 0.0 110.786 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.57 134.41 39.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.624 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.08 92.18 8.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.368 0.604 . . . . 0.0 111.27 -175.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -100.77 -85.71 0.41 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 172.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.529 HD11 ' CD1' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -128.87 178.28 1.75 Allowed Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 20.4 Cg_exo -66.68 148.84 83.67 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.109 1.873 . . . . 0.0 111.409 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -47.04 110.47 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.506 2.804 . . . . 0.0 112.724 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.06 -26.8 5.24 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.576 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 86.2 m95 -82.05 120.43 25.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.815 0.341 . . . . 0.0 110.302 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -112.84 105.35 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.444 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.41 ' HB3' HD11 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -79.15 130.58 35.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.394 0.616 . . . . 0.0 110.846 178.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.27 153.06 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.85 124.08 60.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.683 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.72 55.62 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -58.4 -11.71 11.69 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.507 2.805 . . . . 0.0 114.552 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -18.19 55.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.14 5.77 32.46 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.872 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' H ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.87 118.96 51.63 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.724 0.297 . . . . 0.0 111.2 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.57 123.81 13.06 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.745 2.296 . . . . 0.0 111.296 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.554 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 13.4 p90 -116.06 142.97 46.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.235 0.54 . . . . 0.0 109.599 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 10.9 m-85 -110.17 116.83 32.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.681 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.581 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -98.39 110.44 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.046 0.927 . . . . 0.0 110.032 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.45 126.71 31.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.394 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -98.98 6.3 46.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.332 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -88.56 -58.61 2.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.069 0.461 . . . . 0.0 109.774 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.0 p -104.38 -4.1 23.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.528 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.88 64.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.339 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.1 143.94 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.54 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -117.53 100.9 7.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.01 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.5 t -123.86 149.12 46.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.96 0.409 . . . . 0.0 111.494 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.554 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.2 m95 -96.67 5.02 51.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.55 108.68 19.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.596 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.539 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 19.7 t0 -63.19 113.75 10.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.814 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.61 -1.86 11.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.403 2.735 . . . . 0.0 112.56 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 8' ' ' PHE . 13.2 mtm180 -105.93 -5.06 19.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 0.0 110.04 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 21.2 mt -101.78 -33.73 9.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.353 177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.911 178.72 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -67.02 119.15 62.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.591 0.234 . . . . 0.0 110.454 178.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 11.8 Cg_exo -70.17 -30.88 19.7 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.882 2.388 . . . . 0.0 112.14 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.73 -32.54 3.95 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.238 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -123.06 120.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.887 0.375 . . . . 0.0 110.882 -176.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.33 -40.42 58.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.04 80.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.177 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.09 -76.28 0.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.152 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER -114.72 160.5 33.1 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -56.37 153.01 36.32 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.569 2.179 . . . . 0.0 112.148 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -52.44 110.73 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.024 2.483 . . . . 0.0 112.162 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.14 -20.26 6.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.343 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 81.9 m95 -82.14 120.33 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -114.31 111.11 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.746 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.484 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.45 104.72 9.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.183 175.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 16' ' ' ARG . 27.2 mtt-85 -103.01 121.83 43.36 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.25 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mm -80.52 109.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.844 0.354 . . . . 0.0 110.271 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . . . -81.75 148.8 62.42 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.033 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.38 3.46 1.06 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.591 2.861 . . . . 0.0 114.525 -172.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.614 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -87.38 -15.17 38.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 10.87 29.32 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.581 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -107.68 112.42 62.15 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.54 109.53 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.866 1.711 . . . . 0.0 110.659 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -105.8 125.92 51.56 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.592 0.711 . . . . 0.0 109.256 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.439 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 26.2 m-85 -91.88 109.84 21.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.156 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.439 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.87 114.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.937 178.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 118.61 21.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.035 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -91.41 6.56 44.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.335 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -95.9 -54.6 3.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.916 0.388 . . . . 0.0 110.355 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -111.89 5.02 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm 64.38 74.13 0.41 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.13 175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.58 145.4 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.492 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.439 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.75 105.17 8.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.711 0.291 . . . . 0.0 110.537 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 t -123.87 146.95 48.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -89.91 -11.35 42.08 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.759 0.79 . . . . 0.0 109.747 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.39 119.91 40.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.269 -171.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.45 ' HB3' HD11 ' A' ' 40' ' ' LEU . 64.1 t0 -48.32 116.87 5.31 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.057 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.38 -13.4 35.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.249 2.633 . . . . 0.0 113.517 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 39' ' ' ARG . 4.0 mtm105 -85.16 3.19 40.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.962 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 37' ' ' ASP . 14.3 mt -102.1 -18.52 15.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.195 0.522 . . . . 0.0 110.16 174.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.511 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.848 0 N-CA-C 112.094 -0.402 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.38 153.8 58.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.68 78.65 2.03 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.933 2.422 . . . . 0.0 111.562 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.69 -156.6 7.94 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.987 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.625 HG23 ' HB3' ' A' ' 11' ' ' PRO . 15.3 mm -86.03 83.08 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.02 30.88 0.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.291 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.16 102.83 3.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.298 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 t80 70.41 -64.29 0.37 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.87 0.731 . . . . 0.0 111.839 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.13 166.49 11.37 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.32 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.29 152.82 80.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.697 2.265 . . . . 0.0 112.1 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.625 ' HB3' HG23 ' A' ' 5' ' ' ILE . 9.6 Cg_endo -52.94 116.19 2.75 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.113 2.542 . . . . 0.0 112.325 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.5 -14.38 9.31 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.933 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.403 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 60.7 m95 -88.94 94.95 10.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 110.009 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -86.84 107.39 18.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.587 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.51 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.54 122.71 27.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.403 0.62 . . . . 0.0 110.804 178.136 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -130.92 133.96 46.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.272 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -89.18 112.03 23.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.775 0.322 . . . . 0.0 110.498 -177.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.409 ' HB2' ' HZ3' ' A' ' 35' ' ' TRP . . . -79.07 152.84 77.1 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.236 178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.74 -1.62 3.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.158 2.572 . . . . 0.0 112.504 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -75.16 -23.62 57.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.526 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.34 -4.01 29.73 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.56 123.39 37.44 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.938 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 36.2 Cg_exo -63.3 114.63 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.0 110.531 166.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.4 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 10.9 p90 -106.03 135.04 48.2 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -103.65 114.52 28.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.044 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -99.16 111.68 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.117 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 0.0 OUTLIER -81.48 120.48 25.06 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.57 -178.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -91.72 -4.3 55.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.174 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -84.05 -56.18 3.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.466 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.4 p -108.01 0.96 22.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.068 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 69.61 69.94 0.24 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.738 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.57 149.51 52.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.18 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.15 106.67 9.73 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -123.13 147.32 46.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.017 0.437 . . . . 0.0 111.336 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.409 ' HZ3' ' HB2' ' A' ' 18' ' ' ALA . 25.7 m95 -93.87 -15.95 24.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.44 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.45 115.79 31.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.525 ' OD2' ' HG2' ' A' ' 39' ' ' ARG . 3.9 t70 -53.48 127.0 48.83 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.924 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.37 -32.84 95.03 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.192 2.594 . . . . 0.0 114.166 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.525 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -79.22 -16.62 56.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.195 -176.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.517 ' HG ' ' OD2' ' A' ' 37' ' ' ASP . 77.8 mt -70.56 -31.77 68.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.026 0.441 . . . . 0.0 110.499 175.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.733 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.907 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.87 118.64 7.28 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.548 0.174 . . . . 0.0 110.807 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -69.37 -72.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.179 1.92 . . . . 0.0 111.83 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.76 67.87 0.35 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.5 175.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -80.08 99.38 7.68 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.078 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.38 -4.67 57.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.369 0.605 . . . . 0.0 111.05 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.69 164.03 31.21 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.147 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.408 ' CD2' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -79.91 174.12 6.62 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.689 172.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.89 140.04 92.44 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.765 1.643 . . . . 0.0 111.246 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.12 117.56 2.92 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.806 2.337 . . . . 0.0 112.393 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.421 ' HA3' HD22 ' A' ' 29' ' ' ASN . . . 121.27 -24.08 7.44 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.007 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -78.49 112.61 15.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 110.569 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.494 ' HB3' HG21 ' A' ' 26' ' ' ILE . 18.5 tt0 -107.4 106.72 17.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.637 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.493 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.1 ptp -81.77 133.36 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 110.83 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -134.53 138.93 45.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.056 175.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.506 HD12 HG23 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -89.63 108.3 19.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.181 0.515 . . . . 0.0 110.347 -178.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.6 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . . . -76.24 152.95 84.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.386 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.31 7.19 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.393 2.729 . . . . 0.0 114.278 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.6 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -90.51 -17.5 26.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.153 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.35 31.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.781 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.77 124.42 34.34 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.677 0.275 . . . . 0.0 111.355 -177.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.95 123.42 11.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.555 2.17 . . . . 0.0 111.339 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.5 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 20.5 p90 -114.4 139.33 49.58 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.203 0.525 . . . . 0.0 109.629 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 19.6 m-85 -104.67 112.56 25.69 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.581 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -97.51 112.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.666 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 4.0 t70 -77.71 124.36 27.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.02 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -94.27 2.73 55.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.231 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.421 HD22 ' HA3' ' A' ' 12' ' ' GLY . 53.4 m-80 -86.85 -62.2 1.56 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.084 0.469 . . . . 0.0 110.112 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.1 p -106.51 -1.3 23.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.897 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 68.15 72.39 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.846 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.17 141.89 51.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.492 HG21 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -116.29 97.72 6.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.758 0.313 . . . . 0.0 110.54 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.68 149.38 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.763 0.316 . . . . 0.0 111.011 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.5 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.1 m95 -89.83 -16.87 29.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -79.95 124.89 29.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.631 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.489 ' OD1' ' HG2' ' A' ' 39' ' ' ARG . 10.8 t70 -72.83 120.61 81.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.577 . . . . 0.0 111.435 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD2' ' CD2' ' A' ' 9' ' ' LEU . 49.4 Cg_endo -92.26 14.45 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.475 2.784 . . . . 0.0 114.884 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 1.4 ptp180 -94.45 -19.4 20.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.952 0.796 . . . . 0.0 109.899 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -80.48 -37.37 31.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.688 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.216 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 112.288 -0.325 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.87 133.79 61.38 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.459 0.171 . . . . 0.0 110.816 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.67 106.82 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.021 2.48 . . . . 0.0 112.359 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.02 -151.9 16.48 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.018 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mm -104.12 95.62 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.93 163.42 21.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 -177.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.2 87.83 4.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.655 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 169.08 156.91 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.943 0.897 . . . . 0.0 109.983 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -82.83 174.43 6.06 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -57.39 140.8 94.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.124 1.216 . . . . 0.0 110.015 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.68 -27.91 16.05 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.262 2.642 . . . . 0.0 113.898 -174.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.59 -9.15 82.13 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.035 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -93.32 119.46 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.05 0.453 . . . . 0.0 110.195 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -109.81 108.11 18.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.76 131.24 37.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.29 0.567 . . . . 0.0 110.537 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -133.77 142.63 48.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.276 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 17' ' ' ILE . 0.4 OUTLIER -97.85 109.11 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 109.97 179.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.492 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . . . -81.24 159.29 68.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.535 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.67 0.82 1.28 Allowed 'Trans proline' 0 N--CA 1.478 0.59 0 C-N-CA 123.474 2.782 . . . . 0.0 114.53 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -87.03 -7.61 57.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 13.65 65.16 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.64 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -108.18 120.01 48.08 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.608 0.242 . . . . 0.0 111.429 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -63.62 114.42 2.54 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.328 2.019 . . . . 0.0 111.536 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.514 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.8 p90 -113.13 139.88 48.36 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' HD1' ' HB3' ' A' ' 15' ' ' MET . 20.4 m-85 -105.05 113.0 26.34 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.625 0.726 . . . . 0.0 110.027 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -94.4 115.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.66 126.08 32.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.872 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.52 10.61 39.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.411 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -93.84 -46.12 7.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 109.975 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 18.71 8.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.67 58.53 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.843 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 148.35 43.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.924 0.392 . . . . 0.0 111.235 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.58 102.03 6.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.209 178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 t -123.65 149.59 45.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.514 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.5 m95 -91.69 -20.99 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.298 0.57 . . . . 0.0 110.477 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -86.08 118.47 25.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.533 -176.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -64.53 117.89 42.18 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.77 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.34 -17.55 58.03 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.952 2.435 . . . . 0.0 112.958 -178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 35.3 mtm180 -83.59 -20.42 33.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 0.0 110.899 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.9 mt -79.71 -36.51 37.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.358 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.49 75.01 77.75 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 111.568 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.44 -50.85 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.767 1.645 . . . . 0.0 110.787 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.87 -172.04 17.72 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.73 63.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.505 0.669 . . . . 0.0 109.863 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -77.93 140.97 39.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.212 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.11 84.8 2.34 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.593 0.711 . . . . 0.0 110.705 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.96 -13.04 60.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.587 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 173.2 3.25 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.879 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 12.2 Cg_exo -70.73 147.84 57.48 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 111.619 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.4 125.59 6.06 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.072 2.515 . . . . 0.0 112.492 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.74 -29.99 7.78 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.463 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.553 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 68.0 m95 -79.67 122.72 26.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.192 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -120.12 116.22 25.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 136.33 36.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 0.0 110.463 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.58 155.8 47.26 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.92 112.63 41.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.506 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.517 ' HB1' ' OD1' ' A' ' 20' ' ' ASN . . . -80.07 151.94 73.53 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.175 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.31 -7.47 6.82 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.774 2.983 . . . . 0.0 114.458 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.517 ' OD1' ' HB1' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -84.02 -9.08 58.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.076 177.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.27 10.33 51.54 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.735 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.43 116.07 56.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.219 . . . . 0.0 111.349 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.39 122.95 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.375 2.05 . . . . 0.0 111.146 166.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.514 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.0 p90 -122.08 145.19 48.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.57 112.99 25.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.009 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.482 HD12 HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -97.33 110.5 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.018 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 9.2 t70 -77.52 119.82 21.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.038 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.75 -1.91 58.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.949 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -84.74 -67.69 0.78 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.105 0.479 . . . . 0.0 110.475 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.6 p -99.57 -1.6 37.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.62 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER 65.85 75.92 0.33 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.548 177.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 142.73 50.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.445 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.56 93.35 4.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.04 0.447 . . . . 0.0 109.952 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.47 150.21 33.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.514 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 5.1 m95 -100.43 -36.79 9.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.457 0.646 . . . . 0.0 109.58 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' O ' ' HE2' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -75.42 111.29 10.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.729 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -60.95 128.96 89.89 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-O 121.124 0.488 . . . . 0.0 111.867 -174.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.77 6.32 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.04 2.494 . . . . 0.0 112.38 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -93.44 -9.7 37.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 37' ' ' ASP . 1.7 pp -112.19 -48.63 3.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.367 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 36' ' ' GLU . 14.8 pttt . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.446 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.56 -53.28 2.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 119.727 -0.178 . . . . 0.0 111.432 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.527 ' HB2' ' H ' ' A' ' 4' ' ' GLY . 11.2 Cg_endo -90.58 -132.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.668 2.245 . . . . 0.0 111.708 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.527 ' H ' ' HB2' ' A' ' 3' ' ' PRO . . . -107.62 154.28 16.62 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.819 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mt 50.52 62.19 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 122.96 0.504 . . . . 0.0 110.903 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.495 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 9.3 mm100 54.66 -103.3 0.17 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.833 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m 59.58 -168.91 0.15 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.002 0.521 . . . . 0.0 112.118 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -131.32 -66.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.617 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.23 167.39 12.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.983 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 11.4 Cg_exo -70.01 142.65 47.37 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.964 2.443 . . . . 0.0 111.347 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.11 101.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.078 2.519 . . . . 0.0 111.878 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.41 -27.69 1.67 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.536 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 69.5 m95 -84.01 116.67 22.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -111.04 102.75 11.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.715 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.66 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 3.7 ptt? -83.16 105.13 13.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.337 0.589 . . . . 0.0 110.424 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 16' ' ' ARG . 2.3 mpp_? -102.72 143.35 32.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 mm -89.19 110.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.84 0.353 . . . . 0.0 110.939 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.98 143.51 96.31 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.402 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.75 -21.27 24.86 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.363 2.708 . . . . 0.0 113.383 -175.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.68 -13.97 61.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.494 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.53 9.02 39.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.738 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.77 108.73 61.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.744 -0.228 . . . . 0.0 110.755 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -55.81 122.01 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.303 2.002 . . . . 0.0 111.478 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.518 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 p90 -112.57 133.48 54.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.648 0.737 . . . . 0.0 109.488 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 12.9 m-85 -99.83 106.67 18.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.778 -173.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -93.25 110.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.703 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t70 -77.47 123.6 26.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.21 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -90.5 0.7 57.22 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.927 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -84.51 -54.88 4.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.854 0.359 . . . . 0.0 110.22 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.9 p -106.49 -2.34 22.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 62.7 64.63 0.89 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.149 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -113.91 141.93 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.426 176.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -115.46 95.67 5.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.312 0.577 . . . . 0.0 110.084 176.019 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.05 142.87 49.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.206 -173.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.518 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 2.1 m95 -92.42 -23.56 19.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.608 0.718 . . . . 0.0 109.381 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.44 102.84 6.15 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.483 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -51.57 130.1 35.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.589 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.44 14.78 2.34 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.314 2.676 . . . . 0.0 113.971 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 -44.31 5.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.409 0.623 . . . . 0.0 109.376 173.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mt -81.91 -39.4 23.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.257 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.45 ' HB3' ' HZ1' ' A' ' 41' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.798 173.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.29 116.32 66.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 O-C-N 122.804 -0.233 . . . . 0.0 110.448 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.23 163.8 30.45 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.885 2.39 . . . . 0.0 112.409 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.2 75.36 2.3 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.83 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.34 55.82 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.031 0.443 . . . . 0.0 110.576 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -93.62 -136.17 0.18 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.395 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.8 1.03 32.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.588 0.709 . . . . 0.0 110.571 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.77 -152.43 0.43 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.942 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' CD2' ' HD2' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -110.46 -177.37 0.45 Allowed Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.96 157.11 13.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.076 1.851 . . . . 0.0 111.915 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -50.68 -35.52 47.68 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.296 2.664 . . . . 0.0 113.323 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.2 5.71 79.0 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.604 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -108.14 119.85 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.477 0.638 . . . . 0.0 110.623 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -107.6 111.77 24.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.733 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.2 OUTLIER -84.21 127.18 33.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.304 0.573 . . . . 0.0 110.206 177.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -136.79 133.45 35.97 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.8 OUTLIER -87.04 120.43 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.288 -178.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.562 ' HB2' ' OD1' ' A' ' 20' ' ' ASN . . . -82.95 147.8 55.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.405 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.33 -1.07 3.38 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.386 2.724 . . . . 0.0 114.044 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.562 ' OD1' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -79.87 -29.09 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.33 -2.92 8.94 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.289 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.28 123.92 36.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 122.624 -0.339 . . . . 0.0 111.338 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 33.3 Cg_exo -61.35 128.41 24.86 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.593 2.196 . . . . 0.0 111.006 167.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.531 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.1 p90 -119.66 148.45 43.35 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.104 0.478 . . . . 0.0 109.781 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -114.4 112.85 23.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.592 0.71 . . . . 0.0 109.694 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.552 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -95.19 112.08 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.562 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.91 127.25 31.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.238 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -100.61 11.3 39.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -94.64 -48.75 5.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.1 p -115.72 2.47 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.197 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.24 65.5 0.97 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.266 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.95 142.31 51.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.481 HG22 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -108.23 99.19 8.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 t -117.93 152.15 36.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.531 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.7 m95 -95.37 -12.92 25.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.622 0.725 . . . . 0.0 109.9 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.38 122.48 31.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.888 -175.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.85 116.97 51.57 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.773 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD2' ' CD2' ' A' ' 9' ' ' LEU . 72.4 Cg_endo -76.78 15.19 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.363 2.709 . . . . 0.0 113.347 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.89 -15.34 14.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.2 mt -88.84 -15.75 33.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.124 174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.949 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -78.3 124.45 85.68 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.5 0.191 . . . . 0.0 110.573 178.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 26.6 Cg_exo -62.32 125.02 15.36 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.706 2.27 . . . . 0.0 111.462 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.93 72.61 0.47 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.243 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -108.25 42.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.333 0.587 . . . . 0.0 110.457 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -99.32 0.02 42.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.456 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.92 137.85 55.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.412 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -126.66 149.28 49.61 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.448 0.642 . . . . 0.0 109.81 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 1.3 mp -89.9 177.88 2.21 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.03 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' CD ' ' HB3' ' A' ' 9' ' ' LEU . 39.8 Cg_exo -59.12 153.74 50.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.359 2.04 . . . . 0.0 112.302 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.18 118.6 4.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.294 2.663 . . . . 0.0 112.438 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.2 -22.59 12.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.836 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -83.38 127.01 33.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.535 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -118.9 107.86 14.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.66 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.456 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.1 OUTLIER -81.27 118.55 22.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.377 0.608 . . . . 0.0 110.208 175.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -127.27 141.98 51.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.084 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 17' ' ' ILE . 1.6 mm -95.3 112.63 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.635 -175.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.31 153.68 92.14 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.284 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.44 -11.85 18.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.018 2.479 . . . . 0.0 112.558 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -79.74 -1.64 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.63 66.12 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.93 120.21 46.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.13 -173.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.39 120.62 8.25 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.641 2.228 . . . . 0.0 111.029 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.8 p90 -116.23 141.8 47.67 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.445 ' CD1' HD11 ' A' ' 9' ' ' LEU . 8.1 m-85 -108.0 111.47 23.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.909 -175.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.499 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -97.63 115.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.17 126.51 31.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.646 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.02 8.1 44.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -94.92 -49.87 5.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -113.29 7.39 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? 58.67 67.28 0.95 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.071 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.68 145.47 51.52 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.924 0.392 . . . . 0.0 111.189 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.489 HG22 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -112.08 109.11 18.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.146 178.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.43 143.73 49.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.411 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 9.3 m95 -97.11 -33.46 11.5 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.862 0.839 . . . . 0.0 108.808 174.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.15 111.74 14.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.442 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.0 132.38 67.88 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.652 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HA ' ' HG3' ' A' ' 41' ' ' LYS . 57.3 Cg_endo -71.75 12.83 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.078 2.519 . . . . 0.0 112.748 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.69 2.73 54.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.211 0.529 . . . . 0.0 109.882 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.04 -15.46 12.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.555 176.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.921 -0.562 . . . . 0.0 110.154 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.67 118.64 68.32 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 110.692 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.69 55.72 5.75 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.969 2.446 . . . . 0.0 112.151 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.51 -92.19 0.42 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.104 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.6 84.28 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.279 0.561 . . . . 0.0 110.858 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.534 ' HG2' ' N ' ' A' ' 7' ' ' SER . 4.2 tt0 -98.36 150.7 21.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.304 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.534 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -62.36 105.24 0.59 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -62.06 -58.83 6.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.141 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.403 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -91.72 170.98 8.51 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.632 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 13.7 Cg_exo -70.33 149.42 63.25 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.599 2.2 . . . . 0.0 111.279 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -51.59 114.01 1.39 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.936 2.424 . . . . 0.0 112.263 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.69 -23.55 5.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.632 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 77.3 m95 -78.8 125.03 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 111.208 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -122.13 107.86 12.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.137 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.429 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptm -81.2 126.02 31.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.415 0.626 . . . . 0.0 110.181 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -124.85 142.95 51.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.012 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.403 HG22 HD12 ' A' ' 17' ' ' ILE . 1.1 mm -93.32 119.48 41.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.318 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.0 156.77 71.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.082 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.37 -20.1 24.55 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.998 2.465 . . . . 0.0 112.378 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.34 -18.82 65.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.2 177.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.6 11.33 59.46 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.42 117.93 53.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.775 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 120.11 7.73 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.395 2.063 . . . . 0.0 111.32 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.6 p90 -115.7 134.68 54.79 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 24.5 m-85 -99.13 113.25 25.39 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.066 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -100.12 114.81 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.561 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -84.46 126.02 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.007 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -90.81 4.08 52.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -89.63 -55.68 3.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.331 0.586 . . . . 0.0 110.069 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.3 p -95.24 -11.52 27.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.392 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? 65.54 44.52 3.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.95 155.46 26.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.904 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.467 HG21 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.46 116.32 25.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -124.54 149.51 46.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.498 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.428 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 42.7 m95 -91.43 -20.13 22.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.611 0.719 . . . . 0.0 109.703 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.79 109.1 19.89 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.733 -172.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -49.09 124.75 13.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.7 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.36 -10.8 26.04 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.79 2.327 . . . . 0.0 113.077 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -77.42 -5.78 51.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.744 0.307 . . . . 0.0 110.909 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.4 mt -74.67 -13.29 60.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.185 0.517 . . . . 0.0 110.129 172.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.145 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 112.292 -0.323 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.26 143.82 30.0 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.41 109.71 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.299 2.666 . . . . 0.0 112.435 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.33 2.54 85.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.793 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.52 79.48 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.18 0.514 . . . . 0.0 110.939 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.82 -5.15 14.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.112 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.97 92.92 6.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.845 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.04 -36.06 5.75 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.4 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.75 167.3 9.41 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.246 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.27 160.09 24.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.735 2.29 . . . . 0.0 111.892 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.24 -25.76 66.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 112.521 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.44 ' HA3' ' OD1' ' A' ' 29' ' ' ASN . . . -77.9 -4.58 85.9 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.692 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -105.02 131.28 52.74 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.55 -0.382 . . . . 0.0 110.273 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HB3' HG23 ' A' ' 26' ' ' ILE . 20.4 tt0 -114.67 103.01 10.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.573 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.548 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -82.0 128.12 33.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.255 0.55 . . . . 0.0 110.095 176.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -134.86 131.99 38.04 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -90.69 109.49 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.63 151.49 74.31 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.467 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.8 13.01 0.19 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.56 2.84 . . . . 0.0 114.442 -173.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -9.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.66 53.39 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.396 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.27 112.19 61.33 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.608 0.242 . . . . 0.0 110.814 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 26.0 Cg_exo -65.4 114.27 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.142 1.895 . . . . 0.0 111.255 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.474 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 8.0 p90 -107.81 133.62 51.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.45 0.643 . . . . 0.0 109.811 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.53 115.96 31.5 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.949 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.58 ' CG1' HG22 ' A' ' 33' ' ' THR . 0.0 OUTLIER -102.01 110.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 122.165 0.983 . . . . 0.0 109.799 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.72 126.39 30.79 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.648 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -100.74 7.91 43.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.748 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.44 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 1.7 m-80 -88.34 -50.12 6.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -115.54 2.5 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.267 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 63.21 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.056 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.56 150.15 49.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.421 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.58 HG22 ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -123.24 113.69 19.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.726 -179.101 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -123.5 140.94 52.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.474 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 32.9 m95 -89.1 -17.91 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.904 0.859 . . . . 0.0 108.831 172.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -93.28 112.57 24.53 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.913 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' OD2' ' HG ' ' A' ' 40' ' ' LEU . 10.1 t70 -56.99 129.09 78.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 -177.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.98 6.51 5.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.062 2.508 . . . . 0.0 113.654 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -97.57 -56.75 2.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.806 0.336 . . . . 0.0 110.764 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HG ' ' OD2' ' A' ' 37' ' ' ASP . 1.9 mt -82.07 -45.27 15.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.462 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 14.9 mttt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.402 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.34 123.28 80.18 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.649 0.261 . . . . 0.0 110.884 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -57.53 114.45 1.95 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.769 2.313 . . . . 0.0 111.753 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.1 -87.74 0.14 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt 55.26 67.18 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.516 0.674 . . . . 0.0 110.375 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.55 ' HB3' HH12 ' A' ' 39' ' ' ARG . 4.9 mt-30 -106.39 91.81 3.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.04 -176.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.53 140.87 46.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.819 174.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 76.0 159.88 0.22 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.542 0.687 . . . . 0.0 110.755 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.489 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -81.33 169.54 18.67 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.321 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 21.3 Cg_exo -67.05 160.45 47.26 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.152 2.568 . . . . 0.0 111.659 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.08 -15.7 41.12 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.911 2.407 . . . . 0.0 113.136 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.98 -5.3 83.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.712 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.467 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 65.1 m95 -104.77 135.91 45.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.906 0.353 . . . . 0.0 110.665 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -128.08 112.46 14.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.76 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.446 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.58 122.28 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.288 175.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 17.5 mtt180 -124.54 153.65 41.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.42 112.88 41.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.061 0.457 . . . . 0.0 110.7 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.64 158.64 65.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.481 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.15 -10.89 6.76 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.171 2.58 . . . . 0.0 112.405 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.28 -26.97 68.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.235 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.62 57.11 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.75 121.44 44.09 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.865 -176.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.87 116.94 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.728 2.285 . . . . 0.0 111.778 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 32.8 p90 -111.91 140.16 46.8 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 37' ' ' ASP . 42.9 m-85 -103.33 110.14 22.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.679 0.752 . . . . 0.0 110.136 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -92.99 117.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.591 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -84.21 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.638 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -100.49 11.09 40.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -93.18 -45.54 7.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 42.4 p -121.31 -0.9 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.364 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 64.53 63.26 0.75 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.972 176.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.78 144.64 49.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.578 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.488 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -111.7 103.32 11.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.237 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.05 150.67 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.499 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -95.41 -2.82 48.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.79 102.83 15.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.545 ' HB3' ' HG ' ' A' ' 40' ' ' LEU . 5.0 t0 -55.95 120.43 33.6 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.422 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.34 -11.78 29.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.891 2.394 . . . . 0.0 112.921 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.55 HH12 ' HB3' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -89.56 -2.79 58.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.5 177.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 37' ' ' ASP . 67.2 mt -80.34 -14.16 58.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.399 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.292 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.47 -52.34 70.37 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.652 0.226 . . . . 0.0 111.252 174.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.45 148.08 42.32 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.597 1.532 . . . . 0.0 111.756 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.06 -156.73 18.66 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.354 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 mm -73.85 104.1 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.353 0.597 . . . . 0.0 110.938 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.424 HE21 ' HB2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -144.18 111.34 5.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.642 177.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.23 113.4 17.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.026 0.441 . . . . 0.0 111.081 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -102.26 -122.89 0.18 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.718 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.528 HD22 ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -138.36 159.87 66.14 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.5 152.35 77.91 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.531 2.154 . . . . 0.0 111.418 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.48 118.16 3.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.783 2.322 . . . . 0.0 112.495 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.75 7.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.678 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -83.7 130.85 34.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 111.483 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -128.38 115.2 17.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.511 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -97.68 135.06 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.344 0.592 . . . . 0.0 111.688 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -136.95 142.29 42.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.962 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -92.44 114.35 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.209 -175.445 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.598 ' HB1' ' OD1' ' A' ' 20' ' ' ASN . . . -82.45 149.27 60.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.092 177.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.28 -6.39 9.9 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.231 2.621 . . . . 0.0 114.675 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.598 ' OD1' ' HB1' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -80.5 -7.77 59.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.52 3.83 52.96 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.29 111.96 62.99 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.636 0.255 . . . . 0.0 111.06 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 24.1 Cg_exo -65.64 120.48 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.121 1.881 . . . . 0.0 110.283 167.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.53 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.4 p90 -105.06 138.92 40.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' CE2' HD22 ' A' ' 9' ' ' LEU . 16.4 m-85 -109.41 109.76 20.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.066 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.588 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -93.35 120.85 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.943 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.58 119.27 29.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -84.53 -6.16 59.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.382 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.63 -55.78 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 110.137 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -90.58 -9.91 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.716 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.97 53.35 3.07 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.994 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.39 150.38 50.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.876 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.521 HG22 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -107.84 114.82 29.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.967 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 155.97 25.02 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.53 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 99.6 m95 -90.11 -74.34 0.49 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.874 0.845 . . . . 0.0 110.016 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -70.47 129.18 38.55 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 -172.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -61.37 149.92 81.78 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-O 121.312 0.577 . . . . 0.0 112.191 -171.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -82.98 15.37 2.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.997 2.465 . . . . 0.0 111.78 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -91.6 -19.89 22.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.997 177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -35.19 14.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.158 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.5 pttm . . . . . 0 C--O 1.244 0.798 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.618 179.851 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -56.39 126.38 68.85 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 2.2 Cg_endo -82.86 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.166 2.577 . . . . 0.0 111.466 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 3' ' ' PRO . . . -81.84 97.09 1.83 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.82 69.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.259 0.552 . . . . 0.0 111.65 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.02 53.73 1.97 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.697 175.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.37 103.9 11.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.417 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.13 -88.44 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.013 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER -109.85 165.83 11.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.99 142.06 93.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.172 1.915 . . . . 0.0 111.464 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.29 112.91 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.776 2.317 . . . . 0.0 111.729 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.43 -24.74 4.37 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 68.4 m95 -86.96 125.36 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.817 0.342 . . . . 0.0 110.533 176.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -117.61 112.83 21.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -76.02 118.27 18.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.19 175.106 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -121.81 134.83 54.91 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mm -88.77 114.47 27.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.158 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.7 150.98 73.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.93 1.82 2.1 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.279 2.653 . . . . 0.0 114.412 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -13.75 41.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.96 8.1 37.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.136 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.99 117.78 54.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.878 -0.19 . . . . 0.0 111.402 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -60.0 121.23 9.47 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 111.043 166.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.501 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.9 p90 -117.98 136.16 53.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.2 113.17 25.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.61 0.719 . . . . 0.0 110.154 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -100.34 116.99 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 124.35 27.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.121 178.13 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -92.93 5.41 51.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.518 -175.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -92.01 -52.84 4.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.5 p -112.02 0.83 16.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.141 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER 62.04 70.48 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.531 176.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.91 150.37 46.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.343 175.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.03 108.04 12.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.66 0.267 . . . . 0.0 111.056 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.5 t -124.2 143.95 50.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.501 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.6 m95 -89.65 -21.69 22.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.773 0.797 . . . . 0.0 109.517 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 28.8 mm-40 -83.05 113.57 20.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.374 -176.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.77 120.38 41.3 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.129 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.14 9.47 1.41 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.02 2.48 . . . . 0.0 113.931 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -43.46 6.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mt -86.17 -24.1 26.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 36' ' ' GLU . 2.0 mmtm . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.183 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -54.51 34.69 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.29 -35.94 98.92 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.078 1.852 . . . . 0.0 112.519 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.63 25.85 73.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.874 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mm -114.32 40.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.499 0.666 . . . . 0.0 110.907 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -29.7 41.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.06 127.55 46.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.122 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -115.47 -165.23 1.01 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -105.69 158.07 33.18 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.96 138.09 76.44 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.977 2.452 . . . . 0.0 112.072 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.5 111.56 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.759 2.306 . . . . 0.0 111.599 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.38 -27.35 4.0 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -84.16 101.57 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' HG2' ' HD2' ' A' ' 16' ' ' ARG . 2.7 tt0 -98.6 104.48 16.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.323 -174.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.625 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -79.65 119.03 22.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.0 109.866 174.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.526 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -124.36 139.66 53.69 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 17' ' ' ILE . 1.7 mm -88.72 104.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.877 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.17 156.11 92.23 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.391 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 -3.01 2.94 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.208 2.605 . . . . 0.0 113.046 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -78.33 -17.19 56.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.277 0.561 . . . . 0.0 109.534 172.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.34 1.55 55.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.943 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HG2' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.57 129.35 24.11 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.66 -0.27 . . . . 0.0 110.926 -175.267 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 121.74 9.57 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.789 2.326 . . . . 0.0 111.412 168.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.1 p90 -119.51 141.04 49.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.162 0.506 . . . . 0.0 109.948 176.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.625 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.3 m-85 -106.24 112.63 25.74 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.988 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.538 ' O ' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -98.23 112.82 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.653 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.97 113.94 18.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.418 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -81.94 13.29 3.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.371 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -97.42 -57.69 2.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.23 0.538 . . . . 0.0 109.899 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -93.5 -14.39 26.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.5 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 mttt 71.95 37.49 1.02 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.305 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.73 154.27 21.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.768 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.503 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -119.41 116.12 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.715 -175.581 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 t -123.59 141.43 52.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.567 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -92.23 -10.55 38.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.884 0.849 . . . . 0.0 109.221 174.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.93 112.2 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.554 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.537 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 33.1 t0 -62.45 112.57 6.74 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.32 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HG2' HD21 ' A' ' 9' ' ' LEU . 42.8 Cg_endo -69.86 -9.64 26.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.871 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -74.98 -16.18 60.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.128 0.489 . . . . 0.0 109.899 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 12.0 mt -87.9 -10.78 49.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.149 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.611 -0.196 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -56.27 21.32 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.61 0.205 . . . . 0.0 111.463 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -86.54 0.25 7.98 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.967 1.778 . . . . 0.0 111.79 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.31 115.18 2.4 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.187 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.11 139.57 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.849 0.357 . . . . 0.0 110.166 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.87 86.21 6.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.609 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.42 116.44 13.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.754 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.577 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -57.97 -63.96 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.337 178.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 173.07 4.81 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.39 147.95 92.2 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.733 1.622 . . . . 0.0 110.249 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -58.47 -10.92 9.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.802 2.334 . . . . 0.0 113.606 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.07 1.24 80.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.509 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.477 ' HE3' ' HB3' ' A' ' 25' ' ' PHE . 37.9 m95 -105.14 115.17 29.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.022 0.439 . . . . 0.0 110.061 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB3' HG23 ' A' ' 26' ' ' ILE . 21.0 tt0 -98.47 99.73 10.93 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.707 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.636 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.3 ptp -79.63 92.92 5.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.434 0.635 . . . . 0.0 110.455 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 16' ' ' ARG . 44.5 mtt-85 -85.71 128.55 34.82 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.031 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 17' ' ' ILE . 3.7 mm -88.03 102.12 12.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.185 -178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.78 146.02 90.24 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.696 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.27 -5.62 5.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.842 2.361 . . . . 0.0 112.502 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.18 -17.05 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 0.0 109.874 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.76 60.05 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.037 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.94 110.3 62.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.925 -177.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.0 117.65 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.025 . . . . 0.0 110.861 167.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.9 p90 -111.6 127.53 55.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.727 0.775 . . . . 0.0 109.862 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.636 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.9 m-85 -93.58 103.94 16.09 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.463 -172.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.416 HG23 ' HB3' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -95.22 109.09 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.455 176.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.9 127.29 32.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.247 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -100.18 12.0 38.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.0 111.023 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -100.42 -51.02 3.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.021 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.5 p -111.67 4.6 18.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.905 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 64.88 1.19 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.366 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.74 144.53 48.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.766 174.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.37 101.77 7.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.403 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.769 0.318 . . . . 0.0 111.566 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.544 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -89.78 -17.78 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.768 0.794 . . . . 0.0 109.101 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.85 114.55 21.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.486 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.45 120.8 68.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.979 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.05 10.19 3.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.161 2.574 . . . . 0.0 113.767 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.577 ' HD3' ' O ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -102.65 -43.8 5.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 mt -73.49 -38.77 65.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.111 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.53 -0.747 . . . . 0.0 110.077 178.189 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.843 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.04 110.8 56.49 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.877 0.37 . . . . 0.0 110.833 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.04 -16.81 13.96 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.568 2.179 . . . . 0.0 112.341 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.02 98.72 0.51 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.973 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mm -76.65 86.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.8 0.333 . . . . 0.0 110.488 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 70.36 -0.02 3.02 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.543 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.65 ' HB2' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.35 84.99 7.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.47 0.652 . . . . 0.0 110.627 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -99.07 -172.94 2.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.853 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.435 HD21 ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -134.89 163.62 49.92 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.885 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.88 148.31 89.81 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.522 2.148 . . . . 0.0 111.52 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.65 119.58 5.36 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.844 2.363 . . . . 0.0 112.093 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.47 -24.37 6.89 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.914 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -83.86 125.99 32.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 110.918 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.07 122.12 33.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.494 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.615 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 1.9 ptt? -89.26 124.03 34.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -128.55 143.85 51.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.92 125.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 0.0 110.597 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.506 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . . . -89.43 165.09 27.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 18' ' ' ALA . 21.6 Cg_endo -60.88 -15.0 35.57 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.357 2.705 . . . . 0.0 113.928 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.13 56.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.008 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.93 20.66 60.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.057 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.428 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 9.5 mmm180 -107.8 120.94 45.6 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.82 -0.224 . . . . 0.0 110.435 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.45 113.64 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.048 1.832 . . . . 0.0 111.061 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.44 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.7 p90 -112.45 138.45 49.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.615 ' CE2' ' HB3' ' A' ' 15' ' ' MET . 7.2 m-85 -103.58 114.47 28.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.885 -174.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.519 HD12 HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -101.3 112.68 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.53 -178.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.2 120.41 22.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.348 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -89.81 -1.51 58.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.436 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.19 -57.63 3.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.2 p -113.23 6.87 17.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.978 -176.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.04 67.95 0.65 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.59 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 149.5 42.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -126.05 108.23 11.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.817 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 36' ' ' GLU . 4.1 t -124.19 148.53 47.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.335 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.44 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 38.9 m95 -91.26 -15.46 29.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.611 0.719 . . . . 0.0 110.153 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' O ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -107.19 107.88 19.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.863 -175.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -58.38 146.26 72.47 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.708 -175.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.14 11.8 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.79 2.326 . . . . 0.0 112.268 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.65 ' HD2' ' HB2' ' A' ' 7' ' ' SER . 1.6 ptt180 -103.13 -7.35 21.36 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.353 0.597 . . . . 0.0 109.726 175.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.5 mt -92.97 -47.36 7.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.699 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.813 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.56 162.36 67.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 122.181 0.193 . . . . 0.0 110.634 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.3 59.92 1.42 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.883 2.389 . . . . 0.0 111.479 173.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.44 136.21 2.68 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -175.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 mt -81.32 58.03 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.634 0.717 . . . . 0.0 111.419 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -174.24 -172.27 0.68 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.806 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -80.72 157.26 25.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.14 13.82 2.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.268 0.556 . . . . 0.0 111.993 -177.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.61 169.48 7.31 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.534 175.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.24 150.66 39.33 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 121.997 1.798 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.38 -27.92 25.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.299 2.666 . . . . 0.0 113.7 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.82 -13.41 83.46 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.22 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.407 ' CE3' ' HG3' ' A' ' 38' ' ' PRO . 80.5 m95 -92.84 121.42 34.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.976 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -118.52 105.58 11.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.447 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.495 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptp -83.19 128.73 34.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.258 0.551 . . . . 0.0 110.731 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.85 152.35 48.61 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.71 111.61 32.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.089 0.471 . . . . 0.0 110.328 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.83 155.81 82.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.689 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.64 -7.75 7.88 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.391 2.727 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -70.4 -21.54 62.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.6 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.73 -0.14 59.3 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.64 46.52 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.703 -177.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.03 126.8 23.35 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.723 2.282 . . . . 0.0 111.208 169.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.402 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.1 p90 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.508 0.67 . . . . 0.0 109.952 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.495 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 20.3 m-85 -104.78 114.41 28.61 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.531 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.615 ' O ' HG21 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -98.05 118.8 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.723 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.64 119.97 28.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.197 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -85.12 -3.84 58.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.855 0.36 . . . . 0.0 110.905 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -80.56 -57.29 3.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 109.609 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -90.35 -12.75 36.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.488 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 mttm 60.92 55.07 3.25 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.09 152.88 48.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.366 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.74 116.39 26.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.947 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -123.21 145.26 48.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.499 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.402 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 7.4 m95 -89.66 -20.05 24.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.739 0.781 . . . . 0.0 109.411 176.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.8 110.16 17.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.911 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -49.82 120.77 11.68 Favored Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.012 0.82 . . . . 0.0 111.738 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HG3' ' CE3' ' A' ' 13' ' ' TRP . 29.9 Cg_endo -64.05 -12.65 33.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.113 2.542 . . . . 0.0 113.049 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -74.79 -12.05 60.3 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.433 ' C ' ' HG3' ' A' ' 41' ' ' LYS . 14.2 mt -88.58 -31.74 18.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.837 173.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.433 ' HG3' ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 124.602 1.161 . . . . 0.0 112.719 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 9' ' ' LEU . 53.8 Cg_exo -54.28 147.21 46.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.445 1.43 . . . . 0.0 110.941 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 38.2 Cg_exo -63.81 10.02 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.454 2.769 . . . . 0.0 114.159 -176.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.96 -0.18 27.11 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 174.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -104.74 128.75 52.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 110.467 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -114.96 111.31 20.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.631 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.614 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -85.53 115.4 23.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.231 0.539 . . . . 0.0 110.424 176.23 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -113.91 142.58 45.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.277 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mm -93.07 101.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.296 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 153.79 72.02 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.407 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.64 -16.98 16.14 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.944 2.429 . . . . 0.0 112.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -63.61 -25.99 68.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.429 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.93 -0.37 44.94 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.13 125.4 32.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.53 0.205 . . . . 0.0 111.229 -176.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.33 123.79 14.17 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.926 2.417 . . . . 0.0 111.493 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.431 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 22.0 p90 -121.22 137.52 54.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.299 0.571 . . . . 0.0 109.902 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 20.5 m-85 -101.2 112.44 24.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.477 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.415 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -100.51 119.19 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.654 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.628 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 1.1 t70 -83.41 132.41 34.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.896 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -100.77 8.57 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.415 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -88.29 -58.26 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 109.882 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 47.6 p -98.94 -23.45 15.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.845 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 78.94 70.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.904 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -129.21 166.6 19.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.574 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.415 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -128.49 109.89 11.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.664 -174.033 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 t -124.02 146.82 48.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.486 0.184 . . . . 0.0 110.709 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.431 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 21.6 m95 -90.25 -36.23 14.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.486 0.66 . . . . 0.0 109.398 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.93 121.51 19.21 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.754 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -61.12 115.23 13.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.409 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.4 -12.18 34.6 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.005 2.47 . . . . 0.0 113.072 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 39' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 110.355 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.71 152.77 71.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.279 1.986 . . . . 0.0 111.122 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.83 -2.19 5.11 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.918 2.412 . . . . 0.0 113.511 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' HD21 ' A' ' 29' ' ' ASN . . . -92.36 -11.55 59.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.588 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -99.35 111.98 24.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 110.118 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 26' ' ' ILE . 12.1 tt0 -100.59 104.19 15.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.585 -177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.405 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -69.09 127.54 33.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.539 0.685 . . . . 0.0 109.592 174.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -125.6 123.66 39.51 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.581 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 102.98 14.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.688 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -65.46 152.19 92.8 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.119 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 31.4 Cg_exo -60.2 -4.0 2.77 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.001 2.468 . . . . 0.0 112.273 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.19 -25.39 61.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.31 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.25 5.78 48.97 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.522 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.28 120.36 47.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.458 0.17 . . . . 0.0 110.802 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.35 113.18 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.286 1.99 . . . . 0.0 111.252 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.0 p90 -111.43 135.99 51.21 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 15' ' ' MET . 22.9 m-85 -101.16 116.4 32.73 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.481 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -102.48 113.64 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.954 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 35.9 t0 -80.65 126.37 31.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.549 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -90.16 -7.79 52.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.83 0.348 . . . . 0.0 110.521 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.414 HD21 ' HA3' ' A' ' 12' ' ' GLY . 61.3 m-80 -82.52 -54.59 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.274 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -94.43 -12.48 27.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.45 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 1.2 mtmt 62.83 58.27 1.58 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.279 0.562 . . . . 0.0 111.076 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.7 152.75 47.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.633 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.481 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -122.83 112.86 18.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.693 -177.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t -123.97 147.13 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.853 0.359 . . . . 0.0 110.877 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.522 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 48.8 m95 -91.27 -9.54 44.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.859 0.838 . . . . 0.0 109.858 177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.66 125.75 52.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.337 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -61.19 116.0 17.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.67 -16.28 50.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.561 2.84 . . . . 0.0 113.528 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 -178.647 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 15' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 20.4 Cg_exo -66.68 148.84 83.67 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.109 1.873 . . . . 0.0 111.409 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -47.04 110.47 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.506 2.804 . . . . 0.0 112.724 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.06 -26.8 5.24 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.557 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 86.2 m95 -82.05 120.43 25.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.815 0.341 . . . . 0.0 110.302 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -112.84 105.35 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.444 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.566 ' HB3' HD11 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -79.15 130.58 35.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.394 0.616 . . . . 0.0 110.846 178.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.27 153.06 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.85 124.08 60.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.683 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.72 55.62 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -58.4 -11.71 11.69 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.507 2.805 . . . . 0.0 114.552 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -18.19 55.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.14 5.77 32.46 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.872 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' H ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.87 118.96 51.63 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.724 0.297 . . . . 0.0 111.2 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.57 123.81 13.06 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.745 2.296 . . . . 0.0 111.296 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.574 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 13.4 p90 -116.06 142.97 46.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.235 0.54 . . . . 0.0 109.599 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 10.9 m-85 -110.17 116.83 32.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.681 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.542 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.39 110.44 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.046 0.927 . . . . 0.0 110.032 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.45 126.71 31.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.394 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -98.98 6.3 46.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.332 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -88.56 -58.61 2.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.069 0.461 . . . . 0.0 109.774 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.0 p -104.38 -4.1 23.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.528 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.88 64.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.339 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.1 143.94 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.542 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -117.53 100.9 7.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.01 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.5 t -123.86 149.12 46.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.96 0.409 . . . . 0.0 111.494 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.2 m95 -96.67 5.02 51.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.55 108.68 19.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.596 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.533 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 19.7 t0 -63.19 113.75 10.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.814 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.61 -1.86 11.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.403 2.735 . . . . 0.0 112.56 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 0.0 110.04 176.812 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 47.0 Cg_exo -56.37 153.01 36.32 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.569 2.179 . . . . 0.0 112.148 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 64.5 Cg_exo -52.44 110.73 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.024 2.483 . . . . 0.0 112.162 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.14 -20.26 6.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.343 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 81.9 m95 -82.14 120.33 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -114.31 111.11 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.746 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.484 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.45 104.72 9.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.183 175.518 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 16' ' ' ARG . 27.2 mtt-85 -103.01 121.83 43.36 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.25 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mm -80.52 109.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.844 0.354 . . . . 0.0 110.271 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -81.75 148.8 62.42 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.033 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 23.7 Cg_exo -65.38 3.46 1.06 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.591 2.861 . . . . 0.0 114.525 -172.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -15.17 38.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 10.87 29.32 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.581 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -107.68 112.42 62.15 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.54 109.53 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.866 1.711 . . . . 0.0 110.659 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -105.8 125.92 51.56 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.592 0.711 . . . . 0.0 109.256 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 26.2 m-85 -91.88 109.84 21.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.156 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.438 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.87 114.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.937 178.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 118.61 21.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.035 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -91.41 6.56 44.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.335 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -95.9 -54.6 3.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.916 0.388 . . . . 0.0 110.355 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -111.89 5.02 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm 64.38 74.13 0.41 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.13 175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.58 145.4 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.492 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.438 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.75 105.17 8.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.711 0.291 . . . . 0.0 110.537 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 t -123.87 146.95 48.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -89.91 -11.35 42.08 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.759 0.79 . . . . 0.0 109.747 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.39 119.91 40.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.269 -171.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.405 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 64.1 t0 -48.32 116.87 5.31 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.057 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.38 -13.4 35.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.249 2.633 . . . . 0.0 113.517 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 39' ' ' ARG . 4.0 mtm105 . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.962 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.447 HD23 ' HD3' ' A' ' 39' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.29 152.82 80.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.697 2.265 . . . . 0.0 112.1 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.94 116.19 2.75 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.113 2.542 . . . . 0.0 112.325 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.5 -14.38 9.31 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.933 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 60.7 m95 -88.94 94.95 10.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 110.009 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -86.84 107.39 18.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.587 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.504 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.54 122.71 27.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.403 0.62 . . . . 0.0 110.804 178.136 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -130.92 133.96 46.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.272 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -89.18 112.03 23.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.775 0.322 . . . . 0.0 110.498 -177.052 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.07 152.84 77.1 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.236 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.74 -1.62 3.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.158 2.572 . . . . 0.0 112.504 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -75.16 -23.62 57.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.526 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.34 -4.01 29.73 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.56 123.39 37.44 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.938 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 36.2 Cg_exo -63.3 114.63 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.0 110.531 166.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 10.9 p90 -106.03 135.04 48.2 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -103.65 114.52 28.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.044 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.577 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -99.16 111.68 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.117 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 0.0 OUTLIER -81.48 120.48 25.06 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.57 -178.685 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -91.72 -4.3 55.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.174 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -84.05 -56.18 3.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.466 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.4 p -108.01 0.96 22.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.068 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 69.61 69.94 0.24 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.738 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.57 149.51 52.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.18 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.577 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.15 106.67 9.73 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -123.13 147.32 46.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.017 0.437 . . . . 0.0 111.336 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 25.7 m95 -93.87 -15.95 24.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.44 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.45 115.79 31.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 39' ' ' ARG . 3.9 t70 -53.48 127.0 48.83 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.924 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.37 -32.84 95.03 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.192 2.594 . . . . 0.0 114.166 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.537 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.195 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.412 ' CD2' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.89 140.04 92.44 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.765 1.643 . . . . 0.0 111.246 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.12 117.56 2.92 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.806 2.337 . . . . 0.0 112.393 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.442 ' HA3' HD21 ' A' ' 29' ' ' ASN . . . 121.27 -24.08 7.44 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.007 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -78.49 112.61 15.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 110.569 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HG2' ' HD2' ' A' ' 16' ' ' ARG . 18.5 tt0 -107.4 106.72 17.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.637 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.51 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.1 ptp -81.77 133.36 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 110.83 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.492 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -134.53 138.93 45.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.056 175.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.63 108.3 19.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.181 0.515 . . . . 0.0 110.347 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 152.95 84.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.386 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.31 7.19 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.393 2.729 . . . . 0.0 114.278 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -17.5 26.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.35 31.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.781 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.77 124.42 34.34 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.677 0.275 . . . . 0.0 111.355 -177.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.95 123.42 11.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.555 2.17 . . . . 0.0 111.339 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.517 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 20.5 p90 -114.4 139.33 49.58 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.203 0.525 . . . . 0.0 109.629 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 19.6 m-85 -104.67 112.56 25.69 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.49 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -97.51 112.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.666 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 4.0 t70 -77.71 124.36 27.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.02 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -94.27 2.73 55.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.231 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.442 HD21 ' HA3' ' A' ' 12' ' ' GLY . 53.4 m-80 -86.85 -62.2 1.56 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.084 0.469 . . . . 0.0 110.112 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.1 p -106.51 -1.3 23.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.897 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 68.15 72.39 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.846 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.17 141.89 51.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.49 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -116.29 97.72 6.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.758 0.313 . . . . 0.0 110.54 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.68 149.38 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.763 0.316 . . . . 0.0 111.011 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.1 m95 -89.83 -16.87 29.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -79.95 124.89 29.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.631 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.471 ' OD1' ' HG2' ' A' ' 39' ' ' ARG . 10.8 t70 -72.83 120.61 81.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.577 . . . . 0.0 111.435 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' ASP . 49.4 Cg_endo -92.26 14.45 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.475 2.784 . . . . 0.0 114.884 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 1.4 ptp180 . . . . . 0 N--CA 1.448 -0.565 0 CA-C-N 118.952 0.796 . . . . 0.0 109.899 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 39' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 41.0 Cg_exo -57.39 140.8 94.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.124 1.216 . . . . 0.0 110.015 172.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 73.5 Cg_exo -49.68 -27.91 16.05 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.262 2.642 . . . . 0.0 113.898 -174.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.59 -9.15 82.13 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.035 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -93.32 119.46 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.05 0.453 . . . . 0.0 110.195 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 26' ' ' ILE . 16.0 tt0 -109.81 108.11 18.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.76 131.24 37.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.29 0.567 . . . . 0.0 110.537 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -133.77 142.63 48.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.276 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.85 109.11 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 109.97 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.41 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . . . -81.24 159.29 68.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.535 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.67 0.82 1.28 Allowed 'Trans proline' 0 N--CA 1.478 0.59 0 C-N-CA 123.474 2.782 . . . . 0.0 114.53 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -87.03 -7.61 57.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 13.65 65.16 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.64 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -108.18 120.01 48.08 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.608 0.242 . . . . 0.0 111.429 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -63.62 114.42 2.54 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.328 2.019 . . . . 0.0 111.536 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.532 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.8 p90 -113.13 139.88 48.36 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HD1' ' HB3' ' A' ' 15' ' ' MET . 20.4 m-85 -105.05 113.0 26.34 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.625 0.726 . . . . 0.0 110.027 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.536 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -94.4 115.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.66 126.08 32.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.872 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.52 10.61 39.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.411 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -93.84 -46.12 7.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 109.975 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 18.71 8.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.67 58.53 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.843 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 148.35 43.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.924 0.392 . . . . 0.0 111.235 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.536 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.58 102.03 6.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.209 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 t -123.65 149.59 45.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.5 m95 -91.69 -20.99 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.298 0.57 . . . . 0.0 110.477 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.08 118.47 25.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.533 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 38' ' ' PRO . 19.4 t0 -64.53 117.89 42.18 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.77 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 37' ' ' ASP . 19.2 Cg_endo -62.34 -17.55 58.03 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.952 2.435 . . . . 0.0 112.958 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 35.3 mtm180 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 0.0 110.899 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 12.2 Cg_exo -70.73 147.84 57.48 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 111.619 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.4 125.59 6.06 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.072 2.515 . . . . 0.0 112.492 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.74 -29.99 7.78 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.463 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.549 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 68.0 m95 -79.67 122.72 26.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.192 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -120.12 116.22 25.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 136.33 36.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 0.0 110.463 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.58 155.8 47.26 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.92 112.63 41.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.506 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.07 151.94 73.53 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.175 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.31 -7.47 6.82 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.774 2.983 . . . . 0.0 114.458 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -9.08 58.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.076 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.27 10.33 51.54 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.735 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.43 116.07 56.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.219 . . . . 0.0 111.349 -177.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.39 122.95 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.375 2.05 . . . . 0.0 111.146 166.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.531 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.0 p90 -122.08 145.19 48.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.57 112.99 25.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.009 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.33 110.5 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.018 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 9.2 t70 -77.52 119.82 21.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.038 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.75 -1.91 58.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.949 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -84.74 -67.69 0.78 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.105 0.479 . . . . 0.0 110.475 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.6 p -99.57 -1.6 37.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.62 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER 65.85 75.92 0.33 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.548 177.27 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 142.73 50.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.445 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.56 93.35 4.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.04 0.447 . . . . 0.0 109.952 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.47 150.21 33.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.531 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 5.1 m95 -100.43 -36.79 9.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.457 0.646 . . . . 0.0 109.58 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.42 111.29 10.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.729 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.95 128.96 89.89 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-O 121.124 0.488 . . . . 0.0 111.867 -174.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.77 6.32 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.04 2.494 . . . . 0.0 112.38 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 . . . . . 0 C--N 1.328 -0.337 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.725 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 11.4 Cg_exo -70.01 142.65 47.37 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.964 2.443 . . . . 0.0 111.347 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.11 101.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.078 2.519 . . . . 0.0 111.878 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.41 -27.69 1.67 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.534 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 69.5 m95 -84.01 116.67 22.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -111.04 102.75 11.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.715 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.673 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 3.7 ptt? -83.16 105.13 13.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.337 0.589 . . . . 0.0 110.424 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 16' ' ' ARG . 2.3 mpp_? -102.72 143.35 32.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 mm -89.19 110.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.84 0.353 . . . . 0.0 110.939 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.98 143.51 96.31 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.402 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.75 -21.27 24.86 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.363 2.708 . . . . 0.0 113.383 -175.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.68 -13.97 61.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.494 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.53 9.02 39.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.738 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.77 108.73 61.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.744 -0.228 . . . . 0.0 110.755 -178.48 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -55.81 122.01 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.303 2.002 . . . . 0.0 111.478 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.532 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 p90 -112.57 133.48 54.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.648 0.737 . . . . 0.0 109.488 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.673 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 12.9 m-85 -99.83 106.67 18.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.778 -173.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -93.25 110.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.703 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t70 -77.47 123.6 26.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.21 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -90.5 0.7 57.22 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.927 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -84.51 -54.88 4.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.854 0.359 . . . . 0.0 110.22 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.9 p -106.49 -2.34 22.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 62.7 64.63 0.89 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.149 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -113.91 141.93 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.426 176.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.405 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -115.46 95.67 5.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.312 0.577 . . . . 0.0 110.084 176.019 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.05 142.87 49.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.206 -173.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 2.1 m95 -92.42 -23.56 19.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.608 0.718 . . . . 0.0 109.381 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.44 102.84 6.15 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.483 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -51.57 130.1 35.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.589 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.44 14.78 2.34 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.314 2.676 . . . . 0.0 113.971 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-O 121.409 0.623 . . . . 0.0 109.376 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.96 157.11 13.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.076 1.851 . . . . 0.0 111.915 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -50.68 -35.52 47.68 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.296 2.664 . . . . 0.0 113.323 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.2 5.71 79.0 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.604 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 60.6 m95 -108.14 119.85 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.477 0.638 . . . . 0.0 110.623 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -107.6 111.77 24.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.733 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -84.21 127.18 33.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.304 0.573 . . . . 0.0 110.206 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.432 ' NH1' HG21 ' A' ' 26' ' ' ILE . 10.2 mtp180 -136.79 133.45 35.97 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.8 OUTLIER -87.04 120.43 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.288 -178.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -82.95 147.8 55.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.405 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 25.2 Cg_exo -64.33 -1.07 3.38 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.386 2.724 . . . . 0.0 114.044 -174.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -29.09 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.33 -2.92 8.94 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.289 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.28 123.92 36.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 122.624 -0.339 . . . . 0.0 111.338 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 33.3 Cg_exo -61.35 128.41 24.86 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.593 2.196 . . . . 0.0 111.006 167.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.548 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.1 p90 -119.66 148.45 43.35 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.104 0.478 . . . . 0.0 109.781 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -114.4 112.85 23.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.592 0.71 . . . . 0.0 109.694 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.432 HG21 ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -95.19 112.08 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.562 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.91 127.25 31.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.238 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -100.61 11.3 39.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -94.64 -48.75 5.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.1 p -115.72 2.47 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.197 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.24 65.5 0.97 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.266 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.95 142.31 51.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.23 99.19 8.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 t -117.93 152.15 36.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.7 m95 -95.37 -12.92 25.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.622 0.725 . . . . 0.0 109.9 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.38 122.48 31.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.888 -175.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.85 116.97 51.57 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.773 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD2' ' CD2' ' A' ' 9' ' ' LEU . 72.4 Cg_endo -76.78 15.19 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.363 2.709 . . . . 0.0 113.347 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 171.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 1.3 mp . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 9' ' ' LEU . 39.8 Cg_exo -59.12 153.74 50.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.359 2.04 . . . . 0.0 112.302 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.18 118.6 4.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.294 2.663 . . . . 0.0 112.438 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.2 -22.59 12.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.836 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -83.38 127.01 33.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.535 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -118.9 107.86 14.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.66 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.456 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.1 OUTLIER -81.27 118.55 22.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.377 0.608 . . . . 0.0 110.208 175.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -127.27 141.98 51.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.084 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 mm -95.3 112.63 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.635 -175.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.31 153.68 92.14 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.284 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.44 -11.85 18.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.018 2.479 . . . . 0.0 112.558 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.405 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 1.9 m-20 -79.74 -1.64 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.63 66.12 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' CG ' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.93 120.21 46.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.13 -173.341 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.39 120.62 8.25 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.641 2.228 . . . . 0.0 111.029 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.426 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.8 p90 -116.23 141.8 47.67 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -108.0 111.47 23.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.909 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.445 HG13 HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -97.63 115.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.17 126.51 31.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.646 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.02 8.1 44.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -94.92 -49.87 5.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -113.29 7.39 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? 58.67 67.28 0.95 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.071 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.68 145.47 51.52 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.924 0.392 . . . . 0.0 111.189 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.445 HG23 HG13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -112.08 109.11 18.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.146 178.404 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.43 143.73 49.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.426 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 9.3 m95 -97.11 -33.46 11.5 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.862 0.839 . . . . 0.0 108.808 174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -78.15 111.74 14.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.442 179.289 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.0 132.38 67.88 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.652 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.75 12.83 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.078 2.519 . . . . 0.0 112.748 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.211 0.529 . . . . 0.0 109.882 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.616 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 13.7 Cg_exo -70.33 149.42 63.25 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.599 2.2 . . . . 0.0 111.279 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 57.2 Cg_exo -51.59 114.01 1.39 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.936 2.424 . . . . 0.0 112.263 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.69 -23.55 5.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.616 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 77.3 m95 -78.8 125.03 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 111.208 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 26' ' ' ILE . 21.2 tt0 -122.13 107.86 12.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.137 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.444 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptm -81.2 126.02 31.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.415 0.626 . . . . 0.0 110.181 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -124.85 142.95 51.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.012 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 mm -93.32 119.48 41.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.318 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.0 156.77 71.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.082 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.37 -20.1 24.55 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.998 2.465 . . . . 0.0 112.378 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -66.34 -18.82 65.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.2 177.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.6 11.33 59.46 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HG2' ' HB3' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.42 117.93 53.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.775 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 120.11 7.73 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.395 2.063 . . . . 0.0 111.32 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.445 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.6 p90 -115.7 134.68 54.79 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 24.5 m-85 -99.13 113.25 25.39 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.066 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -100.12 114.81 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.561 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -84.46 126.02 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.007 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -90.81 4.08 52.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -89.63 -55.68 3.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.331 0.586 . . . . 0.0 110.069 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.3 p -95.24 -11.52 27.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.392 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? 65.54 44.52 3.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.95 155.46 26.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.904 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.403 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.46 116.32 25.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -124.54 149.51 46.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.498 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.445 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 42.7 m95 -91.43 -20.13 22.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.611 0.719 . . . . 0.0 109.703 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.79 109.1 19.89 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.733 -172.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -49.09 124.75 13.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.7 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.36 -10.8 26.04 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.79 2.327 . . . . 0.0 113.077 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.744 0.307 . . . . 0.0 110.909 177.487 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.27 160.09 24.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.735 2.29 . . . . 0.0 111.892 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.24 -25.76 66.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 112.521 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' HA3' ' OD1' ' A' ' 29' ' ' ASN . . . -77.9 -4.58 85.9 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.692 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -105.02 131.28 52.74 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.55 -0.382 . . . . 0.0 110.273 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 20.4 tt0 -114.67 103.01 10.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.573 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.559 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -82.0 128.12 33.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.255 0.55 . . . . 0.0 110.095 176.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -134.86 131.99 38.04 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -90.69 109.49 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -79.63 151.49 74.31 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.467 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 17.7 Cg_exo -67.8 13.01 0.19 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.56 2.84 . . . . 0.0 114.442 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -9.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.66 53.39 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.396 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.27 112.19 61.33 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.608 0.242 . . . . 0.0 110.814 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 26.0 Cg_exo -65.4 114.27 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.142 1.895 . . . . 0.0 111.255 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.49 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 8.0 p90 -107.81 133.62 51.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.45 0.643 . . . . 0.0 109.811 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.53 115.96 31.5 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.949 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.587 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -102.01 110.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 122.165 0.983 . . . . 0.0 109.799 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.72 126.39 30.79 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.648 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -100.74 7.91 43.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.748 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.453 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 1.7 m-80 -88.34 -50.12 6.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -115.54 2.5 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.267 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 63.21 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.056 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.56 150.15 49.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.421 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.587 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -123.24 113.69 19.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.726 -179.101 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -123.5 140.94 52.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.49 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 32.9 m95 -89.1 -17.91 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.904 0.859 . . . . 0.0 108.831 172.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -93.28 112.57 24.53 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.913 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.99 129.09 78.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.98 6.51 5.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.062 2.508 . . . . 0.0 113.654 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.806 0.336 . . . . 0.0 110.764 179.429 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.524 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.202 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 21.3 Cg_exo -67.05 160.45 47.26 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.152 2.568 . . . . 0.0 111.659 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.08 -15.7 41.12 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.911 2.407 . . . . 0.0 113.136 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.98 -5.3 83.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.712 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.467 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 65.1 m95 -104.77 135.91 45.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.906 0.353 . . . . 0.0 110.665 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -128.08 112.46 14.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.76 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.462 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.58 122.28 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.288 175.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 17.5 mtt180 -124.54 153.65 41.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.42 112.88 41.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.061 0.457 . . . . 0.0 110.7 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.64 158.64 65.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.481 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.15 -10.89 6.76 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.171 2.58 . . . . 0.0 112.405 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.28 -26.97 68.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.235 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.62 57.11 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.75 121.44 44.09 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.865 -176.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.87 116.94 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.728 2.285 . . . . 0.0 111.778 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.516 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 32.8 p90 -111.91 140.16 46.8 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 42.9 m-85 -103.33 110.14 22.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.679 0.752 . . . . 0.0 110.136 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.466 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -92.99 117.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.591 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -84.21 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.638 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -100.49 11.09 40.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -93.18 -45.54 7.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 42.4 p -121.31 -0.9 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.364 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 64.53 63.26 0.75 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.972 176.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.78 144.64 49.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.578 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.466 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -111.7 103.32 11.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.237 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.05 150.67 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -95.41 -2.82 48.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.576 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.79 102.83 15.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.46 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 5.0 t0 -55.95 120.43 33.6 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.422 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.34 -11.78 29.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.891 2.394 . . . . 0.0 112.921 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.524 ' HD2' ' HA ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.5 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.5 152.35 77.91 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.531 2.154 . . . . 0.0 111.418 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.48 118.16 3.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.783 2.322 . . . . 0.0 112.495 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.75 7.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.678 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 78.0 m95 -83.7 130.85 34.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 111.483 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB3' HG22 ' A' ' 26' ' ' ILE . 4.1 tt0 -128.38 115.2 17.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.526 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -97.68 135.06 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.344 0.592 . . . . 0.0 111.688 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -136.95 142.29 42.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.962 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -92.44 114.35 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.209 -175.445 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.45 149.27 60.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.092 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.28 -6.39 9.9 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.231 2.621 . . . . 0.0 114.675 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -7.77 59.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.52 3.83 52.96 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -107.29 111.96 62.99 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.636 0.255 . . . . 0.0 111.06 -178.573 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 24.1 Cg_exo -65.64 120.48 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.121 1.881 . . . . 0.0 110.283 167.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.548 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.4 p90 -105.06 138.92 40.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 16.4 m-85 -109.41 109.76 20.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.066 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.483 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -93.35 120.85 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.943 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.58 119.27 29.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -84.53 -6.16 59.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.382 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.63 -55.78 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 110.137 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -90.58 -9.91 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.716 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.97 53.35 3.07 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.994 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.39 150.38 50.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.876 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.483 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -107.84 114.82 29.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.967 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 155.97 25.02 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 99.6 m95 -90.11 -74.34 0.49 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.874 0.845 . . . . 0.0 110.016 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 6.4 mt-10 -70.47 129.18 38.55 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 -172.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -61.37 149.92 81.78 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-O 121.312 0.577 . . . . 0.0 112.191 -171.562 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -82.98 15.37 2.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.997 2.465 . . . . 0.0 111.78 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.997 177.794 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.99 142.06 93.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.172 1.915 . . . . 0.0 111.464 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.29 112.91 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.776 2.317 . . . . 0.0 111.729 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.43 -24.74 4.37 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 68.4 m95 -86.96 125.36 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.817 0.342 . . . . 0.0 110.533 176.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -117.61 112.83 21.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -76.02 118.27 18.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.19 175.106 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -121.81 134.83 54.91 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mm -88.77 114.47 27.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.158 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.7 150.98 73.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.93 1.82 2.1 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.279 2.653 . . . . 0.0 114.412 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -13.75 41.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.96 8.1 37.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.136 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.99 117.78 54.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.878 -0.19 . . . . 0.0 111.402 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -60.0 121.23 9.47 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 111.043 166.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.516 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.9 p90 -117.98 136.16 53.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.2 113.17 25.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.61 0.719 . . . . 0.0 110.154 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.34 116.99 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 124.35 27.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.121 178.13 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -92.93 5.41 51.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.518 -175.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -92.01 -52.84 4.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.5 p -112.02 0.83 16.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.141 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER 62.04 70.48 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.531 176.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.91 150.37 46.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.343 175.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.03 108.04 12.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.66 0.267 . . . . 0.0 111.056 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.5 t -124.2 143.95 50.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.6 m95 -89.65 -21.69 22.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.773 0.797 . . . . 0.0 109.517 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -83.05 113.57 20.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.374 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.77 120.38 41.3 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.129 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.14 9.47 1.41 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.02 2.48 . . . . 0.0 113.931 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.96 138.09 76.44 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.977 2.452 . . . . 0.0 112.072 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.5 111.56 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.759 2.306 . . . . 0.0 111.599 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.38 -27.35 4.0 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -84.16 101.57 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG2' ' HD2' ' A' ' 16' ' ' ARG . 2.7 tt0 -98.6 104.48 16.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.323 -174.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.641 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -79.65 119.03 22.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.0 109.866 174.499 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.549 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -124.36 139.66 53.69 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 mm -88.72 104.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.877 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.17 156.11 92.23 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.391 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 -3.01 2.94 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.208 2.605 . . . . 0.0 113.046 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.528 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -78.33 -17.19 56.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.277 0.561 . . . . 0.0 109.534 172.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.34 1.55 55.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.943 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HG2' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.57 129.35 24.11 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.66 -0.27 . . . . 0.0 110.926 -175.267 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 121.74 9.57 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.789 2.326 . . . . 0.0 111.412 168.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.584 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.1 p90 -119.51 141.04 49.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.162 0.506 . . . . 0.0 109.948 176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.3 m-85 -106.24 112.63 25.74 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.988 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.501 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.23 112.82 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.653 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.97 113.94 18.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.418 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -81.94 13.29 3.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.371 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -97.42 -57.69 2.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.23 0.538 . . . . 0.0 109.899 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -93.5 -14.39 26.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.5 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 mttt 71.95 37.49 1.02 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.305 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.73 154.27 21.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.768 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.501 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -119.41 116.12 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.715 -175.581 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 t -123.59 141.43 52.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.584 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -92.23 -10.55 38.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.884 0.849 . . . . 0.0 109.221 174.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.93 112.2 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.554 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.525 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 33.1 t0 -62.45 112.57 6.74 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.32 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.86 -9.64 26.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.871 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 39' ' ' ARG . 18.7 mtm180 . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 121.128 0.489 . . . . 0.0 109.899 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 34.9 Cg_exo -60.39 147.95 92.2 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.733 1.622 . . . . 0.0 110.249 172.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 45.4 Cg_exo -58.47 -10.92 9.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.802 2.334 . . . . 0.0 113.606 -175.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.07 1.24 80.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.509 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.496 ' HE3' ' HB3' ' A' ' 25' ' ' PHE . 37.9 m95 -105.14 115.17 29.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.022 0.439 . . . . 0.0 110.061 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 21.0 tt0 -98.47 99.73 10.93 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.707 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.65 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.3 ptp -79.63 92.92 5.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.434 0.635 . . . . 0.0 110.455 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 16' ' ' ARG . 44.5 mtt-85 -85.71 128.55 34.82 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.031 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mm -88.03 102.12 12.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.185 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.78 146.02 90.24 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.696 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.27 -5.62 5.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.842 2.361 . . . . 0.0 112.502 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.18 -17.05 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 0.0 109.874 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.76 60.05 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.037 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.41 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -107.94 110.3 62.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.925 -177.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.0 117.65 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.025 . . . . 0.0 110.861 167.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.561 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.9 p90 -111.6 127.53 55.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.727 0.775 . . . . 0.0 109.862 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.9 m-85 -93.58 103.94 16.09 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.463 -172.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.618 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -95.22 109.09 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.455 176.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.9 127.29 32.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.247 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -100.18 12.0 38.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.0 111.023 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -100.42 -51.02 3.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.021 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.5 p -111.67 4.6 18.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.905 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 64.88 1.19 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.366 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.74 144.53 48.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.766 174.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.618 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -122.37 101.77 7.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.403 178.782 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.769 0.318 . . . . 0.0 111.566 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.561 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -89.78 -17.78 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.768 0.794 . . . . 0.0 109.101 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.85 114.55 21.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.486 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.45 120.8 68.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.979 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.05 10.19 3.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.161 2.574 . . . . 0.0 113.767 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.88 148.31 89.81 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.522 2.148 . . . . 0.0 111.52 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.65 119.58 5.36 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.844 2.363 . . . . 0.0 112.093 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.47 -24.37 6.89 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.914 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -83.86 125.99 32.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 110.918 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.07 122.12 33.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.494 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.631 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 1.9 ptt? -89.26 124.03 34.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -128.55 143.85 51.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.92 125.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 0.0 110.597 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -89.43 165.09 27.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 21.6 Cg_endo -60.88 -15.0 35.57 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.357 2.705 . . . . 0.0 113.928 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.13 56.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.008 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.93 20.66 60.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.057 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 9.5 mmm180 -107.8 120.94 45.6 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.82 -0.224 . . . . 0.0 110.435 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.45 113.64 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.048 1.832 . . . . 0.0 111.061 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.46 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.7 p90 -112.45 138.45 49.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 15' ' ' MET . 7.2 m-85 -103.58 114.47 28.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.885 -174.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.3 112.68 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.53 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.2 120.41 22.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.348 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -89.81 -1.51 58.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.436 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.19 -57.63 3.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.2 p -113.23 6.87 17.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.978 -176.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.04 67.95 0.65 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.59 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 149.5 42.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.05 108.23 11.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -124.19 148.53 47.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.335 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.46 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 38.9 m95 -91.26 -15.46 29.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.611 0.719 . . . . 0.0 110.153 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.19 107.88 19.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.863 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -58.38 146.26 72.47 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.708 -175.115 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.14 11.8 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.79 2.326 . . . . 0.0 112.268 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 . . . . . 0 N--CA 1.441 -0.925 0 CA-C-O 121.353 0.597 . . . . 0.0 109.726 175.098 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 39' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.24 150.66 39.33 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 121.997 1.798 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.38 -27.92 25.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.299 2.666 . . . . 0.0 113.7 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.82 -13.41 83.46 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.22 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.413 ' CE3' ' HG3' ' A' ' 38' ' ' PRO . 80.5 m95 -92.84 121.42 34.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.976 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.5 tt0 -118.52 105.58 11.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.447 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.51 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptp -83.19 128.73 34.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.258 0.551 . . . . 0.0 110.731 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.85 152.35 48.61 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.71 111.61 32.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.089 0.471 . . . . 0.0 110.328 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.83 155.81 82.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.689 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.64 -7.75 7.88 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.391 2.727 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -70.4 -21.54 62.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.6 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.73 -0.14 59.3 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.64 46.52 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.703 -177.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.03 126.8 23.35 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.723 2.282 . . . . 0.0 111.208 169.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.421 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.1 p90 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.508 0.67 . . . . 0.0 109.952 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 20.3 m-85 -104.78 114.41 28.61 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.531 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.573 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.05 118.8 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.723 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.64 119.97 28.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.197 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -85.12 -3.84 58.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.855 0.36 . . . . 0.0 110.905 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -80.56 -57.29 3.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 109.609 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -90.35 -12.75 36.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.488 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 mttm 60.92 55.07 3.25 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.09 152.88 48.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.366 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -117.74 116.39 26.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.947 -178.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -123.21 145.26 48.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.499 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.421 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 7.4 m95 -89.66 -20.05 24.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.739 0.781 . . . . 0.0 109.411 176.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.8 110.16 17.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.911 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -49.82 120.77 11.68 Favored Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.012 0.82 . . . . 0.0 111.738 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HG3' ' CE3' ' A' ' 13' ' ' TRP . 29.9 Cg_endo -64.05 -12.65 33.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.113 2.542 . . . . 0.0 113.049 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.429 ' HG2' HD23 ' A' ' 9' ' ' LEU . 1.7 mmp_? . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.8 -51.31 55.16 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.56 -15.26 15.18 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.672 2.248 . . . . 0.0 114.14 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.38 12.36 57.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.199 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.03 101.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.839 0.352 . . . . 0.0 110.446 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -68.43 116.21 8.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.64 73.35 3.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.906 -177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -83.3 -76.51 0.28 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.043 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -105.43 178.68 1.07 Allowed Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 172.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 9' ' ' LEU . 53.8 Cg_exo -54.28 147.21 46.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.445 1.43 . . . . 0.0 110.941 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 38.2 Cg_exo -63.81 10.02 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.454 2.769 . . . . 0.0 114.159 -176.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.96 -0.18 27.11 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 174.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -104.74 128.75 52.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 110.467 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -114.96 111.31 20.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.631 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.614 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -85.53 115.4 23.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.231 0.539 . . . . 0.0 110.424 176.23 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -113.91 142.58 45.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.277 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mm -93.07 101.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.296 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 153.79 72.02 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.407 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.64 -16.98 16.14 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.944 2.429 . . . . 0.0 112.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -63.61 -25.99 68.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.429 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.93 -0.37 44.94 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.13 125.4 32.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.53 0.205 . . . . 0.0 111.229 -176.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.33 123.79 14.17 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.926 2.417 . . . . 0.0 111.493 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.431 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 22.0 p90 -121.22 137.52 54.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.299 0.571 . . . . 0.0 109.902 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 20.5 m-85 -101.2 112.44 24.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.477 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.415 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -100.51 119.19 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.654 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.628 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 1.1 t70 -83.41 132.41 34.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.896 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -100.77 8.57 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.415 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -88.29 -58.26 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 109.882 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 47.6 p -98.94 -23.45 15.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.845 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 78.94 70.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.904 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -129.21 166.6 19.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.574 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.415 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -128.49 109.89 11.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.664 -174.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 t -124.02 146.82 48.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.486 0.184 . . . . 0.0 110.709 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.431 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 21.6 m95 -90.25 -36.23 14.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.486 0.66 . . . . 0.0 109.398 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.93 121.51 19.21 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.754 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.546 ' HB3' ' HG ' ' A' ' 40' ' ' LEU . 66.1 t0 -61.12 115.23 13.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.409 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.4 -12.18 34.6 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.005 2.47 . . . . 0.0 113.072 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 39' ' ' ARG . 0.7 OUTLIER -92.26 2.27 56.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 110.355 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' A' ' 37' ' ' ASP . 63.6 mt -75.21 -11.34 60.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.044 175.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.961 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.428 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.217 -0.353 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 60.57 70.41 0.99 Allowed Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 122.913 0.485 . . . . 0.0 111.513 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -87.55 -144.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.126 2.551 . . . . 0.0 111.757 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.2 -66.92 0.23 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.141 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -93.59 -11.91 8.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.787 0.803 . . . . 0.0 110.78 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.29 -17.36 24.85 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.811 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.11 125.7 49.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.636 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.21 -158.99 0.67 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.731 0.3 . . . . 0.0 110.577 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.06 175.27 2.53 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.71 152.77 71.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.279 1.986 . . . . 0.0 111.122 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.83 -2.19 5.11 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.918 2.412 . . . . 0.0 113.511 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' HD21 ' A' ' 29' ' ' ASN . . . -92.36 -11.55 59.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.588 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -99.35 111.98 24.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 110.118 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 26' ' ' ILE . 12.1 tt0 -100.59 104.19 15.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.585 -177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.405 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -69.09 127.54 33.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.539 0.685 . . . . 0.0 109.592 174.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -125.6 123.66 39.51 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.581 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 102.98 14.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.688 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -65.46 152.19 92.8 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.119 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 31.4 Cg_exo -60.2 -4.0 2.77 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.001 2.468 . . . . 0.0 112.273 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.19 -25.39 61.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.31 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.25 5.78 48.97 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.522 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.28 120.36 47.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.458 0.17 . . . . 0.0 110.802 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.35 113.18 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.286 1.99 . . . . 0.0 111.252 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.0 p90 -111.43 135.99 51.21 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 15' ' ' MET . 22.9 m-85 -101.16 116.4 32.73 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.481 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -102.48 113.64 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.954 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 35.9 t0 -80.65 126.37 31.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.549 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -90.16 -7.79 52.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.83 0.348 . . . . 0.0 110.521 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.414 HD21 ' HA3' ' A' ' 12' ' ' GLY . 61.3 m-80 -82.52 -54.59 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.274 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -94.43 -12.48 27.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.45 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 1.2 mtmt 62.83 58.27 1.58 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.279 0.562 . . . . 0.0 111.076 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.7 152.75 47.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.633 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.481 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -122.83 112.86 18.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.693 -177.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t -123.97 147.13 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.853 0.359 . . . . 0.0 110.877 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.522 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 48.8 m95 -91.27 -9.54 44.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.859 0.838 . . . . 0.0 109.858 177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.66 125.75 52.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.337 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -61.19 116.0 17.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.67 -16.28 50.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.561 2.84 . . . . 0.0 113.528 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -72.52 -16.54 61.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 mt -82.83 -16.81 46.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.197 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.421 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.33 -51.44 1.24 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.17 156.84 17.39 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.92 1.746 . . . . 0.0 111.998 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.99 -116.59 4.82 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.202 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mt 54.35 67.4 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.276 0.56 . . . . 0.0 110.786 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.57 134.41 39.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.624 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.08 92.18 8.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.368 0.604 . . . . 0.0 111.27 -175.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -100.77 -85.71 0.41 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 172.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 15' ' ' MET . 0.7 OUTLIER -128.87 178.28 1.75 Allowed Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 20.4 Cg_exo -66.68 148.84 83.67 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.109 1.873 . . . . 0.0 111.409 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -47.04 110.47 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.506 2.804 . . . . 0.0 112.724 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.06 -26.8 5.24 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.557 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 86.2 m95 -82.05 120.43 25.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.815 0.341 . . . . 0.0 110.302 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -112.84 105.35 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.444 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.566 ' HB3' HD11 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -79.15 130.58 35.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.394 0.616 . . . . 0.0 110.846 178.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.27 153.06 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.85 124.08 60.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.683 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.72 55.62 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -58.4 -11.71 11.69 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.507 2.805 . . . . 0.0 114.552 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -18.19 55.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.14 5.77 32.46 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.872 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' H ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.87 118.96 51.63 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.724 0.297 . . . . 0.0 111.2 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.57 123.81 13.06 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.745 2.296 . . . . 0.0 111.296 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.574 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 13.4 p90 -116.06 142.97 46.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.235 0.54 . . . . 0.0 109.599 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 10.9 m-85 -110.17 116.83 32.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.681 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.542 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.39 110.44 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.046 0.927 . . . . 0.0 110.032 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.45 126.71 31.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.394 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -98.98 6.3 46.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.332 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -88.56 -58.61 2.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.069 0.461 . . . . 0.0 109.774 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.0 p -104.38 -4.1 23.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.528 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.88 64.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.339 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.1 143.94 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.542 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -117.53 100.9 7.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.01 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.5 t -123.86 149.12 46.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.96 0.409 . . . . 0.0 111.494 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.2 m95 -96.67 5.02 51.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.55 108.68 19.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.596 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.533 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 19.7 t0 -63.19 113.75 10.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.814 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.61 -1.86 11.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.403 2.735 . . . . 0.0 112.56 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 8' ' ' PHE . 13.2 mtm180 -105.93 -5.06 19.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 0.0 110.04 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 40' ' ' LEU . 21.2 mt -101.78 -33.73 9.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.353 177.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.911 178.72 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -67.02 119.15 62.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.591 0.234 . . . . 0.0 110.454 178.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 11.8 Cg_exo -70.17 -30.88 19.7 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.882 2.388 . . . . 0.0 112.14 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.73 -32.54 3.95 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.238 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -123.06 120.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.887 0.375 . . . . 0.0 110.882 -176.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.33 -40.42 58.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.04 80.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.177 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.09 -76.28 0.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.152 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER -114.72 160.5 33.1 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 47.0 Cg_exo -56.37 153.01 36.32 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.569 2.179 . . . . 0.0 112.148 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 64.5 Cg_exo -52.44 110.73 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.024 2.483 . . . . 0.0 112.162 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.14 -20.26 6.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.343 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 81.9 m95 -82.14 120.33 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -114.31 111.11 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.746 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.484 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.45 104.72 9.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.183 175.518 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 16' ' ' ARG . 27.2 mtt-85 -103.01 121.83 43.36 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.25 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mm -80.52 109.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.844 0.354 . . . . 0.0 110.271 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -81.75 148.8 62.42 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.033 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 23.7 Cg_exo -65.38 3.46 1.06 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.591 2.861 . . . . 0.0 114.525 -172.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -15.17 38.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 10.87 29.32 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.581 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -107.68 112.42 62.15 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.54 109.53 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.866 1.711 . . . . 0.0 110.659 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -105.8 125.92 51.56 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.592 0.711 . . . . 0.0 109.256 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 26.2 m-85 -91.88 109.84 21.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.156 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.438 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.87 114.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.937 178.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 118.61 21.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.035 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -91.41 6.56 44.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.335 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -95.9 -54.6 3.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.916 0.388 . . . . 0.0 110.355 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -111.89 5.02 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm 64.38 74.13 0.41 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.13 175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.58 145.4 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.492 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.438 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.75 105.17 8.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.711 0.291 . . . . 0.0 110.537 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 t -123.87 146.95 48.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -89.91 -11.35 42.08 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.759 0.79 . . . . 0.0 109.747 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.39 119.91 40.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.269 -171.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.405 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 64.1 t0 -48.32 116.87 5.31 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.057 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 41' ' ' LYS . 31.5 Cg_endo -63.38 -13.4 35.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.249 2.633 . . . . 0.0 113.517 -174.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 39' ' ' ARG . 4.0 mtm105 -85.16 3.19 40.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.962 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -102.1 -18.52 15.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.195 0.522 . . . . 0.0 110.16 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.511 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.848 0 N-CA-C 112.094 -0.402 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.38 153.8 58.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.68 78.65 2.03 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.933 2.422 . . . . 0.0 111.562 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.69 -156.6 7.94 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.987 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 mm -86.03 83.08 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.02 30.88 0.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.291 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.16 102.83 3.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.298 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 t80 70.41 -64.29 0.37 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.87 0.731 . . . . 0.0 111.839 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.447 HD23 ' HD3' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -114.13 166.49 11.37 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.32 -177.017 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.29 152.82 80.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.697 2.265 . . . . 0.0 112.1 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.94 116.19 2.75 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.113 2.542 . . . . 0.0 112.325 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.5 -14.38 9.31 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.933 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 60.7 m95 -88.94 94.95 10.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 110.009 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -86.84 107.39 18.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.587 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.504 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.54 122.71 27.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.403 0.62 . . . . 0.0 110.804 178.136 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -130.92 133.96 46.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.272 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -89.18 112.03 23.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.775 0.322 . . . . 0.0 110.498 -177.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.07 152.84 77.1 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.236 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.74 -1.62 3.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.158 2.572 . . . . 0.0 112.504 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -75.16 -23.62 57.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.526 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.34 -4.01 29.73 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.56 123.39 37.44 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.938 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 36.2 Cg_exo -63.3 114.63 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.0 110.531 166.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 10.9 p90 -106.03 135.04 48.2 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -103.65 114.52 28.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.044 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.577 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -99.16 111.68 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.117 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 0.0 OUTLIER -81.48 120.48 25.06 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.57 -178.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -91.72 -4.3 55.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.174 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -84.05 -56.18 3.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.466 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.4 p -108.01 0.96 22.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.068 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 69.61 69.94 0.24 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.738 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.57 149.51 52.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.18 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.577 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.15 106.67 9.73 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -123.13 147.32 46.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.017 0.437 . . . . 0.0 111.336 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 25.7 m95 -93.87 -15.95 24.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.44 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.45 115.79 31.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 39' ' ' ARG . 3.9 t70 -53.48 127.0 48.83 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.924 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 11.0 Cg_endo -57.37 -32.84 95.03 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.192 2.594 . . . . 0.0 114.166 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.537 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -79.22 -16.62 56.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.195 -176.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.527 ' HG ' ' OD2' ' A' ' 37' ' ' ASP . 77.8 mt -70.56 -31.77 68.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.026 0.441 . . . . 0.0 110.499 175.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.733 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.907 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.87 118.64 7.28 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.548 0.174 . . . . 0.0 110.807 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -69.37 -72.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.179 1.92 . . . . 0.0 111.83 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.76 67.87 0.35 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.5 175.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -80.08 99.38 7.68 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.078 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.38 -4.67 57.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.369 0.605 . . . . 0.0 111.05 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.69 164.03 31.21 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.147 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.412 ' CD2' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -79.91 174.12 6.62 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.689 172.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.89 140.04 92.44 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.765 1.643 . . . . 0.0 111.246 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.12 117.56 2.92 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.806 2.337 . . . . 0.0 112.393 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.442 ' HA3' HD21 ' A' ' 29' ' ' ASN . . . 121.27 -24.08 7.44 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.007 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -78.49 112.61 15.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 110.569 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HG2' ' HD2' ' A' ' 16' ' ' ARG . 18.5 tt0 -107.4 106.72 17.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.637 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.51 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.1 ptp -81.77 133.36 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 110.83 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.492 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -134.53 138.93 45.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.056 175.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.63 108.3 19.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.181 0.515 . . . . 0.0 110.347 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 152.95 84.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.386 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.31 7.19 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.393 2.729 . . . . 0.0 114.278 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -17.5 26.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.35 31.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.781 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.77 124.42 34.34 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.677 0.275 . . . . 0.0 111.355 -177.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.95 123.42 11.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.555 2.17 . . . . 0.0 111.339 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.517 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 20.5 p90 -114.4 139.33 49.58 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.203 0.525 . . . . 0.0 109.629 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 19.6 m-85 -104.67 112.56 25.69 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.49 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -97.51 112.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.666 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 4.0 t70 -77.71 124.36 27.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.02 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -94.27 2.73 55.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.231 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.442 HD21 ' HA3' ' A' ' 12' ' ' GLY . 53.4 m-80 -86.85 -62.2 1.56 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.084 0.469 . . . . 0.0 110.112 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.1 p -106.51 -1.3 23.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.897 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 68.15 72.39 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.846 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.17 141.89 51.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.49 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -116.29 97.72 6.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.758 0.313 . . . . 0.0 110.54 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.68 149.38 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.763 0.316 . . . . 0.0 111.011 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.1 m95 -89.83 -16.87 29.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -79.95 124.89 29.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.631 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.471 ' OD1' ' HG2' ' A' ' 39' ' ' ARG . 10.8 t70 -72.83 120.61 81.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.577 . . . . 0.0 111.435 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' ASP . 49.4 Cg_endo -92.26 14.45 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.475 2.784 . . . . 0.0 114.884 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 1.4 ptp180 -94.45 -19.4 20.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.952 0.796 . . . . 0.0 109.899 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -80.48 -37.37 31.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.688 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.216 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 112.288 -0.325 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.87 133.79 61.38 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.459 0.171 . . . . 0.0 110.816 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.67 106.82 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.021 2.48 . . . . 0.0 112.359 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.02 -151.9 16.48 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.018 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mm -104.12 95.62 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.93 163.42 21.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 -177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.2 87.83 4.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.655 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 169.08 156.91 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.943 0.897 . . . . 0.0 109.983 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -82.83 174.43 6.06 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.32 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 41.0 Cg_exo -57.39 140.8 94.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.124 1.216 . . . . 0.0 110.015 172.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 73.5 Cg_exo -49.68 -27.91 16.05 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.262 2.642 . . . . 0.0 113.898 -174.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.59 -9.15 82.13 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.035 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -93.32 119.46 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.05 0.453 . . . . 0.0 110.195 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 26' ' ' ILE . 16.0 tt0 -109.81 108.11 18.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.76 131.24 37.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.29 0.567 . . . . 0.0 110.537 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -133.77 142.63 48.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.276 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.85 109.11 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 109.97 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.41 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . . . -81.24 159.29 68.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.535 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.67 0.82 1.28 Allowed 'Trans proline' 0 N--CA 1.478 0.59 0 C-N-CA 123.474 2.782 . . . . 0.0 114.53 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -87.03 -7.61 57.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 13.65 65.16 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.64 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -108.18 120.01 48.08 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.608 0.242 . . . . 0.0 111.429 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -63.62 114.42 2.54 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.328 2.019 . . . . 0.0 111.536 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.532 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.8 p90 -113.13 139.88 48.36 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HD1' ' HB3' ' A' ' 15' ' ' MET . 20.4 m-85 -105.05 113.0 26.34 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.625 0.726 . . . . 0.0 110.027 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.536 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -94.4 115.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.66 126.08 32.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.872 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.52 10.61 39.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.411 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -93.84 -46.12 7.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 109.975 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 18.71 8.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.67 58.53 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.843 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 148.35 43.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.924 0.392 . . . . 0.0 111.235 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.536 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.58 102.03 6.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.209 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 t -123.65 149.59 45.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.5 m95 -91.69 -20.99 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.298 0.57 . . . . 0.0 110.477 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.08 118.47 25.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.533 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 38' ' ' PRO . 19.4 t0 -64.53 117.89 42.18 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.77 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 37' ' ' ASP . 19.2 Cg_endo -62.34 -17.55 58.03 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.952 2.435 . . . . 0.0 112.958 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 35.3 mtm180 -83.59 -20.42 33.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 0.0 110.899 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.9 mt -79.71 -36.51 37.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.358 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.49 75.01 77.75 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 111.568 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.44 -50.85 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.767 1.645 . . . . 0.0 110.787 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.87 -172.04 17.72 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.73 63.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.505 0.669 . . . . 0.0 109.863 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -77.93 140.97 39.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.212 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.11 84.8 2.34 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.593 0.711 . . . . 0.0 110.705 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.96 -13.04 60.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.587 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 173.2 3.25 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.879 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 12.2 Cg_exo -70.73 147.84 57.48 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 111.619 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.4 125.59 6.06 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.072 2.515 . . . . 0.0 112.492 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.74 -29.99 7.78 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.463 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.549 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 68.0 m95 -79.67 122.72 26.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.192 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -120.12 116.22 25.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 136.33 36.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 0.0 110.463 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.58 155.8 47.26 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.92 112.63 41.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.506 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.07 151.94 73.53 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.175 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.31 -7.47 6.82 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.774 2.983 . . . . 0.0 114.458 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -9.08 58.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.076 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.27 10.33 51.54 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.735 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.43 116.07 56.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.219 . . . . 0.0 111.349 -177.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.39 122.95 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.375 2.05 . . . . 0.0 111.146 166.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.531 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.0 p90 -122.08 145.19 48.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.57 112.99 25.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.009 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.33 110.5 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.018 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 9.2 t70 -77.52 119.82 21.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.038 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.75 -1.91 58.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.949 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -84.74 -67.69 0.78 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.105 0.479 . . . . 0.0 110.475 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.6 p -99.57 -1.6 37.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.62 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER 65.85 75.92 0.33 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.548 177.27 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 142.73 50.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.445 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.56 93.35 4.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.04 0.447 . . . . 0.0 109.952 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.47 150.21 33.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.531 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 5.1 m95 -100.43 -36.79 9.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.457 0.646 . . . . 0.0 109.58 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' O ' ' HE2' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -75.42 111.29 10.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.729 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -60.95 128.96 89.89 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-O 121.124 0.488 . . . . 0.0 111.867 -174.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HA ' ' OXT' ' A' ' 41' ' ' LYS . 37.6 Cg_endo -68.77 6.32 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.04 2.494 . . . . 0.0 112.38 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -93.44 -9.7 37.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 37' ' ' ASP . 1.7 pp -112.19 -48.63 3.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.367 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.478 ' HE2' ' O ' ' A' ' 36' ' ' GLU . 14.8 pttt . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.446 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.56 -53.28 2.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 119.727 -0.178 . . . . 0.0 111.432 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 6' ' ' GLN . 11.2 Cg_endo -90.58 -132.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.668 2.245 . . . . 0.0 111.708 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' ' 3' ' ' PRO . . . -107.62 154.28 16.62 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.819 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mt 50.52 62.19 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 122.96 0.504 . . . . 0.0 110.903 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.506 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 9.3 mm100 54.66 -103.3 0.17 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.833 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m 59.58 -168.91 0.15 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.002 0.521 . . . . 0.0 112.118 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -131.32 -66.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.617 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.23 167.39 12.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.983 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 11.4 Cg_exo -70.01 142.65 47.37 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.964 2.443 . . . . 0.0 111.347 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.11 101.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.078 2.519 . . . . 0.0 111.878 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.41 -27.69 1.67 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.534 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 69.5 m95 -84.01 116.67 22.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -111.04 102.75 11.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.715 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.673 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 3.7 ptt? -83.16 105.13 13.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.337 0.589 . . . . 0.0 110.424 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 16' ' ' ARG . 2.3 mpp_? -102.72 143.35 32.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 mm -89.19 110.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.84 0.353 . . . . 0.0 110.939 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.98 143.51 96.31 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.402 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.75 -21.27 24.86 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.363 2.708 . . . . 0.0 113.383 -175.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.68 -13.97 61.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.494 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.53 9.02 39.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.738 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.77 108.73 61.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.744 -0.228 . . . . 0.0 110.755 -178.48 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -55.81 122.01 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.303 2.002 . . . . 0.0 111.478 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.532 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 p90 -112.57 133.48 54.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.648 0.737 . . . . 0.0 109.488 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.673 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 12.9 m-85 -99.83 106.67 18.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.778 -173.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -93.25 110.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.703 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t70 -77.47 123.6 26.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.21 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -90.5 0.7 57.22 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.927 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -84.51 -54.88 4.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.854 0.359 . . . . 0.0 110.22 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.9 p -106.49 -2.34 22.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 62.7 64.63 0.89 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.149 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -113.91 141.93 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.426 176.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.405 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -115.46 95.67 5.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.312 0.577 . . . . 0.0 110.084 176.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.05 142.87 49.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.206 -173.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 2.1 m95 -92.42 -23.56 19.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.608 0.718 . . . . 0.0 109.381 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.44 102.84 6.15 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.483 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -51.57 130.1 35.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.589 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.44 14.78 2.34 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.314 2.676 . . . . 0.0 113.971 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 -44.31 5.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.409 0.623 . . . . 0.0 109.376 173.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mt -81.91 -39.4 23.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.257 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.798 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.29 116.32 66.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 O-C-N 122.804 -0.233 . . . . 0.0 110.448 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.23 163.8 30.45 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.885 2.39 . . . . 0.0 112.409 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.2 75.36 2.3 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.83 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.34 55.82 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.031 0.443 . . . . 0.0 110.576 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -93.62 -136.17 0.18 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.395 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.8 1.03 32.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.588 0.709 . . . . 0.0 110.571 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.77 -152.43 0.43 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.942 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -110.46 -177.37 0.45 Allowed Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.96 157.11 13.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.076 1.851 . . . . 0.0 111.915 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -50.68 -35.52 47.68 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.296 2.664 . . . . 0.0 113.323 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.2 5.71 79.0 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.604 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 60.6 m95 -108.14 119.85 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.477 0.638 . . . . 0.0 110.623 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -107.6 111.77 24.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.733 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -84.21 127.18 33.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.304 0.573 . . . . 0.0 110.206 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.432 ' NH1' HG21 ' A' ' 26' ' ' ILE . 10.2 mtp180 -136.79 133.45 35.97 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.8 OUTLIER -87.04 120.43 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.288 -178.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -82.95 147.8 55.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.405 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 25.2 Cg_exo -64.33 -1.07 3.38 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.386 2.724 . . . . 0.0 114.044 -174.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -29.09 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.33 -2.92 8.94 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.289 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.28 123.92 36.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 122.624 -0.339 . . . . 0.0 111.338 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 33.3 Cg_exo -61.35 128.41 24.86 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.593 2.196 . . . . 0.0 111.006 167.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.1 p90 -119.66 148.45 43.35 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.104 0.478 . . . . 0.0 109.781 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -114.4 112.85 23.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.592 0.71 . . . . 0.0 109.694 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.432 HG21 ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -95.19 112.08 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.562 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.91 127.25 31.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.238 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -100.61 11.3 39.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -94.64 -48.75 5.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.1 p -115.72 2.47 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.197 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.24 65.5 0.97 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.266 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.95 142.31 51.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.23 99.19 8.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 t -117.93 152.15 36.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.7 m95 -95.37 -12.92 25.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.622 0.725 . . . . 0.0 109.9 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.38 122.48 31.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.888 -175.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.621 ' HB3' HD12 ' A' ' 40' ' ' LEU . 16.3 t70 -70.85 116.97 51.57 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.773 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD2' ' CD2' ' A' ' 9' ' ' LEU . 72.4 Cg_endo -76.78 15.19 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.363 2.709 . . . . 0.0 113.347 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -105.89 -15.34 14.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 171.29 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' A' ' 37' ' ' ASP . 48.2 mt -88.84 -15.75 33.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.124 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.949 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -78.3 124.45 85.68 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.5 0.191 . . . . 0.0 110.573 178.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 26.6 Cg_exo -62.32 125.02 15.36 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.706 2.27 . . . . 0.0 111.462 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.93 72.61 0.47 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.243 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -108.25 42.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.333 0.587 . . . . 0.0 110.457 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -99.32 0.02 42.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.456 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.92 137.85 55.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.412 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -126.66 149.28 49.61 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.448 0.642 . . . . 0.0 109.81 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 1.3 mp -89.9 177.88 2.21 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.03 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 9' ' ' LEU . 39.8 Cg_exo -59.12 153.74 50.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.359 2.04 . . . . 0.0 112.302 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.18 118.6 4.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.294 2.663 . . . . 0.0 112.438 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.2 -22.59 12.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.836 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -83.38 127.01 33.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.535 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -118.9 107.86 14.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.66 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.456 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.1 OUTLIER -81.27 118.55 22.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.377 0.608 . . . . 0.0 110.208 175.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -127.27 141.98 51.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.084 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 mm -95.3 112.63 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.635 -175.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.31 153.68 92.14 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.284 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.44 -11.85 18.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.018 2.479 . . . . 0.0 112.558 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.405 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 1.9 m-20 -79.74 -1.64 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.63 66.12 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' CG ' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.93 120.21 46.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.13 -173.341 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.39 120.62 8.25 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.641 2.228 . . . . 0.0 111.029 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.426 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.8 p90 -116.23 141.8 47.67 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -108.0 111.47 23.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.909 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.445 HG13 HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -97.63 115.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.17 126.51 31.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.646 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.02 8.1 44.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -94.92 -49.87 5.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -113.29 7.39 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? 58.67 67.28 0.95 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.071 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.68 145.47 51.52 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.924 0.392 . . . . 0.0 111.189 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.445 HG23 HG13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -112.08 109.11 18.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.146 178.404 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.43 143.73 49.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.426 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 9.3 m95 -97.11 -33.46 11.5 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.862 0.839 . . . . 0.0 108.808 174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -78.15 111.74 14.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.442 179.289 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.0 132.38 67.88 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.652 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HA ' ' HG3' ' A' ' 41' ' ' LYS . 57.3 Cg_endo -71.75 12.83 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.078 2.519 . . . . 0.0 112.748 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.69 2.73 54.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.211 0.529 . . . . 0.0 109.882 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.04 -15.46 12.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.555 176.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.921 -0.562 . . . . 0.0 110.154 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.67 118.64 68.32 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 110.692 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.69 55.72 5.75 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.969 2.446 . . . . 0.0 112.151 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.51 -92.19 0.42 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.104 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.6 84.28 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.279 0.561 . . . . 0.0 110.858 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.537 ' HG2' ' N ' ' A' ' 7' ' ' SER . 4.2 tt0 -98.36 150.7 21.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.304 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.537 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -62.36 105.24 0.59 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -62.06 -58.83 6.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.141 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -91.72 170.98 8.51 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.137 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.616 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 13.7 Cg_exo -70.33 149.42 63.25 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.599 2.2 . . . . 0.0 111.279 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 57.2 Cg_exo -51.59 114.01 1.39 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.936 2.424 . . . . 0.0 112.263 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.69 -23.55 5.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.616 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 77.3 m95 -78.8 125.03 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 111.208 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 26' ' ' ILE . 21.2 tt0 -122.13 107.86 12.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.137 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.444 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptm -81.2 126.02 31.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.415 0.626 . . . . 0.0 110.181 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -124.85 142.95 51.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.012 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 mm -93.32 119.48 41.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.318 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.0 156.77 71.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.082 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.37 -20.1 24.55 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.998 2.465 . . . . 0.0 112.378 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -66.34 -18.82 65.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.2 177.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.6 11.33 59.46 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HG2' ' HB3' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.42 117.93 53.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.775 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 120.11 7.73 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.395 2.063 . . . . 0.0 111.32 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.445 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.6 p90 -115.7 134.68 54.79 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 24.5 m-85 -99.13 113.25 25.39 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.066 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -100.12 114.81 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.561 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -84.46 126.02 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.007 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -90.81 4.08 52.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -89.63 -55.68 3.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.331 0.586 . . . . 0.0 110.069 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.3 p -95.24 -11.52 27.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.392 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? 65.54 44.52 3.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.95 155.46 26.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.904 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.403 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.46 116.32 25.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -124.54 149.51 46.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.498 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.445 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 42.7 m95 -91.43 -20.13 22.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.611 0.719 . . . . 0.0 109.703 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.79 109.1 19.89 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.733 -172.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -49.09 124.75 13.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.7 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.36 -10.8 26.04 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.79 2.327 . . . . 0.0 113.077 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -77.42 -5.78 51.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.744 0.307 . . . . 0.0 110.909 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.4 mt -74.67 -13.29 60.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.185 0.517 . . . . 0.0 110.129 172.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.145 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 112.292 -0.323 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.26 143.82 30.0 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.41 109.71 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.299 2.666 . . . . 0.0 112.435 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.33 2.54 85.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.793 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.52 79.48 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.18 0.514 . . . . 0.0 110.939 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.82 -5.15 14.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.112 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.97 92.92 6.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.845 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.04 -36.06 5.75 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.4 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.75 167.3 9.41 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.246 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.27 160.09 24.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.735 2.29 . . . . 0.0 111.892 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.24 -25.76 66.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 112.521 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' HA3' ' OD1' ' A' ' 29' ' ' ASN . . . -77.9 -4.58 85.9 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.692 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -105.02 131.28 52.74 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.55 -0.382 . . . . 0.0 110.273 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 20.4 tt0 -114.67 103.01 10.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.573 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.559 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -82.0 128.12 33.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.255 0.55 . . . . 0.0 110.095 176.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -134.86 131.99 38.04 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -90.69 109.49 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -79.63 151.49 74.31 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.467 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 17.7 Cg_exo -67.8 13.01 0.19 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.56 2.84 . . . . 0.0 114.442 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -9.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.66 53.39 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.396 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.27 112.19 61.33 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.608 0.242 . . . . 0.0 110.814 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 26.0 Cg_exo -65.4 114.27 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.142 1.895 . . . . 0.0 111.255 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.49 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 8.0 p90 -107.81 133.62 51.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.45 0.643 . . . . 0.0 109.811 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.53 115.96 31.5 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.949 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.587 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -102.01 110.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 122.165 0.983 . . . . 0.0 109.799 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.72 126.39 30.79 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.648 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -100.74 7.91 43.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.748 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.453 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 1.7 m-80 -88.34 -50.12 6.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -115.54 2.5 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.267 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 63.21 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.056 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.56 150.15 49.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.421 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.587 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -123.24 113.69 19.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.726 -179.101 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -123.5 140.94 52.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.49 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 32.9 m95 -89.1 -17.91 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.904 0.859 . . . . 0.0 108.831 172.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -93.28 112.57 24.53 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.913 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD2' ' HG ' ' A' ' 40' ' ' LEU . 10.1 t70 -56.99 129.09 78.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 -177.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.98 6.51 5.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.062 2.508 . . . . 0.0 113.654 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -97.57 -56.75 2.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.806 0.336 . . . . 0.0 110.764 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' HG ' ' OD2' ' A' ' 37' ' ' ASP . 1.9 mt -82.07 -45.27 15.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.462 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 14.9 mttt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.402 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.34 123.28 80.18 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.649 0.261 . . . . 0.0 110.884 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -57.53 114.45 1.95 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.769 2.313 . . . . 0.0 111.753 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.1 -87.74 0.14 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt 55.26 67.18 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.516 0.674 . . . . 0.0 110.375 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.568 ' HB3' HH12 ' A' ' 39' ' ' ARG . 4.9 mt-30 -106.39 91.81 3.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.04 -176.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.53 140.87 46.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.819 174.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 76.0 159.88 0.22 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.542 0.687 . . . . 0.0 110.755 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.524 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -81.33 169.54 18.67 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.321 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 21.3 Cg_exo -67.05 160.45 47.26 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.152 2.568 . . . . 0.0 111.659 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.08 -15.7 41.12 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.911 2.407 . . . . 0.0 113.136 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.98 -5.3 83.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.712 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.467 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 65.1 m95 -104.77 135.91 45.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.906 0.353 . . . . 0.0 110.665 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -128.08 112.46 14.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.76 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.462 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.58 122.28 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.288 175.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 17.5 mtt180 -124.54 153.65 41.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.42 112.88 41.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.061 0.457 . . . . 0.0 110.7 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.64 158.64 65.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.481 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.15 -10.89 6.76 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.171 2.58 . . . . 0.0 112.405 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.28 -26.97 68.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.235 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.62 57.11 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.75 121.44 44.09 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.865 -176.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.87 116.94 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.728 2.285 . . . . 0.0 111.778 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.516 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 32.8 p90 -111.91 140.16 46.8 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 42.9 m-85 -103.33 110.14 22.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.679 0.752 . . . . 0.0 110.136 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.466 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -92.99 117.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.591 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -84.21 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.638 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -100.49 11.09 40.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -93.18 -45.54 7.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 42.4 p -121.31 -0.9 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.364 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 64.53 63.26 0.75 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.972 176.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.78 144.64 49.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.578 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.466 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -111.7 103.32 11.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.237 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.05 150.67 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -95.41 -2.82 48.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.79 102.83 15.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.541 ' HB3' ' HG ' ' A' ' 40' ' ' LEU . 5.0 t0 -55.95 120.43 33.6 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.422 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.34 -11.78 29.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.891 2.394 . . . . 0.0 112.921 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.568 HH12 ' HB3' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -89.56 -2.79 58.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.5 177.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' A' ' 37' ' ' ASP . 67.2 mt -80.34 -14.16 58.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.399 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.292 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.47 -52.34 70.37 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.652 0.226 . . . . 0.0 111.252 174.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.45 148.08 42.32 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.597 1.532 . . . . 0.0 111.756 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.06 -156.73 18.66 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.354 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 mm -73.85 104.1 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.353 0.597 . . . . 0.0 110.938 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.18 111.34 5.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.642 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.23 113.4 17.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.026 0.441 . . . . 0.0 111.081 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -102.26 -122.89 0.18 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.718 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER -138.36 159.87 66.14 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.5 152.35 77.91 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.531 2.154 . . . . 0.0 111.418 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.48 118.16 3.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.783 2.322 . . . . 0.0 112.495 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.75 7.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.678 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 78.0 m95 -83.7 130.85 34.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 111.483 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB3' HG22 ' A' ' 26' ' ' ILE . 4.1 tt0 -128.38 115.2 17.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.526 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -97.68 135.06 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.344 0.592 . . . . 0.0 111.688 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -136.95 142.29 42.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.962 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -92.44 114.35 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.209 -175.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.45 149.27 60.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.092 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.28 -6.39 9.9 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.231 2.621 . . . . 0.0 114.675 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -7.77 59.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.52 3.83 52.96 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -107.29 111.96 62.99 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.636 0.255 . . . . 0.0 111.06 -178.573 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 24.1 Cg_exo -65.64 120.48 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.121 1.881 . . . . 0.0 110.283 167.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.4 p90 -105.06 138.92 40.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 16.4 m-85 -109.41 109.76 20.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.066 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.483 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -93.35 120.85 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.943 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.58 119.27 29.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -84.53 -6.16 59.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.382 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.63 -55.78 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 110.137 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -90.58 -9.91 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.716 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.97 53.35 3.07 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.994 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.39 150.38 50.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.876 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.483 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -107.84 114.82 29.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.967 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 155.97 25.02 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 99.6 m95 -90.11 -74.34 0.49 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.874 0.845 . . . . 0.0 110.016 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 6.4 mt-10 -70.47 129.18 38.55 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 -172.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -61.37 149.92 81.78 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-O 121.312 0.577 . . . . 0.0 112.191 -171.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -82.98 15.37 2.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.997 2.465 . . . . 0.0 111.78 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -91.6 -19.89 22.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.997 177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -35.19 14.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.158 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.5 pttm . . . . . 0 C--O 1.244 0.798 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.618 179.851 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -56.39 126.38 68.85 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.336 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 2.2 Cg_endo -82.86 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.166 2.577 . . . . 0.0 111.466 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.84 97.09 1.83 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.82 69.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.259 0.552 . . . . 0.0 111.65 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.02 53.73 1.97 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.697 175.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.37 103.9 11.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.417 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.13 -88.44 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.013 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER -109.85 165.83 11.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.99 142.06 93.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.172 1.915 . . . . 0.0 111.464 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.29 112.91 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.776 2.317 . . . . 0.0 111.729 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.43 -24.74 4.37 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 68.4 m95 -86.96 125.36 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.817 0.342 . . . . 0.0 110.533 176.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -117.61 112.83 21.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -76.02 118.27 18.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.19 175.106 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -121.81 134.83 54.91 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mm -88.77 114.47 27.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.158 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.7 150.98 73.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.93 1.82 2.1 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.279 2.653 . . . . 0.0 114.412 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -13.75 41.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.96 8.1 37.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.136 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.99 117.78 54.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.878 -0.19 . . . . 0.0 111.402 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -60.0 121.23 9.47 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 111.043 166.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.516 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.9 p90 -117.98 136.16 53.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.2 113.17 25.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.61 0.719 . . . . 0.0 110.154 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.34 116.99 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 124.35 27.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.121 178.13 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -92.93 5.41 51.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.518 -175.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -92.01 -52.84 4.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.5 p -112.02 0.83 16.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.141 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER 62.04 70.48 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.531 176.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.91 150.37 46.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.343 175.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.03 108.04 12.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.66 0.267 . . . . 0.0 111.056 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.5 t -124.2 143.95 50.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.6 m95 -89.65 -21.69 22.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.773 0.797 . . . . 0.0 109.517 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 28.8 mm-40 -83.05 113.57 20.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.374 -176.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.77 120.38 41.3 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.129 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.14 9.47 1.41 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.02 2.48 . . . . 0.0 113.931 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -43.46 6.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mt -86.17 -24.1 26.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 36' ' ' GLU . 2.0 mmtm . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.183 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -54.51 34.69 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.29 -35.94 98.92 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.078 1.852 . . . . 0.0 112.519 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.63 25.85 73.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.874 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mm -114.32 40.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.499 0.666 . . . . 0.0 110.907 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -29.7 41.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.06 127.55 46.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.122 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -115.47 -165.23 1.01 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.69 158.07 33.18 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.96 138.09 76.44 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.977 2.452 . . . . 0.0 112.072 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.5 111.56 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.759 2.306 . . . . 0.0 111.599 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.38 -27.35 4.0 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -84.16 101.57 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG2' ' HD2' ' A' ' 16' ' ' ARG . 2.7 tt0 -98.6 104.48 16.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.323 -174.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.641 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -79.65 119.03 22.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.0 109.866 174.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.549 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -124.36 139.66 53.69 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 mm -88.72 104.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.877 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.17 156.11 92.23 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.391 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 -3.01 2.94 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.208 2.605 . . . . 0.0 113.046 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.528 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -78.33 -17.19 56.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.277 0.561 . . . . 0.0 109.534 172.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.34 1.55 55.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.943 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HG2' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.57 129.35 24.11 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.66 -0.27 . . . . 0.0 110.926 -175.267 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 121.74 9.57 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.789 2.326 . . . . 0.0 111.412 168.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.584 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.1 p90 -119.51 141.04 49.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.162 0.506 . . . . 0.0 109.948 176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.3 m-85 -106.24 112.63 25.74 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.988 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.501 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.23 112.82 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.653 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.97 113.94 18.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.418 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -81.94 13.29 3.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.371 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -97.42 -57.69 2.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.23 0.538 . . . . 0.0 109.899 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -93.5 -14.39 26.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.5 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 mttt 71.95 37.49 1.02 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.305 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.73 154.27 21.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.768 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.501 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -119.41 116.12 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.715 -175.581 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 t -123.59 141.43 52.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.584 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -92.23 -10.55 38.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.884 0.849 . . . . 0.0 109.221 174.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.93 112.2 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.554 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.525 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 33.1 t0 -62.45 112.57 6.74 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.32 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.86 -9.64 26.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.871 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 39' ' ' ARG . 18.7 mtm180 -74.98 -16.18 60.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.128 0.489 . . . . 0.0 109.899 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 12.0 mt -87.9 -10.78 49.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.149 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.611 -0.196 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -56.27 21.32 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.61 0.205 . . . . 0.0 111.463 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -86.54 0.25 7.98 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.967 1.778 . . . . 0.0 111.79 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.31 115.18 2.4 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.187 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.11 139.57 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.849 0.357 . . . . 0.0 110.166 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.87 86.21 6.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.609 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.42 116.44 13.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.754 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.581 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -57.97 -63.96 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.337 178.358 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 173.07 4.81 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 34.9 Cg_exo -60.39 147.95 92.2 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.733 1.622 . . . . 0.0 110.249 172.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 45.4 Cg_exo -58.47 -10.92 9.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.802 2.334 . . . . 0.0 113.606 -175.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.07 1.24 80.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.509 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.496 ' HE3' ' HB3' ' A' ' 25' ' ' PHE . 37.9 m95 -105.14 115.17 29.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.022 0.439 . . . . 0.0 110.061 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 21.0 tt0 -98.47 99.73 10.93 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.707 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.65 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.3 ptp -79.63 92.92 5.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.434 0.635 . . . . 0.0 110.455 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 16' ' ' ARG . 44.5 mtt-85 -85.71 128.55 34.82 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.031 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mm -88.03 102.12 12.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.185 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.78 146.02 90.24 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.696 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.27 -5.62 5.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.842 2.361 . . . . 0.0 112.502 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.18 -17.05 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 0.0 109.874 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.76 60.05 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.037 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -107.94 110.3 62.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.925 -177.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.0 117.65 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.025 . . . . 0.0 110.861 167.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.561 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.9 p90 -111.6 127.53 55.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.727 0.775 . . . . 0.0 109.862 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.9 m-85 -93.58 103.94 16.09 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.463 -172.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.618 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -95.22 109.09 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.455 176.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.9 127.29 32.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.247 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -100.18 12.0 38.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.0 111.023 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -100.42 -51.02 3.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.021 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.5 p -111.67 4.6 18.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.905 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 64.88 1.19 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.366 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.74 144.53 48.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.766 174.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.618 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -122.37 101.77 7.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.403 178.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.769 0.318 . . . . 0.0 111.566 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.561 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -89.78 -17.78 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.768 0.794 . . . . 0.0 109.101 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.85 114.55 21.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.486 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.45 120.8 68.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.979 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.05 10.19 3.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.161 2.574 . . . . 0.0 113.767 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.581 ' HD3' ' O ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -102.65 -43.8 5.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 mt -73.49 -38.77 65.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.111 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.53 -0.747 . . . . 0.0 110.077 178.189 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.843 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.04 110.8 56.49 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.877 0.37 . . . . 0.0 110.833 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.04 -16.81 13.96 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.568 2.179 . . . . 0.0 112.341 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.02 98.72 0.51 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.973 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mm -76.65 86.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.8 0.333 . . . . 0.0 110.488 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 70.36 -0.02 3.02 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.543 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.67 ' HB2' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.35 84.99 7.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.47 0.652 . . . . 0.0 110.627 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -99.07 -172.94 2.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.853 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.89 163.62 49.92 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.885 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.88 148.31 89.81 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.522 2.148 . . . . 0.0 111.52 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.65 119.58 5.36 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.844 2.363 . . . . 0.0 112.093 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.47 -24.37 6.89 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.914 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -83.86 125.99 32.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 110.918 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.07 122.12 33.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.494 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.631 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 1.9 ptt? -89.26 124.03 34.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -128.55 143.85 51.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.92 125.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 0.0 110.597 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -89.43 165.09 27.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 21.6 Cg_endo -60.88 -15.0 35.57 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.357 2.705 . . . . 0.0 113.928 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.13 56.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.008 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.93 20.66 60.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.057 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 9.5 mmm180 -107.8 120.94 45.6 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.82 -0.224 . . . . 0.0 110.435 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.45 113.64 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.048 1.832 . . . . 0.0 111.061 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.46 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.7 p90 -112.45 138.45 49.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 15' ' ' MET . 7.2 m-85 -103.58 114.47 28.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.885 -174.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.3 112.68 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.53 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.2 120.41 22.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.348 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -89.81 -1.51 58.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.436 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.19 -57.63 3.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.2 p -113.23 6.87 17.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.978 -176.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.04 67.95 0.65 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.59 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 149.5 42.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.05 108.23 11.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -124.19 148.53 47.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.335 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.46 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 38.9 m95 -91.26 -15.46 29.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.611 0.719 . . . . 0.0 110.153 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.19 107.88 19.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.863 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -58.38 146.26 72.47 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.708 -175.115 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.14 11.8 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.79 2.326 . . . . 0.0 112.268 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.67 ' HD2' ' HB2' ' A' ' 7' ' ' SER . 1.6 ptt180 -103.13 -7.35 21.36 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.353 0.597 . . . . 0.0 109.726 175.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.5 mt -92.97 -47.36 7.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.699 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.813 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.56 162.36 67.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 122.181 0.193 . . . . 0.0 110.634 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.3 59.92 1.42 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.883 2.389 . . . . 0.0 111.479 173.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.44 136.21 2.68 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -175.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 mt -81.32 58.03 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.634 0.717 . . . . 0.0 111.419 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -174.24 -172.27 0.68 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.806 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -80.72 157.26 25.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.14 13.82 2.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.268 0.556 . . . . 0.0 111.993 -177.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -103.61 169.48 7.31 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.534 175.645 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.24 150.66 39.33 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 121.997 1.798 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.38 -27.92 25.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.299 2.666 . . . . 0.0 113.7 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.82 -13.41 83.46 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.22 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.413 ' CE3' ' HG3' ' A' ' 38' ' ' PRO . 80.5 m95 -92.84 121.42 34.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.976 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.5 tt0 -118.52 105.58 11.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.447 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.51 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptp -83.19 128.73 34.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.258 0.551 . . . . 0.0 110.731 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.85 152.35 48.61 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.71 111.61 32.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.089 0.471 . . . . 0.0 110.328 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.83 155.81 82.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.689 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.64 -7.75 7.88 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.391 2.727 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -70.4 -21.54 62.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.6 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.73 -0.14 59.3 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.64 46.52 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.703 -177.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.03 126.8 23.35 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.723 2.282 . . . . 0.0 111.208 169.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.421 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.1 p90 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.508 0.67 . . . . 0.0 109.952 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 20.3 m-85 -104.78 114.41 28.61 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.531 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.573 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.05 118.8 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.723 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.64 119.97 28.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.197 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -85.12 -3.84 58.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.855 0.36 . . . . 0.0 110.905 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -80.56 -57.29 3.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 109.609 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -90.35 -12.75 36.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.488 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 mttm 60.92 55.07 3.25 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.09 152.88 48.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.366 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -117.74 116.39 26.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.947 -178.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -123.21 145.26 48.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.499 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.421 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 7.4 m95 -89.66 -20.05 24.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.739 0.781 . . . . 0.0 109.411 176.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.8 110.16 17.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.911 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -49.82 120.77 11.68 Favored Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.012 0.82 . . . . 0.0 111.738 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HG3' ' CE3' ' A' ' 13' ' ' TRP . 29.9 Cg_endo -64.05 -12.65 33.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.113 2.542 . . . . 0.0 113.049 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.429 ' HG2' HD23 ' A' ' 9' ' ' LEU . 1.7 mmp_? -74.79 -12.05 60.3 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 174.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' C ' ' HG3' ' A' ' 41' ' ' LYS . 14.2 mt -88.58 -31.74 18.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.837 173.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HG3' ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 124.602 1.161 . . . . 0.0 112.719 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 9' ' ' LEU . 53.8 Cg_exo -54.28 147.21 46.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.445 1.43 . . . . 0.0 110.941 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 38.2 Cg_exo -63.81 10.02 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.454 2.769 . . . . 0.0 114.159 -176.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.96 -0.18 27.11 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 174.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -104.74 128.75 52.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 110.467 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -114.96 111.31 20.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.631 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.614 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -85.53 115.4 23.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.231 0.539 . . . . 0.0 110.424 176.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -113.91 142.58 45.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.277 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mm -93.07 101.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.296 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 153.79 72.02 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.407 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.64 -16.98 16.14 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.944 2.429 . . . . 0.0 112.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -63.61 -25.99 68.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.429 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.93 -0.37 44.94 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.13 125.4 32.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.53 0.205 . . . . 0.0 111.229 -176.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.33 123.79 14.17 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.926 2.417 . . . . 0.0 111.493 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.431 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 22.0 p90 -121.22 137.52 54.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.299 0.571 . . . . 0.0 109.902 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 20.5 m-85 -101.2 112.44 24.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.477 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.415 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -100.51 119.19 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.654 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.628 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 1.1 t70 -83.41 132.41 34.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.896 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -100.77 8.57 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.415 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -88.29 -58.26 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 109.882 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 47.6 p -98.94 -23.45 15.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.845 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 78.94 70.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.904 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -129.21 166.6 19.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.574 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.415 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -128.49 109.89 11.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.664 -174.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 t -124.02 146.82 48.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.486 0.184 . . . . 0.0 110.709 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.431 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 21.6 m95 -90.25 -36.23 14.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.486 0.66 . . . . 0.0 109.398 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.93 121.51 19.21 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.754 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -61.12 115.23 13.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.409 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.4 -12.18 34.6 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.005 2.47 . . . . 0.0 113.072 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 39' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 110.355 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.71 152.77 71.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.279 1.986 . . . . 0.0 111.122 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.83 -2.19 5.11 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.918 2.412 . . . . 0.0 113.511 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' HD21 ' A' ' 29' ' ' ASN . . . -92.36 -11.55 59.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.588 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -99.35 111.98 24.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 110.118 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 26' ' ' ILE . 12.1 tt0 -100.59 104.19 15.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.585 -177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.405 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -69.09 127.54 33.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.539 0.685 . . . . 0.0 109.592 174.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -125.6 123.66 39.51 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.581 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 102.98 14.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.688 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -65.46 152.19 92.8 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.119 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 31.4 Cg_exo -60.2 -4.0 2.77 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.001 2.468 . . . . 0.0 112.273 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.19 -25.39 61.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.31 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.25 5.78 48.97 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.522 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.28 120.36 47.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.458 0.17 . . . . 0.0 110.802 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.35 113.18 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.286 1.99 . . . . 0.0 111.252 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.0 p90 -111.43 135.99 51.21 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 15' ' ' MET . 22.9 m-85 -101.16 116.4 32.73 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.481 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -102.48 113.64 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.954 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 35.9 t0 -80.65 126.37 31.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.549 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -90.16 -7.79 52.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.83 0.348 . . . . 0.0 110.521 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.414 HD21 ' HA3' ' A' ' 12' ' ' GLY . 61.3 m-80 -82.52 -54.59 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.274 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -94.43 -12.48 27.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.45 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 1.2 mtmt 62.83 58.27 1.58 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.279 0.562 . . . . 0.0 111.076 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.7 152.75 47.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.633 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.481 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -122.83 112.86 18.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.693 -177.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t -123.97 147.13 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.853 0.359 . . . . 0.0 110.877 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.522 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 48.8 m95 -91.27 -9.54 44.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.859 0.838 . . . . 0.0 109.858 177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.66 125.75 52.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.337 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -61.19 116.0 17.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.67 -16.28 50.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.561 2.84 . . . . 0.0 113.528 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 -178.647 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 15' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 20.4 Cg_exo -66.68 148.84 83.67 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.109 1.873 . . . . 0.0 111.409 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -47.04 110.47 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.506 2.804 . . . . 0.0 112.724 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.06 -26.8 5.24 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.557 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 86.2 m95 -82.05 120.43 25.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.815 0.341 . . . . 0.0 110.302 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -112.84 105.35 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.444 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.566 ' HB3' HD11 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -79.15 130.58 35.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.394 0.616 . . . . 0.0 110.846 178.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.27 153.06 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.85 124.08 60.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.683 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.72 55.62 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -58.4 -11.71 11.69 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.507 2.805 . . . . 0.0 114.552 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -18.19 55.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.14 5.77 32.46 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.872 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' H ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.87 118.96 51.63 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.724 0.297 . . . . 0.0 111.2 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.57 123.81 13.06 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.745 2.296 . . . . 0.0 111.296 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.574 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 13.4 p90 -116.06 142.97 46.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.235 0.54 . . . . 0.0 109.599 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 10.9 m-85 -110.17 116.83 32.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.681 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.542 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.39 110.44 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.046 0.927 . . . . 0.0 110.032 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.45 126.71 31.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.394 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -98.98 6.3 46.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.332 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -88.56 -58.61 2.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.069 0.461 . . . . 0.0 109.774 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.0 p -104.38 -4.1 23.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.528 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.88 64.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.339 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.1 143.94 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.542 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -117.53 100.9 7.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.01 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.5 t -123.86 149.12 46.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.96 0.409 . . . . 0.0 111.494 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.2 m95 -96.67 5.02 51.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.55 108.68 19.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.596 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.533 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 19.7 t0 -63.19 113.75 10.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.814 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.61 -1.86 11.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.403 2.735 . . . . 0.0 112.56 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 0.0 110.04 176.812 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 47.0 Cg_exo -56.37 153.01 36.32 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.569 2.179 . . . . 0.0 112.148 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 64.5 Cg_exo -52.44 110.73 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.024 2.483 . . . . 0.0 112.162 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.14 -20.26 6.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.343 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 81.9 m95 -82.14 120.33 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -114.31 111.11 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.746 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.484 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.45 104.72 9.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.183 175.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 16' ' ' ARG . 27.2 mtt-85 -103.01 121.83 43.36 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.25 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mm -80.52 109.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.844 0.354 . . . . 0.0 110.271 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -81.75 148.8 62.42 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.033 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 23.7 Cg_exo -65.38 3.46 1.06 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.591 2.861 . . . . 0.0 114.525 -172.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -15.17 38.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 10.87 29.32 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.581 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -107.68 112.42 62.15 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.54 109.53 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.866 1.711 . . . . 0.0 110.659 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -105.8 125.92 51.56 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.592 0.711 . . . . 0.0 109.256 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 26.2 m-85 -91.88 109.84 21.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.156 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.438 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.87 114.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.937 178.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 118.61 21.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.035 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -91.41 6.56 44.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.335 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -95.9 -54.6 3.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.916 0.388 . . . . 0.0 110.355 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -111.89 5.02 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm 64.38 74.13 0.41 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.13 175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.58 145.4 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.492 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.438 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.75 105.17 8.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.711 0.291 . . . . 0.0 110.537 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 t -123.87 146.95 48.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -89.91 -11.35 42.08 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.759 0.79 . . . . 0.0 109.747 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.39 119.91 40.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.269 -171.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.405 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 64.1 t0 -48.32 116.87 5.31 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.057 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -63.38 -13.4 35.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.249 2.633 . . . . 0.0 113.517 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 39' ' ' ARG . 4.0 mtm105 . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.962 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.447 HD23 ' HD3' ' A' ' 39' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.29 152.82 80.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.697 2.265 . . . . 0.0 112.1 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.94 116.19 2.75 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.113 2.542 . . . . 0.0 112.325 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.5 -14.38 9.31 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.933 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 60.7 m95 -88.94 94.95 10.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 110.009 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -86.84 107.39 18.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.587 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.504 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.54 122.71 27.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.403 0.62 . . . . 0.0 110.804 178.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -130.92 133.96 46.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.272 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -89.18 112.03 23.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.775 0.322 . . . . 0.0 110.498 -177.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.07 152.84 77.1 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.236 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.74 -1.62 3.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.158 2.572 . . . . 0.0 112.504 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -75.16 -23.62 57.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.526 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.34 -4.01 29.73 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.56 123.39 37.44 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.938 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 36.2 Cg_exo -63.3 114.63 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.0 110.531 166.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 10.9 p90 -106.03 135.04 48.2 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -103.65 114.52 28.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.044 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.577 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -99.16 111.68 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.117 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 0.0 OUTLIER -81.48 120.48 25.06 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.57 -178.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -91.72 -4.3 55.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.174 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -84.05 -56.18 3.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.466 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.4 p -108.01 0.96 22.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.068 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 69.61 69.94 0.24 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.738 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.57 149.51 52.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.18 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.577 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.15 106.67 9.73 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -123.13 147.32 46.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.017 0.437 . . . . 0.0 111.336 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 25.7 m95 -93.87 -15.95 24.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.44 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.45 115.79 31.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 39' ' ' ARG . 3.9 t70 -53.48 127.0 48.83 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.924 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.37 -32.84 95.03 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.192 2.594 . . . . 0.0 114.166 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.537 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.195 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.412 ' CD2' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.89 140.04 92.44 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.765 1.643 . . . . 0.0 111.246 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.12 117.56 2.92 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.806 2.337 . . . . 0.0 112.393 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.442 ' HA3' HD21 ' A' ' 29' ' ' ASN . . . 121.27 -24.08 7.44 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.007 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -78.49 112.61 15.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 110.569 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HG2' ' HD2' ' A' ' 16' ' ' ARG . 18.5 tt0 -107.4 106.72 17.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.637 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.51 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.1 ptp -81.77 133.36 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 110.83 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.492 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -134.53 138.93 45.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.056 175.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.63 108.3 19.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.181 0.515 . . . . 0.0 110.347 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 152.95 84.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.386 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.31 7.19 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.393 2.729 . . . . 0.0 114.278 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -17.5 26.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.35 31.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.781 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.77 124.42 34.34 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.677 0.275 . . . . 0.0 111.355 -177.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.95 123.42 11.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.555 2.17 . . . . 0.0 111.339 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.517 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 20.5 p90 -114.4 139.33 49.58 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.203 0.525 . . . . 0.0 109.629 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 19.6 m-85 -104.67 112.56 25.69 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.49 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -97.51 112.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.666 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 4.0 t70 -77.71 124.36 27.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.02 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -94.27 2.73 55.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.231 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.442 HD21 ' HA3' ' A' ' 12' ' ' GLY . 53.4 m-80 -86.85 -62.2 1.56 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.084 0.469 . . . . 0.0 110.112 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.1 p -106.51 -1.3 23.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.897 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 68.15 72.39 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.846 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.17 141.89 51.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.49 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -116.29 97.72 6.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.758 0.313 . . . . 0.0 110.54 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.68 149.38 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.763 0.316 . . . . 0.0 111.011 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.1 m95 -89.83 -16.87 29.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -79.95 124.89 29.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.631 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.471 ' OD1' ' HG2' ' A' ' 39' ' ' ARG . 10.8 t70 -72.83 120.61 81.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.577 . . . . 0.0 111.435 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' ASP . 49.4 Cg_endo -92.26 14.45 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.475 2.784 . . . . 0.0 114.884 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 1.4 ptp180 . . . . . 0 N--CA 1.448 -0.565 0 CA-C-N 118.952 0.796 . . . . 0.0 109.899 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 39' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 41.0 Cg_exo -57.39 140.8 94.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.124 1.216 . . . . 0.0 110.015 172.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 73.5 Cg_exo -49.68 -27.91 16.05 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.262 2.642 . . . . 0.0 113.898 -174.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.59 -9.15 82.13 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.035 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -93.32 119.46 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.05 0.453 . . . . 0.0 110.195 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 26' ' ' ILE . 16.0 tt0 -109.81 108.11 18.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.76 131.24 37.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.29 0.567 . . . . 0.0 110.537 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -133.77 142.63 48.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.276 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.85 109.11 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 109.97 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.41 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . . . -81.24 159.29 68.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.535 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.67 0.82 1.28 Allowed 'Trans proline' 0 N--CA 1.478 0.59 0 C-N-CA 123.474 2.782 . . . . 0.0 114.53 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -87.03 -7.61 57.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 13.65 65.16 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.64 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -108.18 120.01 48.08 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.608 0.242 . . . . 0.0 111.429 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -63.62 114.42 2.54 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.328 2.019 . . . . 0.0 111.536 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.532 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.8 p90 -113.13 139.88 48.36 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HD1' ' HB3' ' A' ' 15' ' ' MET . 20.4 m-85 -105.05 113.0 26.34 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.625 0.726 . . . . 0.0 110.027 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.536 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -94.4 115.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.66 126.08 32.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.872 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.52 10.61 39.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.411 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -93.84 -46.12 7.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 109.975 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 18.71 8.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.67 58.53 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.843 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 148.35 43.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.924 0.392 . . . . 0.0 111.235 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.536 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.58 102.03 6.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.209 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 t -123.65 149.59 45.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.5 m95 -91.69 -20.99 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.298 0.57 . . . . 0.0 110.477 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.08 118.47 25.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.533 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 38' ' ' PRO . 19.4 t0 -64.53 117.89 42.18 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.77 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 37' ' ' ASP . 19.2 Cg_endo -62.34 -17.55 58.03 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.952 2.435 . . . . 0.0 112.958 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 35.3 mtm180 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 0.0 110.899 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 12.2 Cg_exo -70.73 147.84 57.48 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 111.619 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.4 125.59 6.06 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.072 2.515 . . . . 0.0 112.492 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.74 -29.99 7.78 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.463 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.549 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 68.0 m95 -79.67 122.72 26.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.192 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -120.12 116.22 25.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 136.33 36.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 0.0 110.463 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.58 155.8 47.26 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.92 112.63 41.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.506 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.07 151.94 73.53 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.175 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.31 -7.47 6.82 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.774 2.983 . . . . 0.0 114.458 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -9.08 58.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.076 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.27 10.33 51.54 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.735 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.43 116.07 56.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.219 . . . . 0.0 111.349 -177.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.39 122.95 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.375 2.05 . . . . 0.0 111.146 166.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.531 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.0 p90 -122.08 145.19 48.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.57 112.99 25.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.009 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.33 110.5 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.018 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 9.2 t70 -77.52 119.82 21.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.038 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.75 -1.91 58.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.949 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -84.74 -67.69 0.78 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.105 0.479 . . . . 0.0 110.475 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.6 p -99.57 -1.6 37.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.62 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER 65.85 75.92 0.33 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.548 177.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 142.73 50.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.445 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.56 93.35 4.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.04 0.447 . . . . 0.0 109.952 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.47 150.21 33.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.531 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 5.1 m95 -100.43 -36.79 9.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.457 0.646 . . . . 0.0 109.58 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.42 111.29 10.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.729 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.95 128.96 89.89 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-O 121.124 0.488 . . . . 0.0 111.867 -174.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.77 6.32 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.04 2.494 . . . . 0.0 112.38 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 . . . . . 0 C--N 1.328 -0.337 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.725 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 11.4 Cg_exo -70.01 142.65 47.37 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.964 2.443 . . . . 0.0 111.347 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.11 101.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.078 2.519 . . . . 0.0 111.878 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.41 -27.69 1.67 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.534 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 69.5 m95 -84.01 116.67 22.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -111.04 102.75 11.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.715 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.673 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 3.7 ptt? -83.16 105.13 13.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.337 0.589 . . . . 0.0 110.424 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 16' ' ' ARG . 2.3 mpp_? -102.72 143.35 32.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 mm -89.19 110.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.84 0.353 . . . . 0.0 110.939 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.98 143.51 96.31 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.402 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.75 -21.27 24.86 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.363 2.708 . . . . 0.0 113.383 -175.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.68 -13.97 61.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.494 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.53 9.02 39.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.738 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.77 108.73 61.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.744 -0.228 . . . . 0.0 110.755 -178.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -55.81 122.01 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.303 2.002 . . . . 0.0 111.478 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.532 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 p90 -112.57 133.48 54.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.648 0.737 . . . . 0.0 109.488 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.673 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 12.9 m-85 -99.83 106.67 18.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.778 -173.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -93.25 110.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.703 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t70 -77.47 123.6 26.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.21 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -90.5 0.7 57.22 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.927 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -84.51 -54.88 4.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.854 0.359 . . . . 0.0 110.22 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.9 p -106.49 -2.34 22.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 62.7 64.63 0.89 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.149 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -113.91 141.93 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.426 176.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.405 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -115.46 95.67 5.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.312 0.577 . . . . 0.0 110.084 176.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.05 142.87 49.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.206 -173.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 2.1 m95 -92.42 -23.56 19.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.608 0.718 . . . . 0.0 109.381 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.44 102.84 6.15 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.483 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -51.57 130.1 35.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.589 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.44 14.78 2.34 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.314 2.676 . . . . 0.0 113.971 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-O 121.409 0.623 . . . . 0.0 109.376 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.96 157.11 13.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.076 1.851 . . . . 0.0 111.915 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -50.68 -35.52 47.68 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.296 2.664 . . . . 0.0 113.323 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.2 5.71 79.0 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.604 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 60.6 m95 -108.14 119.85 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.477 0.638 . . . . 0.0 110.623 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -107.6 111.77 24.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.733 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -84.21 127.18 33.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.304 0.573 . . . . 0.0 110.206 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.432 ' NH1' HG21 ' A' ' 26' ' ' ILE . 10.2 mtp180 -136.79 133.45 35.97 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.8 OUTLIER -87.04 120.43 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.288 -178.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -82.95 147.8 55.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.405 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 25.2 Cg_exo -64.33 -1.07 3.38 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.386 2.724 . . . . 0.0 114.044 -174.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -29.09 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.33 -2.92 8.94 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.289 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.28 123.92 36.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 122.624 -0.339 . . . . 0.0 111.338 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 33.3 Cg_exo -61.35 128.41 24.86 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.593 2.196 . . . . 0.0 111.006 167.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.548 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.1 p90 -119.66 148.45 43.35 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.104 0.478 . . . . 0.0 109.781 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -114.4 112.85 23.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.592 0.71 . . . . 0.0 109.694 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.432 HG21 ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -95.19 112.08 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.562 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.91 127.25 31.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.238 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -100.61 11.3 39.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -94.64 -48.75 5.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.1 p -115.72 2.47 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.197 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.24 65.5 0.97 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.266 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.95 142.31 51.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.23 99.19 8.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 t -117.93 152.15 36.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.7 m95 -95.37 -12.92 25.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.622 0.725 . . . . 0.0 109.9 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.38 122.48 31.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.888 -175.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -70.85 116.97 51.57 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.773 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD2' ' CD2' ' A' ' 9' ' ' LEU . 72.4 Cg_endo -76.78 15.19 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.363 2.709 . . . . 0.0 113.347 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 171.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 1.3 mp . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 9' ' ' LEU . 39.8 Cg_exo -59.12 153.74 50.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.359 2.04 . . . . 0.0 112.302 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.18 118.6 4.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.294 2.663 . . . . 0.0 112.438 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.2 -22.59 12.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.836 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -83.38 127.01 33.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.535 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -118.9 107.86 14.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.66 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.456 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.1 OUTLIER -81.27 118.55 22.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.377 0.608 . . . . 0.0 110.208 175.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -127.27 141.98 51.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.084 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 mm -95.3 112.63 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.635 -175.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.31 153.68 92.14 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.284 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.44 -11.85 18.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.018 2.479 . . . . 0.0 112.558 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.405 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 1.9 m-20 -79.74 -1.64 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.63 66.12 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' CG ' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.93 120.21 46.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.13 -173.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.39 120.62 8.25 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.641 2.228 . . . . 0.0 111.029 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.426 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.8 p90 -116.23 141.8 47.67 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -108.0 111.47 23.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.909 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.445 HG13 HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -97.63 115.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.17 126.51 31.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.646 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.02 8.1 44.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -94.92 -49.87 5.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -113.29 7.39 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? 58.67 67.28 0.95 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.071 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.68 145.47 51.52 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.924 0.392 . . . . 0.0 111.189 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.445 HG23 HG13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -112.08 109.11 18.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.146 178.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.43 143.73 49.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.426 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 9.3 m95 -97.11 -33.46 11.5 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.862 0.839 . . . . 0.0 108.808 174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -78.15 111.74 14.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.442 179.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.0 132.38 67.88 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.652 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.75 12.83 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.078 2.519 . . . . 0.0 112.748 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.211 0.529 . . . . 0.0 109.882 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.406 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.616 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 13.7 Cg_exo -70.33 149.42 63.25 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.599 2.2 . . . . 0.0 111.279 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 57.2 Cg_exo -51.59 114.01 1.39 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.936 2.424 . . . . 0.0 112.263 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.69 -23.55 5.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.616 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 77.3 m95 -78.8 125.03 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 111.208 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 26' ' ' ILE . 21.2 tt0 -122.13 107.86 12.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.137 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.444 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptm -81.2 126.02 31.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.415 0.626 . . . . 0.0 110.181 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -124.85 142.95 51.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.012 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 mm -93.32 119.48 41.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.318 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.0 156.77 71.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.082 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.37 -20.1 24.55 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.998 2.465 . . . . 0.0 112.378 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -66.34 -18.82 65.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.2 177.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.6 11.33 59.46 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HG2' ' HB3' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.42 117.93 53.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.775 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 120.11 7.73 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.395 2.063 . . . . 0.0 111.32 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.445 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.6 p90 -115.7 134.68 54.79 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 24.5 m-85 -99.13 113.25 25.39 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.066 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -100.12 114.81 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.561 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -84.46 126.02 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.007 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -90.81 4.08 52.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -89.63 -55.68 3.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.331 0.586 . . . . 0.0 110.069 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.3 p -95.24 -11.52 27.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.392 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? 65.54 44.52 3.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.95 155.46 26.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.904 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.403 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.46 116.32 25.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -124.54 149.51 46.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.498 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.445 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 42.7 m95 -91.43 -20.13 22.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.611 0.719 . . . . 0.0 109.703 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.79 109.1 19.89 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.733 -172.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -49.09 124.75 13.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.7 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.36 -10.8 26.04 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.79 2.327 . . . . 0.0 113.077 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.744 0.307 . . . . 0.0 110.909 177.487 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.27 160.09 24.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.735 2.29 . . . . 0.0 111.892 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.24 -25.76 66.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 112.521 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' HA3' ' OD1' ' A' ' 29' ' ' ASN . . . -77.9 -4.58 85.9 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.692 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -105.02 131.28 52.74 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.55 -0.382 . . . . 0.0 110.273 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 20.4 tt0 -114.67 103.01 10.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.573 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.559 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -82.0 128.12 33.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.255 0.55 . . . . 0.0 110.095 176.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -134.86 131.99 38.04 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -90.69 109.49 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -79.63 151.49 74.31 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.467 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 17.7 Cg_exo -67.8 13.01 0.19 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.56 2.84 . . . . 0.0 114.442 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -9.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.66 53.39 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.396 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.27 112.19 61.33 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.608 0.242 . . . . 0.0 110.814 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 26.0 Cg_exo -65.4 114.27 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.142 1.895 . . . . 0.0 111.255 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.49 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 8.0 p90 -107.81 133.62 51.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.45 0.643 . . . . 0.0 109.811 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.53 115.96 31.5 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.949 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.587 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -102.01 110.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 122.165 0.983 . . . . 0.0 109.799 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.72 126.39 30.79 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.648 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -100.74 7.91 43.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.748 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.453 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 1.7 m-80 -88.34 -50.12 6.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -115.54 2.5 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.267 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 63.21 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.056 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.56 150.15 49.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.421 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.587 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -123.24 113.69 19.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.726 -179.101 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -123.5 140.94 52.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.49 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 32.9 m95 -89.1 -17.91 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.904 0.859 . . . . 0.0 108.831 172.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -93.28 112.57 24.53 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.913 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.99 129.09 78.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.98 6.51 5.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.062 2.508 . . . . 0.0 113.654 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 120.806 0.336 . . . . 0.0 110.764 179.429 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.524 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.202 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 21.3 Cg_exo -67.05 160.45 47.26 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.152 2.568 . . . . 0.0 111.659 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.08 -15.7 41.12 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.911 2.407 . . . . 0.0 113.136 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.98 -5.3 83.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.712 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.467 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 65.1 m95 -104.77 135.91 45.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.906 0.353 . . . . 0.0 110.665 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -128.08 112.46 14.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.76 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.462 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.58 122.28 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.288 175.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 17.5 mtt180 -124.54 153.65 41.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.42 112.88 41.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.061 0.457 . . . . 0.0 110.7 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.64 158.64 65.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.481 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.15 -10.89 6.76 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.171 2.58 . . . . 0.0 112.405 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.28 -26.97 68.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.235 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.62 57.11 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.75 121.44 44.09 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.865 -176.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.87 116.94 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.728 2.285 . . . . 0.0 111.778 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.516 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 32.8 p90 -111.91 140.16 46.8 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 42.9 m-85 -103.33 110.14 22.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.679 0.752 . . . . 0.0 110.136 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.466 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -92.99 117.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.591 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -84.21 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.638 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -100.49 11.09 40.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -93.18 -45.54 7.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 42.4 p -121.31 -0.9 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.364 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 64.53 63.26 0.75 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.972 176.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.78 144.64 49.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.578 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.466 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -111.7 103.32 11.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.237 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.05 150.67 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -95.41 -2.82 48.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.79 102.83 15.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.46 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 5.0 t0 -55.95 120.43 33.6 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.422 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.34 -11.78 29.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.891 2.394 . . . . 0.0 112.921 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.524 ' HD2' ' HA ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.5 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.5 152.35 77.91 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.531 2.154 . . . . 0.0 111.418 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.48 118.16 3.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.783 2.322 . . . . 0.0 112.495 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.75 7.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.678 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 78.0 m95 -83.7 130.85 34.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 111.483 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB3' HG22 ' A' ' 26' ' ' ILE . 4.1 tt0 -128.38 115.2 17.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.526 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -97.68 135.06 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.344 0.592 . . . . 0.0 111.688 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -136.95 142.29 42.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.962 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -92.44 114.35 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.209 -175.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.45 149.27 60.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.092 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.28 -6.39 9.9 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.231 2.621 . . . . 0.0 114.675 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -7.77 59.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.52 3.83 52.96 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -107.29 111.96 62.99 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.636 0.255 . . . . 0.0 111.06 -178.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 24.1 Cg_exo -65.64 120.48 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.121 1.881 . . . . 0.0 110.283 167.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.548 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.4 p90 -105.06 138.92 40.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 16.4 m-85 -109.41 109.76 20.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.066 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.483 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -93.35 120.85 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.943 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.58 119.27 29.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -84.53 -6.16 59.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.382 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.63 -55.78 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 110.137 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -90.58 -9.91 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.716 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.97 53.35 3.07 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.994 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.39 150.38 50.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.876 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.483 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -107.84 114.82 29.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.967 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 155.97 25.02 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 99.6 m95 -90.11 -74.34 0.49 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.874 0.845 . . . . 0.0 110.016 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 6.4 mt-10 -70.47 129.18 38.55 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 -172.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -61.37 149.92 81.78 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-O 121.312 0.577 . . . . 0.0 112.191 -171.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -82.98 15.37 2.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.997 2.465 . . . . 0.0 111.78 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.997 177.794 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.99 142.06 93.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.172 1.915 . . . . 0.0 111.464 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.29 112.91 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.776 2.317 . . . . 0.0 111.729 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.43 -24.74 4.37 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 68.4 m95 -86.96 125.36 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.817 0.342 . . . . 0.0 110.533 176.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -117.61 112.83 21.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -76.02 118.27 18.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.19 175.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -121.81 134.83 54.91 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mm -88.77 114.47 27.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.158 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.7 150.98 73.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.93 1.82 2.1 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.279 2.653 . . . . 0.0 114.412 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -13.75 41.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.96 8.1 37.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.136 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.99 117.78 54.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.878 -0.19 . . . . 0.0 111.402 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -60.0 121.23 9.47 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 111.043 166.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.516 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.9 p90 -117.98 136.16 53.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.2 113.17 25.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.61 0.719 . . . . 0.0 110.154 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.34 116.99 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 124.35 27.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.121 178.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -92.93 5.41 51.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.518 -175.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -92.01 -52.84 4.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.5 p -112.02 0.83 16.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.141 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER 62.04 70.48 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.531 176.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.91 150.37 46.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.343 175.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.03 108.04 12.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.66 0.267 . . . . 0.0 111.056 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.5 t -124.2 143.95 50.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.6 m95 -89.65 -21.69 22.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.773 0.797 . . . . 0.0 109.517 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -83.05 113.57 20.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.374 -176.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.77 120.38 41.3 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.129 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.14 9.47 1.41 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.02 2.48 . . . . 0.0 113.931 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.96 138.09 76.44 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.977 2.452 . . . . 0.0 112.072 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.5 111.56 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.759 2.306 . . . . 0.0 111.599 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.38 -27.35 4.0 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -84.16 101.57 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG2' ' HD2' ' A' ' 16' ' ' ARG . 2.7 tt0 -98.6 104.48 16.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.323 -174.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.641 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -79.65 119.03 22.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.0 109.866 174.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.549 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -124.36 139.66 53.69 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 mm -88.72 104.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.877 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.17 156.11 92.23 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.391 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 -3.01 2.94 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.208 2.605 . . . . 0.0 113.046 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.528 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -78.33 -17.19 56.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.277 0.561 . . . . 0.0 109.534 172.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.34 1.55 55.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.943 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HG2' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.57 129.35 24.11 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.66 -0.27 . . . . 0.0 110.926 -175.267 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 121.74 9.57 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.789 2.326 . . . . 0.0 111.412 168.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.584 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.1 p90 -119.51 141.04 49.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.162 0.506 . . . . 0.0 109.948 176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.3 m-85 -106.24 112.63 25.74 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.988 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.501 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.23 112.82 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.653 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.97 113.94 18.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.418 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -81.94 13.29 3.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.371 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -97.42 -57.69 2.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.23 0.538 . . . . 0.0 109.899 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -93.5 -14.39 26.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.5 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 mttt 71.95 37.49 1.02 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.305 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.73 154.27 21.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.768 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.501 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -119.41 116.12 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.715 -175.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 t -123.59 141.43 52.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.584 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -92.23 -10.55 38.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.884 0.849 . . . . 0.0 109.221 174.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.93 112.2 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.554 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.525 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 33.1 t0 -62.45 112.57 6.74 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.32 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.86 -9.64 26.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.871 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 39' ' ' ARG . 18.7 mtm180 . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 121.128 0.489 . . . . 0.0 109.899 175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 34.9 Cg_exo -60.39 147.95 92.2 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.733 1.622 . . . . 0.0 110.249 172.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 45.4 Cg_exo -58.47 -10.92 9.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.802 2.334 . . . . 0.0 113.606 -175.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.07 1.24 80.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.509 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.496 ' HE3' ' HB3' ' A' ' 25' ' ' PHE . 37.9 m95 -105.14 115.17 29.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.022 0.439 . . . . 0.0 110.061 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 21.0 tt0 -98.47 99.73 10.93 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.707 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.65 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.3 ptp -79.63 92.92 5.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.434 0.635 . . . . 0.0 110.455 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 16' ' ' ARG . 44.5 mtt-85 -85.71 128.55 34.82 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.031 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mm -88.03 102.12 12.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.185 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.78 146.02 90.24 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.696 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.27 -5.62 5.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.842 2.361 . . . . 0.0 112.502 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.18 -17.05 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 0.0 109.874 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.76 60.05 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.037 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.41 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -107.94 110.3 62.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.925 -177.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.0 117.65 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.025 . . . . 0.0 110.861 167.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.561 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.9 p90 -111.6 127.53 55.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.727 0.775 . . . . 0.0 109.862 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.9 m-85 -93.58 103.94 16.09 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.463 -172.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.618 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -95.22 109.09 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.455 176.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.9 127.29 32.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.247 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -100.18 12.0 38.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.0 111.023 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -100.42 -51.02 3.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.021 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.5 p -111.67 4.6 18.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.905 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 64.88 1.19 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.366 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.74 144.53 48.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.766 174.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.618 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -122.37 101.77 7.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.403 178.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.769 0.318 . . . . 0.0 111.566 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.561 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -89.78 -17.78 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.768 0.794 . . . . 0.0 109.101 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.85 114.55 21.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.486 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.45 120.8 68.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.979 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.05 10.19 3.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.161 2.574 . . . . 0.0 113.767 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.88 148.31 89.81 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.522 2.148 . . . . 0.0 111.52 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.65 119.58 5.36 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.844 2.363 . . . . 0.0 112.093 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.47 -24.37 6.89 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.914 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -83.86 125.99 32.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 110.918 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.07 122.12 33.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.494 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.631 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 1.9 ptt? -89.26 124.03 34.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -128.55 143.85 51.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.92 125.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 0.0 110.597 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -89.43 165.09 27.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 21.6 Cg_endo -60.88 -15.0 35.57 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.357 2.705 . . . . 0.0 113.928 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.13 56.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.008 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.93 20.66 60.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.057 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 9.5 mmm180 -107.8 120.94 45.6 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.82 -0.224 . . . . 0.0 110.435 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.45 113.64 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.048 1.832 . . . . 0.0 111.061 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.46 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.7 p90 -112.45 138.45 49.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 15' ' ' MET . 7.2 m-85 -103.58 114.47 28.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.885 -174.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.3 112.68 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.53 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.2 120.41 22.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.348 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -89.81 -1.51 58.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.436 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.19 -57.63 3.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.2 p -113.23 6.87 17.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.978 -176.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.04 67.95 0.65 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.59 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 149.5 42.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.05 108.23 11.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -124.19 148.53 47.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.335 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.46 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 38.9 m95 -91.26 -15.46 29.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.611 0.719 . . . . 0.0 110.153 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.19 107.88 19.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.863 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -58.38 146.26 72.47 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.708 -175.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.14 11.8 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.79 2.326 . . . . 0.0 112.268 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 . . . . . 0 N--CA 1.441 -0.925 0 CA-C-O 121.353 0.597 . . . . 0.0 109.726 175.098 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 39' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.24 150.66 39.33 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 121.997 1.798 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.38 -27.92 25.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.299 2.666 . . . . 0.0 113.7 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.82 -13.41 83.46 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.22 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.413 ' CE3' ' HG3' ' A' ' 38' ' ' PRO . 80.5 m95 -92.84 121.42 34.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.976 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.5 tt0 -118.52 105.58 11.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.447 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.51 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptp -83.19 128.73 34.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.258 0.551 . . . . 0.0 110.731 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.85 152.35 48.61 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.71 111.61 32.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.089 0.471 . . . . 0.0 110.328 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.83 155.81 82.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.689 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.64 -7.75 7.88 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.391 2.727 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -70.4 -21.54 62.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.6 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.73 -0.14 59.3 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.64 46.52 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.703 -177.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.03 126.8 23.35 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.723 2.282 . . . . 0.0 111.208 169.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.421 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.1 p90 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.508 0.67 . . . . 0.0 109.952 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 20.3 m-85 -104.78 114.41 28.61 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.531 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.573 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.05 118.8 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.723 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.64 119.97 28.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.197 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -85.12 -3.84 58.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.855 0.36 . . . . 0.0 110.905 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -80.56 -57.29 3.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 109.609 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -90.35 -12.75 36.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.488 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 mttm 60.92 55.07 3.25 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.09 152.88 48.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.366 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -117.74 116.39 26.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.947 -178.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -123.21 145.26 48.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.499 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.421 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 7.4 m95 -89.66 -20.05 24.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.739 0.781 . . . . 0.0 109.411 176.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.8 110.16 17.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.911 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -49.82 120.77 11.68 Favored Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.012 0.82 . . . . 0.0 111.738 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HG3' ' CE3' ' A' ' 13' ' ' TRP . 29.9 Cg_endo -64.05 -12.65 33.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.113 2.542 . . . . 0.0 113.049 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.429 ' HG2' HD23 ' A' ' 9' ' ' LEU . 1.7 mmp_? . . . . . 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.831 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.8 -51.31 55.16 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.56 -15.26 15.18 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 122.672 2.248 . . . . 0.0 114.14 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.38 12.36 57.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.199 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.03 101.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.839 0.352 . . . . 0.0 110.446 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -68.43 116.21 8.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.42 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.64 73.35 3.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.906 -177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -83.3 -76.51 0.28 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -105.43 178.68 1.07 Allowed Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 172.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 9' ' ' LEU . 53.8 Cg_exo -54.28 147.21 46.78 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.445 1.43 . . . . 0.0 110.941 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 38.2 Cg_exo -63.81 10.02 0.12 Allowed 'Trans proline' 0 N--CA 1.479 0.628 0 C-N-CA 123.454 2.769 . . . . 0.0 114.159 -176.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.96 -0.18 27.11 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.479 -0.649 . . . . 0.0 111.479 174.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -104.74 128.75 52.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.838 0.351 . . . . 0.0 110.467 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -114.96 111.31 20.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.631 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.614 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -85.53 115.4 23.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.231 0.539 . . . . 0.0 110.424 176.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 mtp85 -113.91 142.58 45.95 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.277 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mm -93.07 101.75 12.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.296 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.03 153.79 72.02 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.407 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.64 -16.98 16.14 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.944 2.429 . . . . 0.0 112.359 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -63.61 -25.99 68.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.429 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.93 -0.37 44.94 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.709 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.13 125.4 32.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.53 0.205 . . . . 0.0 111.229 -176.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.33 123.79 14.17 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.926 2.417 . . . . 0.0 111.493 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.431 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 22.0 p90 -121.22 137.52 54.64 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.299 0.571 . . . . 0.0 109.902 175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.614 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 20.5 m-85 -101.2 112.44 24.92 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.477 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.415 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -100.51 119.19 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.654 177.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.628 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 1.1 t70 -83.41 132.41 34.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.896 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -100.77 8.57 43.18 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.051 -0.259 . . . . 0.0 111.415 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -88.29 -58.26 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.259 0.552 . . . . 0.0 109.882 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 47.6 p -98.94 -23.45 15.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.845 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 78.94 70.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.904 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.3 t -129.21 166.6 19.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.574 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.415 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -128.49 109.89 11.8 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.664 -174.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 t -124.02 146.82 48.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.486 0.184 . . . . 0.0 110.709 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.431 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 21.6 m95 -90.25 -36.23 14.85 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.486 0.66 . . . . 0.0 109.398 175.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -71.93 121.51 19.21 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.754 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.546 ' HB3' ' HG ' ' A' ' 40' ' ' LEU . 66.1 t0 -61.12 115.23 13.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.409 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -66.4 -12.18 34.6 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.005 2.47 . . . . 0.0 113.072 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 39' ' ' ARG . 0.7 OUTLIER -92.26 2.27 56.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.952 0.406 . . . . 0.0 110.355 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HG ' ' HB3' ' A' ' 37' ' ' ASP . 63.6 mt -75.21 -11.34 60.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.044 175.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.961 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.428 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.217 -0.353 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 60.57 70.41 0.99 Allowed Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 122.913 0.485 . . . . 0.0 111.513 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -87.55 -144.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.126 2.551 . . . . 0.0 111.757 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.2 -66.92 0.23 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.141 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -93.59 -11.91 8.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.787 0.803 . . . . 0.0 110.78 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.29 -17.36 24.85 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.811 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.11 125.7 49.94 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.636 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.21 -158.99 0.67 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 120.731 0.3 . . . . 0.0 110.577 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.06 175.27 2.53 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.71 152.77 71.98 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.279 1.986 . . . . 0.0 111.122 174.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.83 -2.19 5.11 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.918 2.412 . . . . 0.0 113.511 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' HD21 ' A' ' 29' ' ' ASN . . . -92.36 -11.55 59.54 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.588 175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -99.35 111.98 24.25 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.099 0.476 . . . . 0.0 110.118 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 26' ' ' ILE . 12.1 tt0 -100.59 104.19 15.53 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.585 -177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.405 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -69.09 127.54 33.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.539 0.685 . . . . 0.0 109.592 174.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -125.6 123.66 39.51 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.581 176.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.42 102.98 14.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.688 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -65.46 152.19 92.8 Favored Pre-proline 0 C--N 1.317 -0.832 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.119 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 31.4 Cg_exo -60.2 -4.0 2.77 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.001 2.468 . . . . 0.0 112.273 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -72.19 -25.39 61.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.31 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.25 5.78 48.97 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.522 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.28 120.36 47.96 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.458 0.17 . . . . 0.0 110.802 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.35 113.18 3.02 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.286 1.99 . . . . 0.0 111.252 168.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.522 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.0 p90 -111.43 135.99 51.21 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 15' ' ' MET . 22.9 m-85 -101.16 116.4 32.73 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.252 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.481 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -102.48 113.64 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.954 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 35.9 t0 -80.65 126.37 31.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.549 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -90.16 -7.79 52.8 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.83 0.348 . . . . 0.0 110.521 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.414 HD21 ' HA3' ' A' ' 12' ' ' GLY . 61.3 m-80 -82.52 -54.59 5.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.274 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 62.1 p -94.43 -12.48 27.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.45 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 1.2 mtmt 62.83 58.27 1.58 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.279 0.562 . . . . 0.0 111.076 -178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.7 152.75 47.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.633 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.481 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -122.83 112.86 18.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.693 -177.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.8 t -123.97 147.13 48.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.853 0.359 . . . . 0.0 110.877 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.522 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 48.8 m95 -91.27 -9.54 44.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.859 0.838 . . . . 0.0 109.858 177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -108.66 125.75 52.23 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.337 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -61.19 116.0 17.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 -175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -66.67 -16.28 50.01 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.561 2.84 . . . . 0.0 113.528 -173.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -72.52 -16.54 61.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.887 0.375 . . . . 0.0 110.701 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 mt -82.83 -16.81 46.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.197 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.421 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.33 -51.44 1.24 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 111.501 0.186 . . . . 0.0 111.501 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.17 156.84 17.39 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 121.92 1.746 . . . . 0.0 111.998 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.99 -116.59 4.82 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.202 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mt 54.35 67.4 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.276 0.56 . . . . 0.0 110.786 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.57 134.41 39.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.624 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.08 92.18 8.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.368 0.604 . . . . 0.0 111.27 -175.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.462 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -100.77 -85.71 0.41 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 172.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' A' ' 15' ' ' MET . 0.7 OUTLIER -128.87 178.28 1.75 Allowed Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.557 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 20.4 Cg_exo -66.68 148.84 83.67 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.109 1.873 . . . . 0.0 111.409 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -47.04 110.47 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.506 2.804 . . . . 0.0 112.724 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.06 -26.8 5.24 Favored Glycine 0 N--CA 1.444 -0.795 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.557 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 86.2 m95 -82.05 120.43 25.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.815 0.341 . . . . 0.0 110.302 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -112.84 105.35 13.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.444 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.566 ' HB3' HD11 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -79.15 130.58 35.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.394 0.616 . . . . 0.0 110.846 178.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.27 153.06 46.38 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -105.85 124.08 60.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.683 -177.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.89 154.72 55.62 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.183 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -58.4 -11.71 11.69 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.507 2.805 . . . . 0.0 114.552 -173.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.32 -18.19 55.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.14 5.77 32.46 Favored Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.872 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' H ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.87 118.96 51.63 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.724 0.297 . . . . 0.0 111.2 -177.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.57 123.81 13.06 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.745 2.296 . . . . 0.0 111.296 170.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.574 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 13.4 p90 -116.06 142.97 46.09 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.235 0.54 . . . . 0.0 109.599 176.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 10.9 m-85 -110.17 116.83 32.22 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.681 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.542 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.39 110.44 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 122.046 0.927 . . . . 0.0 110.032 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.45 126.71 31.34 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.394 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -98.98 6.3 46.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.332 -177.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -88.56 -58.61 2.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.069 0.461 . . . . 0.0 109.774 178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.0 p -104.38 -4.1 23.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.528 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.88 64.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.339 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.1 143.94 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.155 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.542 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -117.53 100.9 7.95 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.01 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.5 t -123.86 149.12 46.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.96 0.409 . . . . 0.0 111.494 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.2 m95 -96.67 5.02 51.51 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.55 108.68 19.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.596 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.533 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 19.7 t0 -63.19 113.75 10.47 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.814 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.61 -1.86 11.65 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.403 2.735 . . . . 0.0 112.56 -175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 8' ' ' PHE . 13.2 mtm180 -105.93 -5.06 19.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.923 0.392 . . . . 0.0 110.04 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 40' ' ' LEU . 21.2 mt -101.78 -33.73 9.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.353 177.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.911 178.72 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.464 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -67.02 119.15 62.07 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.591 0.234 . . . . 0.0 110.454 178.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 11.8 Cg_exo -70.17 -30.88 19.7 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.882 2.388 . . . . 0.0 112.14 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.73 -32.54 3.95 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.238 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -123.06 120.09 59.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.887 0.375 . . . . 0.0 110.882 -176.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -75.33 -40.42 58.41 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.04 80.1 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.177 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.09 -76.28 0.06 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.152 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER -114.72 160.5 33.1 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 47.0 Cg_exo -56.37 153.01 36.32 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.569 2.179 . . . . 0.0 112.148 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 64.5 Cg_exo -52.44 110.73 0.49 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.024 2.483 . . . . 0.0 112.162 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.14 -20.26 6.69 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.343 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 81.9 m95 -82.14 120.33 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.01 0.433 . . . . 0.0 110.753 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -114.31 111.11 20.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.746 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.484 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -78.45 104.72 9.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.651 0.739 . . . . 0.0 110.183 175.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 16' ' ' ARG . 27.2 mtt-85 -103.01 121.83 43.36 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.25 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 mm -80.52 109.93 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.844 0.354 . . . . 0.0 110.271 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -81.75 148.8 62.42 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.033 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 23.7 Cg_exo -65.38 3.46 1.06 Allowed 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.591 2.861 . . . . 0.0 114.525 -172.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.38 -15.17 38.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.0 10.87 29.32 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.581 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -107.68 112.42 62.15 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.54 109.53 0.77 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.866 1.711 . . . . 0.0 110.659 162.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -105.8 125.92 51.56 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.592 0.711 . . . . 0.0 109.256 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HA ' ' A' ' 37' ' ' ASP . 26.2 m-85 -91.88 109.84 21.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.156 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.438 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.87 114.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.937 178.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.52 118.61 21.54 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.035 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -91.41 6.56 44.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.335 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -95.9 -54.6 3.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 120.916 0.388 . . . . 0.0 110.355 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -111.89 5.02 18.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.114 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm 64.38 74.13 0.41 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.13 175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.58 145.4 51.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.492 174.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.438 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.75 105.17 8.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.711 0.291 . . . . 0.0 110.537 -179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 t -123.87 146.95 48.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -89.91 -11.35 42.08 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.759 0.79 . . . . 0.0 109.747 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.39 119.91 40.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.269 -171.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.405 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 64.1 t0 -48.32 116.87 5.31 Favored Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.057 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HA ' ' HG3' ' A' ' 41' ' ' LYS . 31.5 Cg_endo -63.38 -13.4 35.81 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.249 2.633 . . . . 0.0 113.517 -174.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 39' ' ' ARG . 4.0 mtm105 -85.16 3.19 40.26 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.033 0.444 . . . . 0.0 110.962 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.3 mt -102.1 -18.52 15.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.195 0.522 . . . . 0.0 110.16 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.511 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.848 0 N-CA-C 112.094 -0.402 . . . . 0.0 112.094 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.38 153.8 58.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.68 78.65 2.03 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.933 2.422 . . . . 0.0 111.562 176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.69 -156.6 7.94 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.987 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 mm -86.03 83.08 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.02 30.88 0.35 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.291 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.16 102.83 3.7 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.298 -176.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.2 t80 70.41 -64.29 0.37 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 123.87 0.731 . . . . 0.0 111.839 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.447 HD23 ' HD3' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -114.13 166.49 11.37 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.32 -177.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.29 152.82 80.16 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.697 2.265 . . . . 0.0 112.1 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.94 116.19 2.75 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.113 2.542 . . . . 0.0 112.325 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.5 -14.38 9.31 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.933 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.415 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 60.7 m95 -88.94 94.95 10.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.0 110.009 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -86.84 107.39 18.29 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.587 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.504 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -80.54 122.71 27.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.403 0.62 . . . . 0.0 110.804 178.136 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -130.92 133.96 46.33 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.272 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -89.18 112.03 23.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 120.775 0.322 . . . . 0.0 110.498 -177.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.07 152.84 77.1 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.236 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.74 -1.62 3.55 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.158 2.572 . . . . 0.0 112.504 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -75.16 -23.62 57.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.526 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.34 -4.01 29.73 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.56 123.39 37.44 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.938 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 36.2 Cg_exo -63.3 114.63 2.58 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.17 1.913 . . . . 0.0 110.531 166.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.416 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 10.9 p90 -106.03 135.04 48.2 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.382 0.61 . . . . 0.0 109.693 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -103.65 114.52 28.85 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.044 -175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.577 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -99.16 111.68 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.117 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HB2' ' CE2' ' A' ' 13' ' ' TRP . 0.0 OUTLIER -81.48 120.48 25.06 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.57 -178.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -91.72 -4.3 55.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.174 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -84.05 -56.18 3.81 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.609 -0.268 . . . . 0.0 110.466 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.4 p -108.01 0.96 22.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.068 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 mptt 69.61 69.94 0.24 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.738 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.57 149.51 52.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.18 176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.577 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.15 106.67 9.73 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -123.13 147.32 46.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.017 0.437 . . . . 0.0 111.336 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.416 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 25.7 m95 -93.87 -15.95 24.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.398 0.618 . . . . 0.0 110.44 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.45 115.79 31.3 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.222 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.537 ' OD2' ' HG2' ' A' ' 39' ' ' ARG . 3.9 t70 -53.48 127.0 48.83 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.924 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.401 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 11.0 Cg_endo -57.37 -32.84 95.03 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.192 2.594 . . . . 0.0 114.166 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.537 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -79.22 -16.62 56.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.195 -176.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.527 ' HG ' ' OD2' ' A' ' 37' ' ' ASP . 77.8 mt -70.56 -31.77 68.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.026 0.441 . . . . 0.0 110.499 175.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HE2' ' HA ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.733 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.907 0 N-CA-C 111.941 -0.464 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.87 118.64 7.28 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.548 0.174 . . . . 0.0 110.807 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -69.37 -72.65 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.179 1.92 . . . . 0.0 111.83 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.76 67.87 0.35 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.5 175.36 9.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -177.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -80.08 99.38 7.68 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.078 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.38 -4.67 57.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.369 0.605 . . . . 0.0 111.05 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.69 164.03 31.21 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.147 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.412 ' CD2' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -79.91 174.12 6.62 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.689 172.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -57.89 140.04 92.44 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 121.765 1.643 . . . . 0.0 111.246 176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.12 117.56 2.92 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.806 2.337 . . . . 0.0 112.393 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.442 ' HA3' HD21 ' A' ' 29' ' ' ASN . . . 121.27 -24.08 7.44 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.007 -177.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -78.49 112.61 15.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.182 0.515 . . . . 0.0 110.569 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' HG2' ' HD2' ' A' ' 16' ' ' ARG . 18.5 tt0 -107.4 106.72 17.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.637 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.51 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.1 ptp -81.77 133.36 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 110.83 178.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.492 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -134.53 138.93 45.05 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.056 175.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.63 108.3 19.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.181 0.515 . . . . 0.0 110.347 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.24 152.95 84.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.386 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.31 7.19 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.393 2.729 . . . . 0.0 114.278 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -17.5 26.95 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 109.14 2.35 31.56 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.781 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.77 124.42 34.34 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.677 0.275 . . . . 0.0 111.355 -177.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.95 123.42 11.9 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.555 2.17 . . . . 0.0 111.339 167.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.517 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 20.5 p90 -114.4 139.33 49.58 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.203 0.525 . . . . 0.0 109.629 175.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 19.6 m-85 -104.67 112.56 25.69 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.49 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -97.51 112.2 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.666 177.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 4.0 t70 -77.71 124.36 27.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.02 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -94.27 2.73 55.85 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.231 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.442 HD21 ' HA3' ' A' ' 12' ' ' GLY . 53.4 m-80 -86.85 -62.2 1.56 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.084 0.469 . . . . 0.0 110.112 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.1 p -106.51 -1.3 23.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.897 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 68.15 72.39 0.31 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.846 176.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.17 141.89 51.34 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.49 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -116.29 97.72 6.2 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.758 0.313 . . . . 0.0 110.54 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.68 149.38 45.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.763 0.316 . . . . 0.0 111.011 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.1 m95 -89.83 -16.87 29.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.68 . . . . 0.0 109.77 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -79.95 124.89 29.09 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.631 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.471 ' OD1' ' HG2' ' A' ' 39' ' ' ARG . 10.8 t70 -72.83 120.61 81.77 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.313 0.577 . . . . 0.0 111.435 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 37' ' ' ASP . 49.4 Cg_endo -92.26 14.45 1.73 Allowed 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.475 2.784 . . . . 0.0 114.884 -178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.471 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 1.4 ptp180 -94.45 -19.4 20.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.952 0.796 . . . . 0.0 109.899 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -80.48 -37.37 31.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.688 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.216 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 112.288 -0.325 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.87 133.79 61.38 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.459 0.171 . . . . 0.0 110.816 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.67 106.82 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 123.021 2.48 . . . . 0.0 112.359 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.02 -151.9 16.48 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.018 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.0 mm -104.12 95.62 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.93 163.42 21.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.228 -177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.2 87.83 4.91 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.655 -176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 169.08 156.91 0.05 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 123.943 0.897 . . . . 0.0 109.983 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -82.83 174.43 6.06 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 172.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 41.0 Cg_exo -57.39 140.8 94.19 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.124 1.216 . . . . 0.0 110.015 172.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 73.5 Cg_exo -49.68 -27.91 16.05 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.262 2.642 . . . . 0.0 113.898 -174.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.59 -9.15 82.13 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.035 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -93.32 119.46 32.48 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.05 0.453 . . . . 0.0 110.195 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 26' ' ' ILE . 16.0 tt0 -109.81 108.11 18.32 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.412 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.431 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -77.76 131.24 37.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.29 0.567 . . . . 0.0 110.537 178.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.6 mtt-85 -133.77 142.63 48.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.276 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -97.85 109.11 22.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.927 0.394 . . . . 0.0 109.97 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.41 ' HB3' ' OD1' ' A' ' 20' ' ' ASN . . . -81.24 159.29 68.1 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.535 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.67 0.82 1.28 Allowed 'Trans proline' 0 N--CA 1.478 0.59 0 C-N-CA 123.474 2.782 . . . . 0.0 114.53 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -87.03 -7.61 57.94 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.43 13.65 65.16 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.64 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -108.18 120.01 48.08 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.608 0.242 . . . . 0.0 111.429 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -63.62 114.42 2.54 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.328 2.019 . . . . 0.0 111.536 167.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.532 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.8 p90 -113.13 139.88 48.36 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.429 ' HD1' ' HB3' ' A' ' 15' ' ' MET . 20.4 m-85 -105.05 113.0 26.34 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.625 0.726 . . . . 0.0 110.027 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.536 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -94.4 115.72 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.787 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.66 126.08 32.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.872 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -97.52 10.61 39.36 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.411 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -93.84 -46.12 7.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.076 0.465 . . . . 0.0 109.975 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 18.71 8.19 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.388 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.67 58.53 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.843 176.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 148.35 43.8 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.924 0.392 . . . . 0.0 111.235 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.536 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -126.58 102.03 6.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.209 178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.3 t -123.65 149.59 45.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.922 0.391 . . . . 0.0 111.317 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.5 m95 -91.69 -20.99 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.298 0.57 . . . . 0.0 110.477 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.08 118.47 25.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.533 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' A' ' 38' ' ' PRO . 19.4 t0 -64.53 117.89 42.18 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.77 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 37' ' ' ASP . 19.2 Cg_endo -62.34 -17.55 58.03 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.952 2.435 . . . . 0.0 112.958 -178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 35.3 mtm180 -83.59 -20.42 33.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.332 . . . . 0.0 110.899 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.9 mt -79.71 -36.51 37.35 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.247 0.949 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.358 176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 111.667 -0.573 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.49 75.01 77.75 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 111.568 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -68.44 -50.85 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 121.767 1.645 . . . . 0.0 110.787 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.87 -172.04 17.72 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mt -112.73 63.27 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.505 0.669 . . . . 0.0 109.863 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -77.93 140.97 39.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.212 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.11 84.8 2.34 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.593 0.711 . . . . 0.0 110.705 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -78.96 -13.04 60.03 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.587 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 173.2 3.25 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.879 173.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 12.2 Cg_exo -70.73 147.84 57.48 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 111.619 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -44.4 125.59 6.06 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.072 2.515 . . . . 0.0 112.492 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.74 -29.99 7.78 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.463 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.549 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 68.0 m95 -79.67 122.72 26.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.192 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -120.12 116.22 25.23 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.84 136.33 36.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.403 0.621 . . . . 0.0 110.463 176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.58 155.8 47.26 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.92 112.63 41.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 120.149 -0.621 . . . . 0.0 110.506 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.07 151.94 73.53 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.175 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.31 -7.47 6.82 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 123.774 2.983 . . . . 0.0 114.458 -173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.02 -9.08 58.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 0.0 110.076 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.27 10.33 51.54 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.735 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.43 116.07 56.97 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.761 -0.219 . . . . 0.0 111.349 -177.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.39 122.95 12.68 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.375 2.05 . . . . 0.0 111.146 166.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.531 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.0 p90 -122.08 145.19 48.4 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.57 112.99 25.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.578 0.704 . . . . 0.0 110.009 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.33 110.5 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.018 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 9.2 t70 -77.52 119.82 21.64 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.038 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -87.75 -1.91 58.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.949 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -84.74 -67.69 0.78 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.105 0.479 . . . . 0.0 110.475 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.6 p -99.57 -1.6 37.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.62 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.7 OUTLIER 65.85 75.92 0.33 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.548 177.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.54 142.73 50.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.445 175.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.56 93.35 4.24 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.04 0.447 . . . . 0.0 109.952 176.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.47 150.21 33.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.426 -175.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.531 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 5.1 m95 -100.43 -36.79 9.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.457 0.646 . . . . 0.0 109.58 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' O ' ' HE2' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -75.42 111.29 10.55 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.729 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -60.95 128.96 89.89 Favored Pre-proline 0 N--CA 1.439 -1.023 0 CA-C-O 121.124 0.488 . . . . 0.0 111.867 -174.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HA ' ' OXT' ' A' ' 41' ' ' LYS . 37.6 Cg_endo -68.77 6.32 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 123.04 2.494 . . . . 0.0 112.38 176.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -93.44 -9.7 37.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 37' ' ' ASP . 1.7 pp -112.19 -48.63 3.02 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.367 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.478 ' HE2' ' O ' ' A' ' 36' ' ' GLU . 14.8 pttt . . . . . 0 C--O 1.249 1.041 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.446 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.56 -53.28 2.02 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 119.727 -0.178 . . . . 0.0 111.432 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 6' ' ' GLN . 11.2 Cg_endo -90.58 -132.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.668 2.245 . . . . 0.0 111.708 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.443 ' H ' ' HB2' ' A' ' 3' ' ' PRO . . . -107.62 154.28 16.62 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.819 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 mt 50.52 62.19 0.24 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 122.96 0.504 . . . . 0.0 110.903 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.506 ' O ' ' HD2' ' A' ' 3' ' ' PRO . 9.3 mm100 54.66 -103.3 0.17 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.833 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m 59.58 -168.91 0.15 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.002 0.521 . . . . 0.0 112.118 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -131.32 -66.8 0.72 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.617 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.23 167.39 12.47 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.983 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 11.4 Cg_exo -70.01 142.65 47.37 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.964 2.443 . . . . 0.0 111.347 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.11 101.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.078 2.519 . . . . 0.0 111.878 178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.41 -27.69 1.67 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.534 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 69.5 m95 -84.01 116.67 22.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -111.04 102.75 11.19 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.715 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.673 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 3.7 ptt? -83.16 105.13 13.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.337 0.589 . . . . 0.0 110.424 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 16' ' ' ARG . 2.3 mpp_? -102.72 143.35 32.48 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 mm -89.19 110.69 21.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 120.84 0.353 . . . . 0.0 110.939 -175.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.98 143.51 96.31 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.402 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.75 -21.27 24.86 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.363 2.708 . . . . 0.0 113.383 -175.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -71.68 -13.97 61.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.494 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.53 9.02 39.3 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.738 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' H ' ' HG2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -108.77 108.73 61.01 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.744 -0.228 . . . . 0.0 110.755 -178.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -55.81 122.01 10.98 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.303 2.002 . . . . 0.0 111.478 169.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.532 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 p90 -112.57 133.48 54.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.648 0.737 . . . . 0.0 109.488 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.673 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 12.9 m-85 -99.83 106.67 18.56 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.778 -173.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -93.25 110.05 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.703 177.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 5.2 t70 -77.47 123.6 26.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.21 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -90.5 0.7 57.22 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.927 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -84.51 -54.88 4.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.854 0.359 . . . . 0.0 110.22 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.9 p -106.49 -2.34 22.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.24 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 62.7 64.63 0.89 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.149 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -113.91 141.93 46.75 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.426 176.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.405 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -115.46 95.67 5.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.312 0.577 . . . . 0.0 110.084 176.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.05 142.87 49.91 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.206 -173.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 2.1 m95 -92.42 -23.56 19.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.608 0.718 . . . . 0.0 109.381 178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.44 102.84 6.15 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.483 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -51.57 130.1 35.33 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.589 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.44 14.78 2.34 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.314 2.676 . . . . 0.0 113.971 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.94 -44.31 5.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.409 0.623 . . . . 0.0 109.376 173.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mt -81.91 -39.4 23.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.257 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.798 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.29 116.32 66.28 Favored Pre-proline 0 C--N 1.323 -0.549 0 O-C-N 122.804 -0.233 . . . . 0.0 110.448 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.23 163.8 30.45 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.885 2.39 . . . . 0.0 112.409 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.2 75.36 2.3 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.83 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.34 55.82 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.031 0.443 . . . . 0.0 110.576 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -93.62 -136.17 0.18 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.395 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.8 1.03 32.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.588 0.709 . . . . 0.0 110.571 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.77 -152.43 0.43 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.942 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.4 OUTLIER -110.46 -177.37 0.45 Allowed Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.96 157.11 13.81 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.076 1.851 . . . . 0.0 111.915 174.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -50.68 -35.52 47.68 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.296 2.664 . . . . 0.0 113.323 -176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.2 5.71 79.0 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.604 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.423 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 60.6 m95 -108.14 119.85 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 117.477 0.638 . . . . 0.0 110.623 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -107.6 111.77 24.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.733 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -84.21 127.18 33.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.304 0.573 . . . . 0.0 110.206 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.432 ' NH1' HG21 ' A' ' 26' ' ' ILE . 10.2 mtp180 -136.79 133.45 35.97 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.8 OUTLIER -87.04 120.43 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.288 -178.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -82.95 147.8 55.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.405 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 25.2 Cg_exo -64.33 -1.07 3.38 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.386 2.724 . . . . 0.0 114.044 -174.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -29.09 39.91 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.33 -2.92 8.94 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.289 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.28 123.92 36.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 122.624 -0.339 . . . . 0.0 111.338 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 33.3 Cg_exo -61.35 128.41 24.86 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.593 2.196 . . . . 0.0 111.006 167.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.1 p90 -119.66 148.45 43.35 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.104 0.478 . . . . 0.0 109.781 176.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -114.4 112.85 23.69 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.592 0.71 . . . . 0.0 109.694 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.432 HG21 ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -95.19 112.08 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.562 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.91 127.25 31.77 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.238 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -100.61 11.3 39.8 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.876 -176.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -94.64 -48.75 5.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.1 p -115.72 2.47 13.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.197 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.24 65.5 0.97 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.266 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.95 142.31 51.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.23 99.19 8.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.451 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 t -117.93 152.15 36.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.839 0.352 . . . . 0.0 110.994 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 10.7 m95 -95.37 -12.92 25.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.622 0.725 . . . . 0.0 109.9 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.38 122.48 31.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.888 -175.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.621 ' HB3' HD12 ' A' ' 40' ' ' LEU . 16.3 t70 -70.85 116.97 51.57 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.773 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.412 ' HD2' ' CD2' ' A' ' 9' ' ' LEU . 72.4 Cg_endo -76.78 15.19 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.363 2.709 . . . . 0.0 113.347 -177.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -105.89 -15.34 14.95 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 171.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' A' ' 37' ' ' ASP . 48.2 mt -88.84 -15.75 33.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.124 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.949 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.7 OUTLIER -78.3 124.45 85.68 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.5 0.191 . . . . 0.0 110.573 178.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 26.6 Cg_exo -62.32 125.02 15.36 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.706 2.27 . . . . 0.0 111.462 176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.93 72.61 0.47 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.243 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -108.25 42.5 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.333 0.587 . . . . 0.0 110.457 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -99.32 0.02 42.1 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.456 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.92 137.85 55.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.412 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -126.66 149.28 49.61 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.448 0.642 . . . . 0.0 109.81 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.455 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 1.3 mp -89.9 177.88 2.21 Favored Pre-proline 0 C--N 1.308 -1.225 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.03 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.455 ' CD ' ' HB3' ' A' ' 9' ' ' LEU . 39.8 Cg_exo -59.12 153.74 50.32 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.359 2.04 . . . . 0.0 112.302 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.18 118.6 4.08 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.294 2.663 . . . . 0.0 112.438 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.2 -22.59 12.09 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.836 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -83.38 127.01 33.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.932 0.396 . . . . 0.0 110.535 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -118.9 107.86 14.1 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.66 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.456 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.1 OUTLIER -81.27 118.55 22.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.377 0.608 . . . . 0.0 110.208 175.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -127.27 141.98 51.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.084 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.6 mm -95.3 112.63 28.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.635 -175.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.31 153.68 92.14 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.284 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.44 -11.85 18.3 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.018 2.479 . . . . 0.0 112.558 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.405 ' HB2' ' CG ' ' A' ' 22' ' ' ARG . 1.9 m-20 -79.74 -1.64 39.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.385 178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.11 2.63 66.12 Favored Glycine 0 CA--C 1.505 -0.567 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 173.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' CG ' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.93 120.21 46.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.13 -173.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -62.39 120.62 8.25 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.641 2.228 . . . . 0.0 111.029 168.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.426 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.8 p90 -116.23 141.8 47.67 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -108.0 111.47 23.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.909 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.445 HG13 HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -97.63 115.55 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.864 179.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.17 126.51 31.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.646 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.02 8.1 44.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.983 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -94.92 -49.87 5.37 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.1 p -113.29 7.39 17.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? 58.67 67.28 0.95 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.071 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.68 145.47 51.52 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.924 0.392 . . . . 0.0 111.189 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.445 HG23 HG13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -112.08 109.11 18.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.146 178.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.43 143.73 49.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.786 -175.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.426 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 9.3 m95 -97.11 -33.46 11.5 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.862 0.839 . . . . 0.0 108.808 174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -78.15 111.74 14.38 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.442 179.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.0 132.38 67.88 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.652 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HA ' ' HG3' ' A' ' 41' ' ' LYS . 57.3 Cg_endo -71.75 12.83 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.078 2.519 . . . . 0.0 112.748 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.69 2.73 54.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.211 0.529 . . . . 0.0 109.882 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.04 -15.46 12.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.555 176.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.921 -0.562 . . . . 0.0 110.154 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 111.828 -0.509 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.67 118.64 68.32 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.702 0.287 . . . . 0.0 110.692 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.69 55.72 5.75 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.969 2.446 . . . . 0.0 112.151 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.51 -92.19 0.42 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.104 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.6 84.28 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.279 0.561 . . . . 0.0 110.858 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.537 ' HG2' ' N ' ' A' ' 7' ' ' SER . 4.2 tt0 -98.36 150.7 21.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.304 177.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.537 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -62.36 105.24 0.59 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 174.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -62.06 -58.83 6.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.141 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.406 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 0.3 OUTLIER -91.72 170.98 8.51 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 175.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.616 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 13.7 Cg_exo -70.33 149.42 63.25 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.599 2.2 . . . . 0.0 111.279 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 57.2 Cg_exo -51.59 114.01 1.39 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.936 2.424 . . . . 0.0 112.263 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.69 -23.55 5.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.616 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 77.3 m95 -78.8 125.03 28.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.986 0.422 . . . . 0.0 111.208 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 26' ' ' ILE . 21.2 tt0 -122.13 107.86 12.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.137 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.444 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptm -81.2 126.02 31.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.415 0.626 . . . . 0.0 110.181 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -124.85 142.95 51.09 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.012 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.1 mm -93.32 119.48 41.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.318 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -81.0 156.77 71.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.082 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.37 -20.1 24.55 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.998 2.465 . . . . 0.0 112.378 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.409 ' HB3' ' HG2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -66.34 -18.82 65.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.2 177.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.6 11.33 59.46 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HG2' ' HB3' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.42 117.93 53.35 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.592 -0.304 . . . . 0.0 110.775 179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.6 120.11 7.73 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.395 2.063 . . . . 0.0 111.32 167.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.445 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.6 p90 -115.7 134.68 54.79 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.444 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 24.5 m-85 -99.13 113.25 25.39 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.066 -174.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -100.12 114.81 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.561 178.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -84.46 126.02 32.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.007 -178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -90.81 4.08 52.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -89.63 -55.68 3.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.331 0.586 . . . . 0.0 110.069 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.3 p -95.24 -11.52 27.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.392 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 mtpm? 65.54 44.52 3.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.926 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.95 155.46 26.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.904 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.403 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -120.46 116.32 25.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.303 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.4 t -124.54 149.51 46.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.498 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.445 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 42.7 m95 -91.43 -20.13 22.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.611 0.719 . . . . 0.0 109.703 174.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.79 109.1 19.89 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.733 -172.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -49.09 124.75 13.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.7 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.36 -10.8 26.04 Favored 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.79 2.327 . . . . 0.0 113.077 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -77.42 -5.78 51.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.744 0.307 . . . . 0.0 110.909 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.4 mt -74.67 -13.29 60.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.185 0.517 . . . . 0.0 110.129 172.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.59 -0.719 . . . . 0.0 110.145 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 112.292 -0.323 . . . . 0.0 112.292 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.26 143.82 30.0 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.41 109.71 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.299 2.666 . . . . 0.0 112.435 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.33 2.54 85.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.793 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.52 79.48 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.18 0.514 . . . . 0.0 110.939 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.82 -5.15 14.99 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.112 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.97 92.92 6.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.845 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.04 -36.06 5.75 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.4 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.75 167.3 9.41 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.246 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.27 160.09 24.39 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.735 2.29 . . . . 0.0 111.892 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -57.24 -25.76 66.46 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.749 2.299 . . . . 0.0 112.521 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' HA3' ' OD1' ' A' ' 29' ' ' ASN . . . -77.9 -4.58 85.9 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.692 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -105.02 131.28 52.74 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.55 -0.382 . . . . 0.0 110.273 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 20.4 tt0 -114.67 103.01 10.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.573 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.559 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -82.0 128.12 33.76 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.255 0.55 . . . . 0.0 110.095 176.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.3 mtp180 -134.86 131.99 38.04 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -90.69 109.49 20.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . . . -79.63 151.49 74.31 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.467 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 18' ' ' ALA . 17.7 Cg_exo -67.8 13.01 0.19 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 123.56 2.84 . . . . 0.0 114.442 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -9.2 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.66 53.39 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.396 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.27 112.19 61.33 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.608 0.242 . . . . 0.0 110.814 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 26.0 Cg_exo -65.4 114.27 2.8 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.142 1.895 . . . . 0.0 111.255 169.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.49 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 8.0 p90 -107.81 133.62 51.93 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.45 0.643 . . . . 0.0 109.811 -179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -103.53 115.96 31.5 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.949 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.587 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -102.01 110.48 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 CA-C-O 122.165 0.983 . . . . 0.0 109.799 178.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.72 126.39 30.79 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.648 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -100.74 7.91 43.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.748 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.453 ' OD1' ' HA3' ' A' ' 12' ' ' GLY . 1.7 m-80 -88.34 -50.12 6.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.0 p -115.54 2.5 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.267 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.67 63.21 0.87 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.056 175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.56 150.15 49.0 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.421 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.587 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -123.24 113.69 19.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.616 0.246 . . . . 0.0 110.726 -179.101 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.9 t -123.5 140.94 52.5 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.657 0.265 . . . . 0.0 111.198 -177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.49 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 32.9 m95 -89.1 -17.91 28.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.904 0.859 . . . . 0.0 108.831 172.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -93.28 112.57 24.53 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.913 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD2' ' HG ' ' A' ' 40' ' ' LEU . 10.1 t70 -56.99 129.09 78.39 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.367 -177.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -84.98 6.51 5.68 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.062 2.508 . . . . 0.0 113.654 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -97.57 -56.75 2.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.806 0.336 . . . . 0.0 110.764 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' HG ' ' OD2' ' A' ' 37' ' ' ASP . 1.9 mt -82.07 -45.27 15.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.462 -176.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 14.9 mttt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.402 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.34 123.28 80.18 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.649 0.261 . . . . 0.0 110.884 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -57.53 114.45 1.95 Allowed 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.769 2.313 . . . . 0.0 111.753 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.1 -87.74 0.14 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mt 55.26 67.18 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.516 0.674 . . . . 0.0 110.375 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.568 ' HB3' HH12 ' A' ' 39' ' ' ARG . 4.9 mt-30 -106.39 91.81 3.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.04 -176.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.53 140.87 46.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.819 174.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 76.0 159.88 0.22 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.542 0.687 . . . . 0.0 110.755 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.524 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -81.33 169.54 18.67 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.321 176.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HD2' ' CD1' ' A' ' 13' ' ' TRP . 21.3 Cg_exo -67.05 160.45 47.26 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.152 2.568 . . . . 0.0 111.659 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.08 -15.7 41.12 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.911 2.407 . . . . 0.0 113.136 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.98 -5.3 83.65 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.712 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.467 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 65.1 m95 -104.77 135.91 45.26 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.906 0.353 . . . . 0.0 110.665 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -128.08 112.46 14.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.76 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.462 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.58 122.28 26.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.22 0.533 . . . . 0.0 110.288 175.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 24' ' ' PHE . 17.5 mtt180 -124.54 153.65 41.79 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.42 112.88 41.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-O 121.061 0.457 . . . . 0.0 110.7 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.64 158.64 65.32 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.481 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.15 -10.89 6.76 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.171 2.58 . . . . 0.0 112.405 175.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -65.28 -26.97 68.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.235 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.62 57.11 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.75 121.44 44.09 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.865 -176.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.87 116.94 3.36 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.728 2.285 . . . . 0.0 111.778 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.516 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 32.8 p90 -111.91 140.16 46.8 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 42.9 m-85 -103.33 110.14 22.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.679 0.752 . . . . 0.0 110.136 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.466 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -92.99 117.65 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.591 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -84.21 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.638 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -100.49 11.09 40.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.898 -177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -93.18 -45.54 7.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 42.4 p -121.31 -0.9 9.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.364 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 64.53 63.26 0.75 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.972 176.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.78 144.64 49.05 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.578 175.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.466 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -111.7 103.32 11.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.237 -179.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -123.05 150.67 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 1.0 OUTLIER -95.41 -2.82 48.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 174.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.79 102.83 15.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.67 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.541 ' HB3' ' HG ' ' A' ' 40' ' ' LEU . 5.0 t0 -55.95 120.43 33.6 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.422 175.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.34 -11.78 29.81 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.891 2.394 . . . . 0.0 112.921 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.568 HH12 ' HB3' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -89.56 -2.79 58.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.925 0.393 . . . . 0.0 110.5 177.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' A' ' 37' ' ' ASP . 67.2 mt -80.34 -14.16 58.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.399 178.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.292 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.47 -52.34 70.37 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.652 0.226 . . . . 0.0 111.252 174.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.45 148.08 42.32 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.597 1.532 . . . . 0.0 111.756 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.06 -156.73 18.66 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.354 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 mm -73.85 104.1 2.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.353 0.597 . . . . 0.0 110.938 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.449 HE21 ' HB2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -144.18 111.34 5.86 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.642 177.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.23 113.4 17.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.026 0.441 . . . . 0.0 111.081 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -102.26 -122.89 0.18 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.718 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER -138.36 159.87 66.14 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.5 152.35 77.91 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.531 2.154 . . . . 0.0 111.418 175.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -49.48 118.16 3.48 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.783 2.322 . . . . 0.0 112.495 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.74 -22.75 7.22 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.678 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 78.0 m95 -83.7 130.85 34.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.1 0.476 . . . . 0.0 111.483 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB3' HG22 ' A' ' 26' ' ' ILE . 4.1 tt0 -128.38 115.2 17.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.563 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.526 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -97.68 135.06 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.344 0.592 . . . . 0.0 111.688 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -136.95 142.29 42.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.483 -0.78 . . . . 0.0 108.962 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -92.44 114.35 29.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.209 -175.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.45 149.27 60.91 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.092 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.28 -6.39 9.9 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.231 2.621 . . . . 0.0 114.675 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -7.77 59.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.52 3.83 52.96 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -107.29 111.96 62.99 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.636 0.255 . . . . 0.0 111.06 -178.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.595 ' HA ' ' HA ' ' A' ' 17' ' ' ILE . 24.1 Cg_exo -65.64 120.48 7.67 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.121 1.881 . . . . 0.0 110.283 167.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 17.4 p90 -105.06 138.92 40.52 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 16.4 m-85 -109.41 109.76 20.71 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.066 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.483 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -93.35 120.85 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.943 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.58 119.27 29.85 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -84.53 -6.16 59.35 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.382 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.63 -55.78 5.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 110.137 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -90.58 -9.91 45.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.716 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 mttm 61.97 53.35 3.07 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.994 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.39 150.38 50.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.876 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.483 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -107.84 114.82 29.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.967 -179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.1 155.97 25.02 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.548 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 99.6 m95 -90.11 -74.34 0.49 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.874 0.845 . . . . 0.0 110.016 176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 6.4 mt-10 -70.47 129.18 38.55 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.18 -172.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -61.37 149.92 81.78 Favored Pre-proline 0 N--CA 1.442 -0.837 0 CA-C-O 121.312 0.577 . . . . 0.0 112.191 -171.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -82.98 15.37 2.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.997 2.465 . . . . 0.0 111.78 -178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -91.6 -19.89 22.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.997 177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -35.19 14.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.158 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.5 pttm . . . . . 0 C--O 1.244 0.798 0 CA-C-O 118.064 -0.969 . . . . 0.0 109.618 179.851 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.604 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -56.39 126.38 68.85 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 2' ' ' SER . 2.2 Cg_endo -82.86 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.166 2.577 . . . . 0.0 111.466 175.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.84 97.09 1.83 Allowed Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.82 69.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.259 0.552 . . . . 0.0 111.65 -177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.02 53.73 1.97 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.697 175.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.37 103.9 11.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.417 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.13 -88.44 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.013 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 13' ' ' TRP . 0.3 OUTLIER -109.85 165.83 11.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.99 142.06 93.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.172 1.915 . . . . 0.0 111.464 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.29 112.91 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.776 2.317 . . . . 0.0 111.729 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.43 -24.74 4.37 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 9' ' ' LEU . 68.4 m95 -86.96 125.36 34.01 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.817 0.342 . . . . 0.0 110.533 176.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -117.61 112.83 21.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' A' ' 15' ' ' MET . 0.0 OUTLIER -76.02 118.27 18.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.19 175.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.8 mtp85 -121.81 134.83 54.91 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mm -88.77 114.47 27.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.158 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.7 150.98 73.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.24 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.93 1.82 2.1 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.279 2.653 . . . . 0.0 114.412 -173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -13.75 41.48 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.96 8.1 37.18 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.136 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.99 117.78 54.32 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.878 -0.19 . . . . 0.0 111.402 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -60.0 121.23 9.47 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.517 2.145 . . . . 0.0 111.043 166.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.516 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 21.9 p90 -117.98 136.16 53.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -101.2 113.17 25.96 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.61 0.719 . . . . 0.0 110.154 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.34 116.99 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 124.35 27.87 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.121 178.13 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -92.93 5.41 51.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.518 -175.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -92.01 -52.84 4.52 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.5 p -112.02 0.83 16.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.141 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER 62.04 70.48 0.58 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.531 176.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.91 150.37 46.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.343 175.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.03 108.04 12.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.66 0.267 . . . . 0.0 111.056 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.5 t -124.2 143.95 50.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.723 0.297 . . . . 0.0 110.743 178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.516 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 6.6 m95 -89.65 -21.69 22.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.773 0.797 . . . . 0.0 109.517 175.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 28.8 mm-40 -83.05 113.57 20.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.374 -176.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.77 120.38 41.3 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.129 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.14 9.47 1.41 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.02 2.48 . . . . 0.0 113.931 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -43.46 6.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mt -86.17 -24.1 26.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HG3' ' HB3' ' A' ' 36' ' ' GLU . 2.0 mmtm . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.183 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -54.51 34.69 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_exo -57.29 -35.94 98.92 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.078 1.852 . . . . 0.0 112.519 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.63 25.85 73.06 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.874 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mm -114.32 40.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.499 0.666 . . . . 0.0 110.907 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -29.7 41.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 172.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.06 127.55 46.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.122 173.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -115.47 -165.23 1.01 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.69 158.07 33.18 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -60.96 138.09 76.44 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.977 2.452 . . . . 0.0 112.072 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -47.5 111.56 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.759 2.306 . . . . 0.0 111.599 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.38 -27.35 4.0 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -172.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -84.16 101.57 11.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 173.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' HG2' ' HD2' ' A' ' 16' ' ' ARG . 2.7 tt0 -98.6 104.48 16.53 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.323 -174.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.641 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -79.65 119.03 22.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.0 109.866 174.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.549 ' HD2' ' HG2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -124.36 139.66 53.69 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 mm -88.72 104.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.877 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.17 156.11 92.23 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.391 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.49 -3.01 2.94 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.208 2.605 . . . . 0.0 113.046 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.528 ' HB2' ' HG2' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -78.33 -17.19 56.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.277 0.561 . . . . 0.0 109.534 172.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.34 1.55 55.68 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.943 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HG2' ' HB2' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -108.57 129.35 24.11 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.66 -0.27 . . . . 0.0 110.926 -175.267 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.8 121.74 9.57 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.789 2.326 . . . . 0.0 111.412 168.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.584 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 24.1 p90 -119.51 141.04 49.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.162 0.506 . . . . 0.0 109.948 176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.3 m-85 -106.24 112.63 25.74 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.988 -175.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.501 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.23 112.82 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.27 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.653 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -79.97 113.94 18.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.418 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -81.94 13.29 3.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.371 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -97.42 -57.69 2.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.23 0.538 . . . . 0.0 109.899 177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.4 p -93.5 -14.39 26.71 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.5 179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.8 mttt 71.95 37.49 1.02 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.305 178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -107.73 154.27 21.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.768 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.501 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -119.41 116.12 25.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.715 -175.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.1 t -123.59 141.43 52.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.584 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -92.23 -10.55 38.19 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.884 0.849 . . . . 0.0 109.221 174.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.93 112.2 20.37 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.554 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.525 ' HA ' ' CE2' ' A' ' 25' ' ' PHE . 33.1 t0 -62.45 112.57 6.74 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.32 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.86 -9.64 26.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.908 2.405 . . . . 0.0 112.871 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 39' ' ' ARG . 18.7 mtm180 -74.98 -16.18 60.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.128 0.489 . . . . 0.0 109.899 175.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 12.0 mt -87.9 -10.78 49.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 173.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.149 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.611 -0.196 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.12 -56.27 21.32 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.61 0.205 . . . . 0.0 111.463 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -86.54 0.25 7.98 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.967 1.778 . . . . 0.0 111.79 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.31 115.18 2.4 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.187 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.11 139.57 30.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.849 0.357 . . . . 0.0 110.166 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.87 86.21 6.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.609 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.42 116.44 13.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.754 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.581 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -57.97 -63.96 1.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.337 178.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.54 173.07 4.81 Favored Pre-proline 0 C--N 1.32 -0.675 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 34.9 Cg_exo -60.39 147.95 92.2 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 121.733 1.622 . . . . 0.0 110.249 172.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 10' ' ' PRO . 45.4 Cg_exo -58.47 -10.92 9.81 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 122.802 2.334 . . . . 0.0 113.606 -175.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.07 1.24 80.0 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.509 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.496 ' HE3' ' HB3' ' A' ' 25' ' ' PHE . 37.9 m95 -105.14 115.17 29.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.022 0.439 . . . . 0.0 110.061 178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 26' ' ' ILE . 21.0 tt0 -98.47 99.73 10.93 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.707 -176.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.65 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . 1.3 ptp -79.63 92.92 5.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.434 0.635 . . . . 0.0 110.455 176.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 16' ' ' ARG . 44.5 mtt-85 -85.71 128.55 34.82 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.031 177.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 mm -88.03 102.12 12.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.185 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.78 146.02 90.24 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.696 176.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.27 -5.62 5.47 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.842 2.361 . . . . 0.0 112.502 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -68.18 -17.05 64.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 0.0 109.874 172.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.76 60.05 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.037 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -107.94 110.3 62.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.571 -0.315 . . . . 0.0 110.925 -177.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.0 117.65 4.38 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.338 2.025 . . . . 0.0 110.861 167.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.561 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.9 p90 -111.6 127.53 55.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.727 0.775 . . . . 0.0 109.862 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CD1' ' HB3' ' A' ' 15' ' ' MET . 14.9 m-85 -93.58 103.94 16.09 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.463 -172.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.618 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -95.22 109.09 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.455 176.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.9 127.29 32.15 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.247 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -100.18 12.0 38.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.905 0.383 . . . . 0.0 111.023 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -100.42 -51.02 3.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.021 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.5 p -111.67 4.6 18.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.905 -179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.0 64.88 1.19 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.366 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.74 144.53 48.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.766 174.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.618 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.1 OUTLIER -122.37 101.77 7.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.403 178.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -125.03 147.7 48.83 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.769 0.318 . . . . 0.0 111.566 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.561 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 13.3 m95 -89.78 -17.78 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.768 0.794 . . . . 0.0 109.101 172.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.85 114.55 21.24 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.486 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -64.45 120.8 68.42 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.979 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.05 10.19 3.28 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.161 2.574 . . . . 0.0 113.767 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.581 ' HD3' ' O ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -102.65 -43.8 5.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 mt -73.49 -38.77 65.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.111 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mtpt . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.53 -0.747 . . . . 0.0 110.077 178.189 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.843 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.04 110.8 56.49 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.877 0.37 . . . . 0.0 110.833 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.04 -16.81 13.96 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.568 2.179 . . . . 0.0 112.341 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.02 98.72 0.51 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.973 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.7 mm -76.65 86.44 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.8 0.333 . . . . 0.0 110.488 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 70.36 -0.02 3.02 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.543 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.67 ' HB2' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.35 84.99 7.3 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.47 0.652 . . . . 0.0 110.627 179.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -99.07 -172.94 2.37 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.853 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.89 163.62 49.92 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.885 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.88 148.31 89.81 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.522 2.148 . . . . 0.0 111.52 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.65 119.58 5.36 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.844 2.363 . . . . 0.0 112.093 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 122.47 -24.37 6.89 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.914 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -83.86 125.99 32.53 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.129 0.49 . . . . 0.0 110.918 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -127.07 122.12 33.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.494 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.631 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 1.9 ptt? -89.26 124.03 34.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.165 0.507 . . . . 0.0 110.437 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -128.55 143.85 51.04 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.92 125.04 42.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.073 0.463 . . . . 0.0 110.597 -178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 19' ' ' PRO . . . -89.43 165.09 27.34 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.345 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 21.6 Cg_endo -60.88 -15.0 35.57 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.357 2.705 . . . . 0.0 113.928 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -2.13 56.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.969 0.414 . . . . 0.0 110.008 177.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.93 20.66 60.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.057 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.445 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . 9.5 mmm180 -107.8 120.94 45.6 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.82 -0.224 . . . . 0.0 110.435 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -62.45 113.64 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.048 1.832 . . . . 0.0 111.061 166.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.46 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 27.7 p90 -112.45 138.45 49.19 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.455 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 15' ' ' MET . 7.2 m-85 -103.58 114.47 28.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.885 -174.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.3 112.68 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.53 -178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.2 120.41 22.23 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.348 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -89.81 -1.51 58.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.436 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.19 -57.63 3.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.174 0.511 . . . . 0.0 109.984 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.2 p -113.23 6.87 17.61 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.978 -176.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.04 67.95 0.65 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.59 176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.89 149.5 42.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.444 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.05 108.23 11.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.782 0.325 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -124.19 148.53 47.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.335 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.46 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 38.9 m95 -91.26 -15.46 29.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.611 0.719 . . . . 0.0 110.153 177.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.19 107.88 19.04 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.863 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -58.38 146.26 72.47 Favored Pre-proline 0 N--CA 1.442 -0.835 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.708 -175.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.14 11.8 2.9 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.79 2.326 . . . . 0.0 112.268 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.67 ' HD2' ' HB2' ' A' ' 7' ' ' SER . 1.6 ptt180 -103.13 -7.35 21.36 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.353 0.597 . . . . 0.0 109.726 175.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 33.5 mt -92.97 -47.36 7.04 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.699 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.813 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.56 162.36 67.66 Favored Pre-proline 0 C--N 1.324 -0.507 0 C-N-CA 122.181 0.193 . . . . 0.0 110.634 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.3 59.92 1.42 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.883 2.389 . . . . 0.0 111.479 173.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 148.44 136.21 2.68 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -175.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.2 mt -81.32 58.03 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 117.634 0.717 . . . . 0.0 111.419 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -174.24 -172.27 0.68 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.806 176.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -80.72 157.26 25.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.14 13.82 2.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.268 0.556 . . . . 0.0 111.993 -177.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 39' ' ' ARG . 0.1 OUTLIER -103.61 169.48 7.31 Favored Pre-proline 0 C--N 1.315 -0.925 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.534 175.645 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.24 150.66 39.33 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 121.997 1.798 . . . . 0.0 111.212 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.38 -27.92 25.61 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.299 2.666 . . . . 0.0 113.7 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.82 -13.41 83.46 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.22 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.413 ' CE3' ' HG3' ' A' ' 38' ' ' PRO . 80.5 m95 -92.84 121.42 34.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.976 -177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.445 ' O ' HG22 ' A' ' 26' ' ' ILE . 3.5 tt0 -118.52 105.58 11.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.447 -178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.51 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.3 ptp -83.19 128.73 34.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.258 0.551 . . . . 0.0 110.731 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.85 152.35 48.61 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.71 111.61 32.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.089 0.471 . . . . 0.0 110.328 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.83 155.81 82.87 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.689 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.64 -7.75 7.88 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.391 2.727 . . . . 0.0 112.285 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -70.4 -21.54 62.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.6 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.73 -0.14 59.3 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.82 120.64 46.52 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.703 -177.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.03 126.8 23.35 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.723 2.282 . . . . 0.0 111.208 169.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.421 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 15.1 p90 -121.07 136.67 54.93 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.508 0.67 . . . . 0.0 109.952 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CD2' ' HB3' ' A' ' 15' ' ' MET . 20.3 m-85 -104.78 114.41 28.61 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.531 -176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.573 ' CG1' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER -98.05 118.8 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.723 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -87.64 119.97 28.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.197 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -85.12 -3.84 58.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.855 0.36 . . . . 0.0 110.905 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -80.56 -57.29 3.65 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 109.609 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p -90.35 -12.75 36.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.488 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 mttm 60.92 55.07 3.25 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -176.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.09 152.88 48.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.366 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.573 HG23 ' CG1' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -117.74 116.39 26.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.947 -178.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.7 t -123.21 145.26 48.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.499 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.421 ' CE3' ' HB3' ' A' ' 24' ' ' PHE . 7.4 m95 -89.66 -20.05 24.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.739 0.781 . . . . 0.0 109.411 176.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -82.8 110.16 17.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.911 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -49.82 120.77 11.68 Favored Pre-proline 0 C--N 1.331 -0.209 0 O-C-N 124.012 0.82 . . . . 0.0 111.738 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HG3' ' CE3' ' A' ' 13' ' ' TRP . 29.9 Cg_endo -64.05 -12.65 33.33 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.113 2.542 . . . . 0.0 113.049 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.429 ' HG2' HD23 ' A' ' 9' ' ' LEU . 1.7 mmp_? -74.79 -12.05 60.3 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.836 0.35 . . . . 0.0 110.365 174.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' C ' ' HG3' ' A' ' 41' ' ' LYS . 14.2 mt -88.58 -31.74 18.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.837 173.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HG3' ' C ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.121 0 C-N-CA 124.602 1.161 . . . . 0.0 112.719 179.288 . . . . . . . . 2 2 . 1 stop_ save_